UNITED STATES SECURITIES AND
    EXCHANGE COMMISSION
    Washington, D.C.
    20549
 
 
 
 
    Form 10-Q
 
 
 
 
    |  |  |  | 
| (Mark One) |  |  | 
|  | 
| 
    þ
 |  | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)  OF THE
    SECURITIES EXCHANGE ACT OF 1934 | 
|  |  | For the quarterly period ended March 31, 2008 | 
| 
    OR
 | 
| 
    o
 |  | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
    SECURITIES EXCHANGE ACT OF 1934 | 
|  |  | For the transition period
    from          to | 
 
    Commission file
    number: 1-32381
 
 
 
 
    HERBALIFE
    LTD.
    (Exact
    name of registrant as specified in its charter)
 
    |  |  |  | 
| Cayman Islands |  | 98-0377871 | 
| (State or other jurisdiction
    of incorporation or organization)
 |  | (I.R.S. Employer Identification No.)
 | 
 
    P.O. Box 309GT
    Ugland House, South Church Street
    Grand Cayman, Cayman Islands 
    (Address
    of principal executive offices) (Zip code)
    (310)
    410-9600
    (Registrants telephone
    number, including area code)
 
    Indicate by check mark whether the registrant (1) has filed
    all reports required to be filed by Section 13 or 15(d) of
    the Securities Exchange Act of 1934 during the preceding
    12 months (or for such shorter period that the registrant
    was required to file such reports), and (2) has been
    subject to such filing requirements for the past
    90 days.  Yes þ     No o
    
 
    Indicate by check mark whether the registrant is a large
    accelerated filer, an accelerated filer, a non-accelerated
    filer, or a smaller reporting company. See the definitions of
    large accelerated filer, accelerated
    filer, and smaller reporting company in
    Rule 12b-2
    of the Exchange Act. (Check one):
 
    |  |  |  |  |  |  |  | 
| 
    Large accelerated
    filer þ
    
 |  | Accelerated
    filer o |  | Non-accelerated
    filer o |  | Smaller reporting
    company o | 
| 
                   (Do
    not check if a smaller reporting company)
 | 
 
    Indicate by check mark whether the registrant is a shell company
    (as defined in
    Rule 12b-2
    of the Exchange
    Act).  Yes o     No þ
    
 
    Number of shares of registrants common shares outstanding
    as of April 28, 2008 was 65,114,740.
 
 
 
 
    PART I.
    FINANCIAL INFORMATION
 
    |  |  | 
    | Item 1. | FINANCIAL
    STATEMENTS | 
 
    HERBALIFE
    LTD.
    
 
    CONSOLIDATED
    BALANCE SHEETS
 
    |  |  |  |  |  |  |  |  |  | 
|  |  | March 31, 
 |  |  | December 31, 
 |  | 
|  |  | 2008 |  |  | 2007 |  | 
|  |  | (Unaudited) |  |  |  |  | 
|  |  | (In thousands, except share amounts) |  | 
|  | 
| 
    ASSETS
 | 
| 
    CURRENT ASSETS:
 |  |  |  |  |  |  |  |  | 
| 
    Cash and cash equivalents
 |  | $ | 191,146 |  |  | $ | 187,407 |  | 
| 
    Receivables, net of allowance for doubtful accounts of $7,963
    (2008) and $7,863 (2007)
 |  |  | 74,105 |  |  |  | 58,729 |  | 
| 
    Inventories, net
 |  |  | 126,512 |  |  |  | 128,648 |  | 
| 
    Prepaid expenses and other current assets
 |  |  | 89,727 |  |  |  | 72,193 |  | 
| 
    Deferred income taxes
 |  |  | 41,366 |  |  |  | 40,119 |  | 
|  |  |  |  |  |  |  |  |  | 
| 
    Total current assets
 |  |  | 522,856 |  |  |  | 487,096 |  | 
|  |  |  |  |  |  |  |  |  | 
| 
    Property, at cost, net of accumulated depreciation and
    amortization of $77,821 (2008) and $66,000 (2007)
 |  |  | 135,724 |  |  |  | 121,027 |  | 
| 
    Deferred compensation plan assets
 |  |  | 18,986 |  |  |  | 19,315 |  | 
| 
    Deferred financing costs, net of accumulated amortization of
    $925 (2008) and $807 (2007)
 |  |  | 2,352 |  |  |  | 2,395 |  | 
| 
    Marketing related intangibles
 |  |  | 310,060 |  |  |  | 310,060 |  | 
| 
    Goodwill
 |  |  | 111,481 |  |  |  | 111,477 |  | 
| 
    Other assets
 |  |  | 16,439 |  |  |  | 15,873 |  | 
|  |  |  |  |  |  |  |  |  | 
| 
    Total assets
 |  | $ | 1,117,898 |  |  | $ | 1,067,243 |  | 
|  |  |  |  |  |  |  |  |  | 
|  | 
| LIABILITIES AND SHAREHOLDERS EQUITY | 
| 
    CURRENT LIABILITIES:
 |  |  |  |  |  |  |  |  | 
| 
    Accounts payable
 |  | $ | 33,131 |  |  | $ | 35,377 |  | 
| 
    Royalty overrides
 |  |  | 126,654 |  |  |  | 127,227 |  | 
| 
    Accrued compensation
 |  |  | 47,309 |  |  |  | 54,067 |  | 
| 
    Accrued expenses
 |  |  | 136,445 |  |  |  | 114,083 |  | 
| 
    Current portion of long-term debt
 |  |  | 3,856 |  |  |  | 4,661 |  | 
| 
    Advance sales deposits
 |  |  | 18,424 |  |  |  | 11,599 |  | 
| 
    Income taxes payable
 |  |  | 30,035 |  |  |  | 28,604 |  | 
|  |  |  |  |  |  |  |  |  | 
| 
    Total current liabilities
 |  |  | 395,854 |  |  |  | 375,618 |  | 
|  |  |  |  |  |  |  |  |  | 
| 
    NON-CURRENT LIABILITIES:
 |  |  |  |  |  |  |  |  | 
| 
    Long-term debt, net of current portion
 |  |  | 329,855 |  |  |  | 360,491 |  | 
| 
    Deferred compensation
 |  |  | 19,978 |  |  |  | 20,233 |  | 
| 
    Deferred income taxes
 |  |  | 108,087 |  |  |  | 107,584 |  | 
| 
    Other non-current liabilities
 |  |  | 21,177 |  |  |  | 21,073 |  | 
|  |  |  |  |  |  |  |  |  | 
| 
    Total liabilities
 |  |  | 874,951 |  |  |  | 884,999 |  | 
|  |  |  |  |  |  |  |  |  | 
| 
    COMMITMENTS AND CONTINGENCIES
 |  |  |  |  |  |  |  |  | 
|  |  |  |  |  |  |  |  |  | 
| 
    SHAREHOLDERS EQUITY:
 |  |  |  |  |  |  |  |  | 
| 
    Common shares, $0.002 par value, 500.0 million shares
    authorized, 65.0 million (2008) and 64.4 million
    (2007) shares issued and outstanding
 |  |  | 130 |  |  |  | 129 |  | 
| 
    Paid-in-capital
    in excess of par value
 |  |  | 188,582 |  |  |  | 160,872 |  | 
| 
    Accumulated other comprehensive loss
 |  |  | (3,909 | ) |  |  | (3,947 | ) | 
| 
    Retained earnings
 |  |  | 58,144 |  |  |  | 25,190 |  | 
|  |  |  |  |  |  |  |  |  | 
| 
    Total shareholders equity
 |  |  | 242,947 |  |  |  | 182,244 |  | 
|  |  |  |  |  |  |  |  |  | 
| 
    Total liabilities and shareholders equity
 |  | $ | 1,117,898 |  |  | $ | 1,067,243 |  | 
|  |  |  |  |  |  |  |  |  | 
 
    See the accompanying notes to consolidated financial statements
    
    3
 
 
    HERBALIFE
    LTD.
    
 
    CONSOLIDATED
    STATEMENTS OF INCOME
 
    |  |  |  |  |  |  |  |  |  | 
|  |  | Three Months Ended |  | 
|  |  | March 31, 
 |  |  | March 31, 
 |  | 
|  |  | 2008 |  |  | 2007 |  | 
|  |  | (Unaudited) 
 |  | 
|  |  | (In thousands, except per share amounts) |  | 
|  | 
| 
    Product sales
 |  | $ | 520,726 |  |  | $ | 437,993 |  | 
| 
    Handling & freight income
 |  |  | 83,711 |  |  |  | 70,106 |  | 
|  |  |  |  |  |  |  |  |  | 
| 
    Net sales
 |  |  | 604,437 |  |  |  | 508,099 |  | 
| 
    Cost of sales
 |  |  | 117,666 |  |  |  | 107,283 |  | 
|  |  |  |  |  |  |  |  |  | 
| 
    Gross profit
 |  |  | 486,771 |  |  |  | 400,816 |  | 
| 
    Royalty overrides
 |  |  | 212,720 |  |  |  | 180,260 |  | 
| 
    Selling, general and administrative expenses
 |  |  | 184,400 |  |  |  | 149,428 |  | 
|  |  |  |  |  |  |  |  |  | 
| 
    Operating income
 |  |  | 89,651 |  |  |  | 71,128 |  | 
| 
    Interest expense, net
 |  |  | 3,791 |  |  |  | 2,204 |  | 
|  |  |  |  |  |  |  |  |  | 
| 
    Income before income taxes
 |  |  | 85,860 |  |  |  | 68,924 |  | 
| 
    Income taxes
 |  |  | 23,493 |  |  |  | 27,744 |  | 
|  |  |  |  |  |  |  |  |  | 
| 
    NET INCOME
 |  | $ | 62,367 |  |  | $ | 41,180 |  | 
|  |  |  |  |  |  |  |  |  | 
| 
    Earnings per share:
 |  |  |  |  |  |  |  |  | 
| 
    Basic
 |  | $ | 0.97 |  |  | $ | 0.57 |  | 
| 
    Diluted
 |  | $ | 0.93 |  |  | $ | 0.55 |  | 
| 
    Weighted average shares outstanding:
 |  |  |  |  |  |  |  |  | 
| 
    Basic
 |  |  | 64,381 |  |  |  | 71,722 |  | 
| 
    Diluted
 |  |  | 67,200 |  |  |  | 74,943 |  | 
 
    See the accompanying notes to consolidated financial statements
    
    4
 
 
    HERBALIFE,
    LTD.
    
 
    CONSOLIDATED
    STATEMENTS OF CASH FLOWS
 
    |  |  |  |  |  |  |  |  |  | 
|  |  | Three Months Ended |  | 
|  |  | March 31, 
 |  |  | March 31, 
 |  | 
|  |  | 2008 |  |  | 2007 |  | 
|  |  | (Unaudited) 
 |  | 
|  |  | (In thousands) |  | 
|  | 
| 
    CASH FLOWS FROM OPERATING ACTIVITIES:
 |  |  |  |  |  |  |  |  | 
| 
    Net income
 |  | $ | 62,367 |  |  | $ | 41,180 |  | 
| 
    Adjustments to reconcile net income to net cash provided by
    operating activities:
 |  |  |  |  |  |  |  |  | 
| 
    Depreciation and amortization
 |  |  | 10,371 |  |  |  | 8,263 |  | 
| 
    Stock-based compensation expense
 |  |  | 5,133 |  |  |  | 3,482 |  | 
| 
    Excess tax benefits from share-based payment arrangements
 |  |  | (10,709 | ) |  |  | (1,321 | ) | 
| 
    Amortization of discount and deferred financing costs
 |  |  | 118 |  |  |  | 76 |  | 
| 
    Deferred income taxes
 |  |  | (92 | ) |  |  | 3,951 |  | 
| 
    Unrealized foreign exchange loss
 |  |  | 1,926 |  |  |  | 2,474 |  | 
| 
    Write-off of deferred financing costs and unamortized discounts
 |  |  |  |  |  |  | 204 |  | 
| 
    Other
 |  |  | 556 |  |  |  | 887 |  | 
| 
    Changes in operating assets and liabilities:
 |  |  |  |  |  |  |  |  | 
| 
    Receivables
 |  |  | (13,843 | ) |  |  | 3,025 |  | 
| 
    Inventories
 |  |  | 7,734 |  |  |  | 15,174 |  | 
| 
    Prepaid expenses and other current assets
 |  |  | (16,482 | ) |  |  | (10,312 | ) | 
| 
    Other assets
 |  |  | (77 | ) |  |  | (103 | ) | 
| 
    Accounts payable
 |  |  | (3,182 | ) |  |  | (13,441 | ) | 
| 
    Royalty overrides
 |  |  | (4,156 | ) |  |  | (12,858 | ) | 
| 
    Accrued expenses and accrued compensation
 |  |  | 4,965 |  |  |  | (14,254 | ) | 
| 
    Advance sales deposits
 |  |  | 6,242 |  |  |  | (4,350 | ) | 
| 
    Income taxes payable
 |  |  | 12,184 |  |  |  | 23,860 |  | 
| 
    Deferred compensation liability
 |  |  | (255 | ) |  |  | 163 |  | 
|  |  |  |  |  |  |  |  |  | 
| 
    NET CASH PROVIDED BY OPERATING ACTIVITIES
 |  | $ | 62,800 |  |  | $ | 46,100 |  | 
|  |  |  |  |  |  |  |  |  | 
| 
    CASH FLOWS FROM INVESTING ACTIVITIES:
 |  |  |  |  |  |  |  |  | 
| 
    Purchases of property
 |  |  | (23,931 | ) |  |  | (9,060 | ) | 
| 
    Proceeds from sale of property
 |  |  |  |  |  |  | 36 |  | 
| 
    Deferred compensation plan assets
 |  |  | 330 |  |  |  | (395 | ) | 
|  |  |  |  |  |  |  |  |  | 
| 
    NET CASH USED IN INVESTING ACTIVITIES
 |  | $ | (23,601 | ) |  | $ | (9,419 | ) | 
|  |  |  |  |  |  |  |  |  | 
| 
    CASH FLOWS FROM FINANCING ACTIVITIES:
 |  |  |  |  |  |  |  |  | 
| 
    Principal payments on long-term debt
 |  |  | (32,099 | ) |  |  | (31,301 | ) | 
| 
    Dividends paid
 |  |  | (12,869 | ) |  |  |  |  | 
| 
    Increase in deferred financing costs
 |  |  | (75 | ) |  |  |  |  | 
| 
    Share repurchases
 |  |  | (17,668 | ) |  |  |  |  | 
| 
    Proceeds from stock options exercised
 |  |  | 12,553 |  |  |  | 976 |  | 
| 
    Excess tax benefits from share-based payment arrangements
 |  |  | 10,709 |  |  |  | 1,321 |  | 
|  |  |  |  |  |  |  |  |  | 
| 
    NET CASH USED IN FINANCING ACTIVITIES
 |  | $ | (39,449 | ) |  | $ | (29,004 | ) | 
|  |  |  |  |  |  |  |  |  | 
| 
    EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS
 |  |  | 3,989 |  |  |  | 207 |  | 
|  |  |  |  |  |  |  |  |  | 
| 
    NET CHANGE IN CASH AND CASH EQUIVALENTS
 |  |  | 3,739 |  |  |  | 7,884 |  | 
| 
    CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD
 |  |  | 187,407 |  |  |  | 154,323 |  | 
|  |  |  |  |  |  |  |  |  | 
| 
    CASH AND CASH EQUIVALENTS, END OF PERIOD
 |  | $ | 191,146 |  |  | $ | 162,207 |  | 
|  |  |  |  |  |  |  |  |  | 
| 
    CASH PAID FOR:
 |  |  |  |  |  |  |  |  | 
| 
    Interest
 |  | $ | 4,976 |  |  | $ | 3,270 |  | 
|  |  |  |  |  |  |  |  |  | 
| 
    Income taxes
 |  | $ | 11,411 |  |  | $ | 7,737 |  | 
|  |  |  |  |  |  |  |  |  | 
| 
    NON-CASH ACTIVITIES:
 |  |  |  |  |  |  |  |  | 
| 
    Acquisitions of property through capital leases
 |  | $ | 657 |  |  | $ | 47 |  | 
|  |  |  |  |  |  |  |  |  | 
 
    See the accompanying notes to consolidated financial statements
    
    5
 
 
    HERBALIFE
    LTD.
    
 
    NOTES TO
    CONSOLIDATED FINANCIAL STATEMENTS
    
    (Unaudited)
 
 
    Herbalife Ltd. (and together with its subsidiaries,
    Herbalife or the Company) is a leading
    global network marketing company that sells weight management,
    nutritional supplements, energy & fitness products and
    personal care products through a network of over
    1.8 million independent distributors, except in China,
    where the Company currently sells its products through retail
    stores and an employed sales force. The Company reports revenue
    in five geographic regions: North America, which consists of the
    U.S., Canada and Jamaica; Mexico and Central America, which
    consists of Mexico, Costa Rica, El Salvador, Panama and
    Dominican Republic; South America, which includes Brazil; EMEA,
    which includes Europe, the Middle East and Africa; and Asia
    Pacific, which includes Asia, New Zealand and Australia.
 
 
    The unaudited interim financial information of the Company has
    been prepared in accordance with Article 10 of the
    Securities and Exchange Commissions
    Regulation S-X.
    Accordingly, it does not include all of the information required
    by generally accepted accounting principles, or GAAP, in the
    U.S. for complete financial statements. The Companys
    unaudited consolidated financial statements as of March 31,
    2008, and for the three months ended March 31, 2008 and
    2007, include Herbalife and all of its direct and indirect
    subsidiaries. In the opinion of management, the accompanying
    financial information contains all adjustments, consisting of
    normal recurring adjustments, necessary to present fairly the
    Companys unaudited consolidated financial statements as of
    March 31, 2008, and for the three months ended
    March 31, 2008 and 2007. These unaudited consolidated
    financial statements should be read in conjunction with
    Companys Annual Report on
    Form 10-K
    for the year ended December 31, 2007. Operating results for
    the three months ended March 31, 2008 are not necessarily
    indicative of the results that may be expected for the year
    ending December 31, 2008.
 
    New
    Accounting Pronouncements
 
    In March 2008, the Financial Accounting Standards Board, or
    FASB, issued Statement of Financial Accounting Standards, or
    SFAS, No. 161, Disclosures about Derivative Instruments
    and Hedging Activities  An Amendment of FASB
    Statement No. 133, or SFAS 161. SFAS 161
    expands the disclosure requirements for derivative instruments
    and hedging activities. This Statement specifically requires
    entities to provide enhanced disclosures addressing the
    following: (a) how and why an entity uses derivative
    instruments, (b) how derivative instruments and related
    hedged items are accounted for under Statement 133 and its
    related interpretations, and (c) how derivative instruments
    and related hedged items affect an entitys financial
    position, financial performance, and cash flows. SFAS 161
    is effective for fiscal years and interim periods beginning
    after November 15, 2008. The Company is currently
    evaluating the potential impact, if any, of the adoption of
    SFAS 161 on the Companys consolidated financial
    statements.
 
    In February 2008, the FASB issued FASB Staff Position
    FAS 157-2,
    or FSP
    FAS 157-2.
    FSP
    FAS 157-2
    will delay the effective date of SFAS 157, Fair Value
    Measurement, or SFAS 157, for all nonfinancial assets
    and nonfinancial liabilities, except those that are recognized
    or disclosed at fair value in the financial statements on a
    recurring basis (at least annually). FSP
    FAS 157-2
    partially defers the effective date of SFAS 157 to fiscal
    years beginning after November 15, 2008, and interim
    periods within those fiscal years for items within the scope of
    FSP 157-2.
    The Company is currently evaluating the potential impact, if
    any, of the application of FSP
    FAS 157-2
    to its nonfinancial assets and nonfinancial liabilities on its
    consolidated financial statements.
 
    In December 2007, the FASB issued SFAS No. 141
    (revised 2007), Business Combinations, or SFAS 141R,
    which replaces FASB Statement No. 141. SFAS 141R
    establishes principles and requirements for how an acquirer
    recognizes and measures in its financial statements the
    identifiable assets acquired, the liabilities assumed, any non
    controlling interest in the acquiree and the goodwill acquired.
    SFAS 141R also modifies the recognition for preacquisition
    contingencies, such as environmental or legal issues,
    restructuring plans and acquired research and development value
    in purchase accounting. SFAS 141R amends SFAS 109,
    Accounting for Income Taxes, to require the acquirer to
    recognize changes in the amount of its deferred tax benefits
    that are recognizable because of a
    
    6
 
 
    HERBALIFE
    LTD.
    
 
    NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
    
    (Unaudited)
 
    business combination either in income from continuing operations
    in the period of the combination or directly in contributed
    capital, depending on the circumstances. SFAS 141R also
    establishes disclosure requirements which will enable users to
    evaluate the nature and financial effects of the business
    combination. SFAS 141R is effective as of the beginning of
    an entitys fiscal year that begins after December 15,
    2008. The Company is currently evaluating the potential impact,
    if any, of the adoption of SFAS No. 141R on the
    Companys consolidated financial statements.
 
    Adoption
    of New Accounting Standards
 
    In September 2006, the FASB issued SFAS No. 157,which
    defines fair value, establishes a framework for measuring fair
    value in accordance with GAAP and expands disclosures about fair
    value measurements. The provisions of SFAS 157 are
    effective for fiscal years beginning after November 15,
    2007. In February 2008, the FASB issued FASB Staff Position,
    FAS 157-1,
    or FSP
    FAS 157-1.
    FSP 157-1
    amends SFAS 157 to exclude SFAS 13, Accounting for
    Leases, and its related interpretive accounting
    pronouncements that address leasing transactions. On
    January 1, 2008, the Company adopted the provisions of
    SFAS 157 related to its financial assets and liabilities,
    except as it applies to those nonfinancial assets and
    nonfinancial liabilities as noted in FSP
    FAS 157-2.
    The adoption did not have a material impact on the
    Companys consolidated financial statements.
 
    SFAS No. 157, defines fair value as the price that
    would be received to sell an asset or paid to transfer a
    liability in an orderly transaction between market participants
    at the measurement date (exit price). SFAS 157 establishes
    a fair value hierarchy, which prioritizes the inputs used in
    measuring fair value into three broad levels as follows:
 
    Level 1 inputs are quoted prices (unadjusted) in active
    markets for identical assets or liabilities that the reporting
    entity has the ability to access at the measurement date.
 
    Level 2 inputs include quoted prices for similar assets or
    liabilities in active markets, quoted prices for identical or
    similar assets or liabilities in markets that are not active,
    inputs other than quoted prices that are observable for the
    asset or liability and inputs that are derived principally from
    or corroborated by observable market data by correlation or
    other means.
 
    Level 3 inputs are unobservable inputs for the asset or
    liability.
 
    The Company measures certain assets and liabilities at fair
    value as discussed throughout the notes to its consolidated
    financial statements. Assets or liabilities that have recurring
    measurements and are measured at fair value are shown below:
 
    Fair
    Value Measurements at Reporting Date Using
 
    |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  |  |  |  | Quoted Prices 
 |  |  |  |  |  |  |  | 
|  |  |  |  |  | in Active 
 |  |  | Significant 
 |  |  |  |  | 
|  |  |  |  |  | Markets for 
 |  |  | Other 
 |  |  | Significant 
 |  | 
|  |  |  |  |  | Identical 
 |  |  | Observable 
 |  |  | Unobservable 
 |  | 
|  |  | March 31, 
 |  |  | Assets 
 |  |  | Inputs 
 |  |  | Inputs 
 |  | 
| 
    Description
 |  | 2008 |  |  | (Level 1) |  |  | (Level 2) |  |  | (Level 3) |  | 
|  |  | (In millions) |  | 
| 
    Financial Liabilities:
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
    Forward exchange contracts
 |  | $ | (5.4 | ) |  | $ |  |  |  | $ | (5.4 | ) |  | $ |  |  | 
| 
    Interest rate swap
 |  |  | (2.5 | ) |  |  |  |  |  |  | (2.5 | ) |  |  |  |  | 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
    Total financial liabilities
 |  | $ | (7.9 | ) |  | $ |  |  |  | $ | (7.9 | ) |  | $ |  |  | 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
 
    In January 2008, the Company adopted SFAS No. 159,
    The Fair Value Option for Financial Assets and Financial
    Liabilities, or SFAS 159, which permits entities to
    choose to measure many financial instruments, and
    
    7
 
 
    HERBALIFE
    LTD.
    
 
    NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
    
    (Unaudited)
 
    certain other items, at fair value. SFAS 159 also
    establishes presentation and disclosure requirements designed to
    facilitate comparisons between entities that choose different
    measurement attributes for similar types of assets and
    liabilities. The adoption of SFAS No. 159 did not have
    a material impact on the Companys consolidated financial
    statements.
 
    In January 2008, the Company adopted FASB Staff Position
    No. FIN 39-1,
    Amendment of FASB Interpretation No. 39, or FSP
    FIN 39-1.
    FSP
    FIN 39-1
    modifies FIN No. 39, Offsetting of Amounts Related
    to Certain Contracts and permits companies to offset cash
    collateral receivables or payables with net derivative positions
    under certain circumstances. The adoption of FSP
    FIN 39-1
    did not have a material impact on the Companys
    consolidated financial statements.
 
    Reclassifications
 
    Certain reclassifications were made to the prior period
    financial statements to conform to current period presentation.
 
 
    Long-term debt consists of the following:
 
    |  |  |  |  |  |  |  |  |  | 
|  |  | As of |  | 
|  |  | March 31, 
 |  |  | December 31, 
 |  | 
|  |  | 2008 |  |  | 2007 |  | 
|  |  | (In millions) |  | 
|  | 
| 
    Borrowings under senior credit facility
 |  | $ | 326.7 |  |  | $ | 357.1 |  | 
| 
    Capital leases
 |  |  | 6.6 |  |  |  | 7.4 |  | 
| 
    Other debt
 |  |  | 0.4 |  |  |  | 0.7 |  | 
|  |  |  |  |  |  |  |  |  | 
| 
    Total
 |  |  | 333.7 |  |  |  | 365.2 |  | 
| 
    Less: current portion
 |  |  | 3.8 |  |  |  | 4.7 |  | 
|  |  |  |  |  |  |  |  |  | 
| 
    Long-term portion
 |  | $ | 329.9 |  |  | $ | 360.5 |  | 
|  |  |  |  |  |  |  |  |  | 
 
    On July 21, 2006, the Company entered into a
    $300.0 million senior secured credit facility, comprised of
    a $200.0 million term loan and a $100.0 million
    revolving credit facility, with a syndicate of financial
    institutions as lenders and replaced the $225.0 million
    senior secured credit facility, originally entered into on
    December 21, 2004. The term loan bears interest at LIBOR
    plus a margin of 1.5%, or the base rate, which represents the
    prime rate offered by major U.S. banks, plus a margin of
    0.50%, and matures on July 21, 2013. The revolving credit
    facility bears interest at LIBOR plus a margin of 1.25%, or the
    base rate, which represents the prime rate offered by major
    U.S. banks, plus a margin of 0.25%, and is available until
    July 21, 2012.
 
    The Company incurred approximately $2.3 million of debt
    issuance costs in connection with entering into the new credit
    facility in July 2006, which are being amortized over the term
    of the new credit facility.
 
    On August 23, 2006, the Company borrowed
    $200.0 million pursuant to the term loan under the new
    credit facility to fund the redemption of its
    91/2% Notes
    due 2011 under the old credit facility. In September 2006, the
    Company prepaid $20.0 million of its new term loan
    borrowings. In March 2007, the Company made another prepayment
    of $29.5 million and expensed approximately
    $0.2 million of related unamortized deferred financing
    costs. As of March 31, 2008 and December 31, 2007, the
    amounts outstanding under the term loan were $148.0 million
    and $148.4 million, respectively.
 
    In September 2007, the Company and its lenders amended the
    credit agreement governing the new credit facility, increasing
    the amount of its current revolving credit facility by an
    aggregate principal amount of $150.0 million to finance the
    increase in the share repurchase program (see Note 11 of
    the notes to unaudited
    
    8
 
 
    HERBALIFE
    LTD.
    
 
    NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
    
    (Unaudited)
 
    consolidated financial statements for further discussion on the
    share repurchase program). During 2007, the Company borrowed an
    aggregate amount of $293.7 million under the revolving
    credit facility to fund its share repurchase program and paid
    $85.0 million of the revolving credit facility. During the
    first quarter of 2008, the Company paid $30.0 million of
    the revolving credit facility. As of March 31, 2008 and
    December 31, 2007, the amounts outstanding under the
    revolving credit facility were $178.7 million and
    $208.7 million, respectively.
 
    Through the course of conducting regular operations, certain
    vendors may require letters of credit to be issued in order to
    secure insurance policies or goods that are purchased. As of
    March 31, 2008 and December 31, 2007, the Company had
    no outstanding letters of credit.
 
 
    The Company is from time to time engaged in routine litigation.
    The Company regularly reviews all pending litigation matters in
    which it is involved and establishes reserves deemed appropriate
    by management for these litigation matters when a probable loss
    estimate can be made.
 
    Herbalife International and certain of its independent
    distributors have been named as defendants in a purported class
    action lawsuit filed February 17, 2005, in the Superior
    Court of California, County of San Francisco, and served on
    Herbalife International on March 14, 2005
    (Minton v. Herbalife International, et al). The case
    was transferred to the Los Angeles County Superior Court. The
    plaintiff is challenging the marketing practices of certain
    Herbalife International independent distributors and Herbalife
    International under various state laws prohibiting endless
    chain schemes, insufficient disclosure in assisted
    marketing plans, unfair and deceptive business practices, and
    fraud and deceit. The plaintiff alleges that the Freedom Group
    system operated by certain independent distributors of Herbalife
    International products places too much emphasis on recruiting
    and encourages excessively large purchases of product and
    promotional materials by distributors. The plaintiff also
    alleges that Freedom Group pressured distributors to disseminate
    misleading promotional materials. The plaintiff seeks to hold
    Herbalife International vicariously liable for the actions of
    its independent distributors and is seeking damages and
    injunctive relief. On January 24, 2007, the Superior Court
    denied class certification of all claims, except for the claim
    under California law prohibiting endless chain
    schemes. That claim was granted California class
    certification, provided that class counsel is able to substitute
    in as a plaintiff a California resident with claims typical of
    the class. The Company believes that it has meritorious defenses
    to the suit.
 
    Herbalife International and certain of its distributors were
    defendants in a class action lawsuit filed July 16, 2003,
    in the Circuit Court of Ohio County in the State of West
    Virginia (Mey v. Herbalife International, Inc., et
    al). The complaint alleged that certain telemarketing
    practices of certain Herbalife International distributors
    violated the Telephone Consumer Protection Act, or TCPA, and
    sought to hold Herbalife International vicariously liable for
    the practices of its independent distributors. More
    specifically, the plaintiffs complaint alleged that
    several of Herbalife Internationals distributors used
    pre-recorded telephone messages and faxes to contact prospective
    customers in violation of the TCPAs prohibition of such
    practices. Without in any way acknowledging liability or
    wrongdoing by the Company or its independent distributors, the
    Company and the other defendants have reached a binding
    settlement with the plaintiffs. Under the terms of the
    settlement, the defendants collectively paid $7 million
    into a fund to be distributed to qualifying class members. The
    relevant amount paid by the Company was previously fully
    reserved in the Companys financial statements. The
    settlement received the final approval of the Court in January
    2008.
 
    As a marketer of dietary and nutritional supplements and other
    products that are ingested by consumers or applied to their
    bodies, the Company has been and is currently subjected to
    various product liability claims. The effects of these claims to
    date have not been material to the Company, and the reasonably
    possible range of exposure on currently existing claims is not
    material to the Company. The Company believes that it has
    meritorious defenses to the allegations contained in the
    lawsuits. The Company currently maintains product liability
    insurance with an annual deductible of $10 million.
    
    9
 
 
    HERBALIFE
    LTD.
    
 
    NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
    
    (Unaudited)
 
    Certain of the Companys subsidiaries have been subject to
    tax audits by governmental authorities in their respective
    countries. In certain of these tax audits, governmental
    authorities are proposing that significant amounts of additional
    taxes and related interest and penalties are due. The Company
    and its tax advisors believe that there are substantial defenses
    to their allegations that additional taxes are owed, and the
    Company is vigorously contesting the additional proposed taxes
    and related charges.
 
    These matters may take several years to resolve, and the Company
    cannot be sure of their ultimate resolution. However, it is the
    opinion of management that adverse outcomes, if any, will not
    likely result in a material adverse effect on the Companys
    financial condition and operating results. This opinion is based
    on the belief that any losses suffered in excess of amounts
    reserved would not be material, and that the Company has
    meritorious defenses. Although the Company has reserved an
    amount that the Company believes represents the most likely
    outcome of the resolution of these disputes, if the Company is
    incorrect in the assessment the Company may have to record
    additional expenses.
 
 
    |  |  |  |  |  |  |  |  |  | 
|  |  | Three Months Ended |  | 
|  |  | March 31, 
 |  |  | March 31, 
 |  | 
|  |  | 2008 |  |  | 2007 |  | 
|  |  | (In millions) |  | 
|  | 
| 
    Net income
 |  | $ | 62.4 |  |  | $ | 41.2 |  | 
| 
    Unrealized loss on derivative instruments, net of tax
 |  |  | (0.9 | ) |  |  | (0.1 | ) | 
| 
    Foreign currency translation adjustment
 |  |  | 1.0 |  |  |  | (0.3 | ) | 
|  |  |  |  |  |  |  |  |  | 
| 
    Comprehensive income
 |  | $ | 62.5 |  |  | $ | 40.8 |  | 
|  |  |  |  |  |  |  |  |  | 
 
 
    The Company is a network marketing company that sells a wide
    range of weight management products, nutritional supplements and
    personal care products within one industry segment as defined
    under SFAS No. 131, Disclosures about Segments of
    an Enterprise and Related Information. The Companys
    products are primarily manufactured by third party providers and
    then sold to independent distributors who sell Herbalife
    products to retail consumers or other distributors.
 
    The Company sells products in 65 countries throughout the world
    and is organized and managed by geographic regions. The Company
    aggregates its operating segments into one reporting segment, as
    management believes that the Companys operating segments
    have similar operating characteristics and similar long term
    operating performance. In making this determination, management
    believes that the operating segments are similar in the nature
    of the products sold, the product acquisition process, the types
    of customers products are sold to, the methods used to
    distribute the products, and the nature of the regulatory
    environment.
 
    Revenues reflect sales of products to distributors based on the
    distributors geographic location.
    
    10
 
 
    HERBALIFE
    LTD.
    
 
    NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
    
    (Unaudited)
 
    In late 2007, the Company changed its geographic regions from
    seven to five regions as part of the Companys on-going
    Realignment for Growth plan. These changes were intended to
    create growth opportunities for distributors, support faster
    decision making across the organization by reducing the number
    of layers of management, improve the sharing of ideas and tools
    and accelerate growth in the Companys high potential
    markets. Historical information presented related to the
    Companys geographic regions has been reclassified to
    conform with its current geographic presentation. The
    Companys reporting segments operating information
    and sales by product line are as follows:
 
    |  |  |  |  |  |  |  |  |  | 
|  |  | Three Months Ended |  | 
|  |  | March 31, 
 |  |  | March 31, 
 |  | 
|  |  | 2008 |  |  | 2007 |  | 
|  |  | (In millions) |  | 
|  | 
| 
    Net Sales:
 |  |  |  |  |  |  |  |  | 
| 
    United States
 |  | $ | 114.0 |  |  | $ | 99.7 |  | 
| 
    Mexico
 |  |  | 93.6 |  |  |  | 94.0 |  | 
| 
    Others
 |  |  | 396.8 |  |  |  | 314.4 |  | 
|  |  |  |  |  |  |  |  |  | 
| 
    Total Net Sales
 |  | $ | 604.4 |  |  | $ | 508.1 |  | 
|  |  |  |  |  |  |  |  |  | 
| 
    Operating Margin(1):
 |  |  |  |  |  |  |  |  | 
| 
    United States
 |  | $ | 47.2 |  |  | $ | 36.1 |  | 
| 
    Mexico
 |  |  | 38.8 |  |  |  | 36.2 |  | 
| 
    Others
 |  |  | 188.1 |  |  |  | 148.2 |  | 
|  |  |  |  |  |  |  |  |  | 
| 
    Total Operating Margin
 |  | $ | 274.1 |  |  | $ | 220.5 |  | 
| 
    Selling, general and administrative expenses
 |  | $ | 184.4 |  |  | $ | 149.4 |  | 
| 
    Interest expense, net
 |  |  | 3.8 |  |  |  | 2.2 |  | 
|  |  |  |  |  |  |  |  |  | 
| 
    Income before income taxes
 |  |  | 85.9 |  |  |  | 68.9 |  | 
| 
    Income taxes
 |  |  | 23.5 |  |  |  | 27.7 |  | 
|  |  |  |  |  |  |  |  |  | 
| 
    Net Income
 |  | $ | 62.4 |  |  | $ | 41.2 |  | 
|  |  |  |  |  |  |  |  |  | 
 
    |  |  |  |  |  |  |  |  |  | 
|  |  | As of |  | 
|  |  | March 31, 
 |  |  | December 31, 
 |  | 
|  |  | 2008 |  |  | 2007 |  | 
|  |  | (In millions) |  | 
|  | 
| 
    Total Assets:
 |  |  |  |  |  |  |  |  | 
| 
    United States
 |  | $ | 675.6 |  |  | $ | 668.6 |  | 
| 
    Mexico
 |  |  | 67.8 |  |  |  | 62.3 |  | 
| 
    Others
 |  |  | 374.5 |  |  |  | 336.3 |  | 
|  |  |  |  |  |  |  |  |  | 
| 
    Total Assets
 |  | $ | 1,117.9 |  |  | $ | 1,067.2 |  | 
|  |  |  |  |  |  |  |  |  | 
    
    11
 
 
    HERBALIFE
    LTD.
    
 
    NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
    
    (Unaudited)
 
    During the quarter ended June 30, 2007, the Company
    reorganized its product categories to add one more product line
    in order to better reflect its current product offerings.
    Historical information presented related to the Company product
    lines has been reclassified to conform to the current product
    line presentation.
 
    |  |  |  |  |  |  |  |  |  | 
|  |  | Three Months Ended |  | 
|  |  | March 31, 
 |  |  | March 31, 
 |  | 
|  |  | 2008 |  |  | 2007 |  | 
|  |  | (In millions) |  | 
|  | 
| 
    Net sales by product line:
 |  |  |  |  |  |  |  |  | 
| 
    Weight Management
 |  | $ | 380.8 |  |  | $ | 320.7 |  | 
| 
    Targeted Nutrition
 |  |  | 125.6 |  |  |  | 103.0 |  | 
| 
    Energy & Fitness
 |  |  | 24.0 |  |  |  | 20.4 |  | 
| 
    Outer Nutrition
 |  |  | 40.2 |  |  |  | 36.4 |  | 
| 
    Literature, promotional and other(2)
 |  |  | 33.8 |  |  |  | 27.6 |  | 
|  |  |  |  |  |  |  |  |  | 
| 
    Total Net Sales
 |  | $ | 604.4 |  |  | $ | 508.1 |  | 
|  |  |  |  |  |  |  |  |  | 
| 
    Net sales by geographic region:
 |  |  |  |  |  |  |  |  | 
| 
    North America(3)
 |  | $ | 118.6 |  |  | $ | 104.5 |  | 
| 
    Mexico & Central America(4)
 |  |  | 97.6 |  |  |  | 95.9 |  | 
| 
    South America(5)
 |  |  | 102.0 |  |  |  | 60.9 |  | 
| 
    EMEA(6)
 |  |  | 158.0 |  |  |  | 143.2 |  | 
| 
    Asia Pacific(7)
 |  |  | 128.2 |  |  |  | 103.6 |  | 
|  |  |  |  |  |  |  |  |  | 
| 
    Total Net Sales
 |  | $ | 604.4 |  |  | $ | 508.1 |  | 
|  |  |  |  |  |  |  |  |  | 
 
 
    |  |  |  | 
    | (1) |  | Operating margin consists of net sales less cost of sales and
    royalty overrides. | 
|  | 
    | (2) |  | Product buybacks and returns in all product categories are
    included in the literature, promotional and other category. | 
|  | 
    | (3) |  | Consists of the U.S., Canada and Jamaica. | 
|  | 
    | (4) |  | Consists of Mexico, Costa Rica, El Salvador, Panama and
    Dominican Republic. | 
|  | 
    | (5) |  | Includes Brazil. | 
|  | 
    | (6) |  | Includes Europe, Middle East and Africa. | 
|  | 
    | (7) |  | Includes Asia, New Zealand and Australia. | 
 
    |  |  | 
    | 7. | Stock
    Based Compensation | 
 
    The Company has five stock-based compensation plans, the WH
    Holdings (Cayman Islands) Ltd. Stock Incentive Plan, or the
    Management Plan, the WH Holdings (Cayman Islands) Ltd.
    Independent Directors Stock Incentive Plan, or the Independent
    Directors Plan, the Herbalife Ltd. 2004 Stock Incentive Plan, or
    the 2004 Stock Incentive Plan, the Herbalife Ltd. 2005 Stock
    Incentive Plan, or the 2005 Stock Incentive Plan, and the
    Herbalife Ltd. Independent Directors Deferred Compensation and
    Stock Unit Plan, or the Independent Director Stock Unit Plan.
    The Management Plan provides for the grant of options to
    purchase common shares of Herbalife to members of the
    Companys management. The Independent Directors Plan
    provides for the grant of options to purchase common shares of
    Herbalife to the Companys independent directors. The 2004
    Stock Incentive Plan replaced the Management Plan and the
    Independent Directors Plan and after the adoption thereof, no
    additional awards were made under either the Management Plan or
    the Independent Directors Plan. However, the shares remaining
    available for issuance under these plans were absorbed by and
    became available for issuance under the 2004 Stock
    
    12
 
 
    HERBALIFE
    LTD.
    
 
    NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
    
    (Unaudited)
 
    Incentive Plan. The terms of the 2005 Stock Incentive Plan are
    substantially similar to the terms of the 2004 Stock Incentive
    Plan. The 2005 Stock Incentive Plan authorizes the issuance of
    4,000,000 common shares pursuant to awards, plus any shares that
    remained available for issuance under the 2004 Stock Incentive
    Plan at the time of the adoption of the 2005 Stock Incentive
    Plan. The purpose of the Independent Directors Stock Unit Plan
    is to facilitate equity ownership in the Company by its
    independent directors through the award of stock units and to
    allow for deferral by the independent directors of compensation
    realized in connection with such stock units. The Companys
    stock compensation awards outstanding as of March 31, 2008
    include stock options, stock appreciation rights, or SARS, and
    stock units.
 
    The Company records compensation expense over the requisite
    service period which is equal to the vesting period. For awards
    granted prior to January 1, 2006, compensation expense is
    recognized on a graded-vesting basis over the vesting term. For
    awards granted on or after January 1, 2006, compensation
    expense is recognized on a straight-line basis over the vesting
    term. Stock-based compensation expense is included in selling,
    general and administrative expenses in the consolidated
    statements of income. For the three months ended March 31,
    2008 and 2007, stock-based compensation expenses amounted to
    $5.1 million and $3.5 million, respectively, and the
    related income tax benefits recognized in earnings amounted to
    $1.9 million and $1.2 million, respectively.
 
    As of March 31, 2008, the total unrecognized compensation
    cost related to non-vested stock awards was $71.5 million
    and the related weighted-average period over which it is
    expected to be recognized is approximately 2.0 years.
 
    For the three months ended March 31, 2008 and 2007, excess
    tax benefits of $11.2 million and $1.3 million,
    respectively, were generated from option exercises.
 
    The Companys stock-based compensation plans provide for
    grants of stock options, SARS, and stock units, which are
    collectively referred to herein as awards. Stock options
    typically vest quarterly over a five-year period beginning on
    the grant date, and certain stock option grants vest over a
    period of less than five years. Certain SARS vest quarterly over
    a five-year period beginning on the grant date. Other SARS vest
    annually over a three-year period. The contractual term of stock
    options and SARS is ten years. Stock unit awards under the 2005
    Incentive Plan, or Incentive Plan Stock Units, vest annually
    over a three year period which is equal to the contractual term.
    Stock units awarded under the Independent Directors Stock Unit
    Plan, or Independent Director Stock Units, vest at a rate of 25%
    on each January 15, April 15, July 15 and
    October 15. In March 2008, the Company granted stock unit
    awards to its Chairman and Chief Executive Officer, which vest
    over a four-year period at a rate of 30% during each of the
    first three years and 10% during the fourth year. Unless
    otherwise determined at the time of grant, the value of each
    stock unit shall be equal to one common share of Herbalife.
 
    In March 2008, the Company granted SARS with market conditions
    to its Chairman and Chief Executive Officer which will fully
    vest at the end of four years subject to his continued
    employment through that date and the achievement of certain
    conditions related to the market value of the Companys
    common stock. The market conditions include targets for stock
    price appreciation of both a 10% and a 15% compound annual
    growth rate.
 
    With the exception of awards with market conditions, the fair
    value of each award is estimated on the date of grant using the
    Black-Scholes-Merton option-pricing model based on the
    assumptions in the following tables. The expected term of the
    award is based on the simple average of the average vesting
    period and the life of the award because of the limited
    historical data. All groups of employees have been determined to
    have similar historical exercise patterns for valuation
    purposes. The expected volatility of stock awards is primarily
    based upon the historical volatility of the Companys
    common shares and, due to the limited period of public trading
    data for its common shares, it is also validated against the
    volatility rates of a peer group of companies. The risk free
    interest rate is based on the implied yield on a
    U.S. Treasury zero-coupon issue with a remaining term equal
    to the expected term of the award. The dividend yield reflects
    that the Company has not historically paid regular cash
    dividends from inception to the first quarter of 2007. Dividends
    paid by the predecessor company in 2002 and prior and special
    
    13
 
 
    HERBALIFE
    LTD.
    
 
    NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
    
    (Unaudited)
 
    dividends paid in 2004 in connection with the Companys
    initial public offering have been excluded from the calculation.
    Commencing in the second quarter of 2007, the board of directors
    approved a regular quarterly dividend program and the Company
    declared a $0.20 per share cash dividend for each of the
    consecutive four quarters. However, there is no guarantee that
    the board of directors will not terminate the quarterly dividend
    program.
 
    There were no stock options granted during the three months
    ended March 31, 2008 and 2007. The following table
    summarizes the weighted average assumptions used in the
    calculation of fair market value for SARS and stock units
    granted during the three months ended March 31, 2008 and
    2007:
 
    |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  |  |  |  | Incentive Plan 
 |  |  | Independent Directors 
 |  | 
|  |  | SARS |  |  | Stock Units |  |  | Stock Units |  | 
|  |  | Three Months 
 |  |  | Three Months 
 |  |  | Three Months 
 |  | 
|  |  | Ended 
 |  |  | Ended 
 |  |  | Ended 
 |  | 
|  |  | March 31, |  |  | March 31, |  |  | March 31, |  | 
|  |  | 2008 |  |  | 2007 |  |  | 2008 |  |  | 2007 |  |  | 2008 |  |  | 2007 |  | 
|  | 
| 
    Expected volatility
 |  |  | 39.48 | % |  |  |  |  |  |  | 39.45 | % |  |  |  |  |  |  | 39.73 | % |  |  | 41.82 | % | 
| 
    Dividends yield
 |  |  | 2.00 | % |  |  |  |  |  |  | zero |  |  |  |  |  |  |  | zero |  |  |  | zero |  | 
| 
    Expected term
 |  |  | 5.8 years |  |  |  |  |  |  |  | 2.7 years |  |  |  |  |  |  |  | 3.0 years |  |  |  | 3.0 years |  | 
| 
    Risk-free interest rate
 |  |  | 2.56 | % |  |  |  |  |  |  | 1.83 | % |  |  |  |  |  |  | 2.49 | % |  |  | 5.00 | % | 
 
    The following tables summarize the activity under the
    stock-based compensation plans for the three months ended
    March 31, 2008:
 
    |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  |  |  |  |  |  |  | Weighted 
 |  |  |  |  | 
|  |  |  |  |  | Weighted 
 |  |  | Average 
 |  |  |  |  | 
|  |  |  |  |  | Average 
 |  |  | Remaining 
 |  |  | Aggregate 
 |  | 
|  |  |  |  |  | Exercise 
 |  |  | Contractual 
 |  |  | Intrinsic 
 |  | 
| 
    Stock Options & SARS
 |  | Shares |  |  | Price |  |  | Term |  |  | Value |  | 
|  |  | (In thousands) |  |  |  |  |  |  |  |  | (In millions) |  | 
|  | 
| 
    Outstanding at December 31, 2007
 |  |  | 8,159 |  |  | $ | 20.80 |  |  |  |  |  |  |  |  |  | 
| 
    Granted
 |  |  | 1,486 |  |  |  | 45.88 |  |  |  |  |  |  |  |  |  | 
| 
    Exercised
 |  |  | (1,009 | ) |  |  | 12.68 |  |  |  |  |  |  |  |  |  | 
| 
    Forfeited
 |  |  | (25 | ) |  |  | 26.43 |  |  |  |  |  |  |  |  |  | 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
    Outstanding at March 31, 2008
 |  |  | 8,611 |  |  | $ | 26.07 |  |  |  | 7.0 years |  |  | $ | 185.4 |  | 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
    Exercisable at March 31, 2008
 |  |  | 3,593 |  |  | $ | 17.49 |  |  |  | 5.8 years |  |  | $ | 107.8 |  | 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
 
    |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  |  |  |  | Weighted Average 
 |  |  | Aggregate 
 |  | 
| 
    Incentive Plan and Independent Directors Stock Units
 |  | Shares |  |  | Grant Date Fair Value |  |  | Fair Value |  | 
|  |  | (In thousands) |  |  |  |  |  | (In millions) |  | 
|  | 
| 
    Outstanding and nonvested at December 31, 2007
 |  |  | 273.9 |  |  | $ | 38.40 |  |  | $ | 10.5 |  | 
| 
    Granted
 |  |  | 398.5 |  |  |  | 44.76 |  |  |  | 17.8 |  | 
| 
    Vested
 |  |  | (27.6 | ) |  |  | 32.67 |  |  |  | (0.9 | ) | 
| 
    Cancelled
 |  |  | (4.3 | ) |  |  | 39.13 |  |  |  | (0.1 | ) | 
|  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
    Outstanding and nonvested at March 31, 2008
 |  |  | 640.5 |  |  | $ | 42.60 |  |  | $ | 27.3 |  | 
|  |  |  |  |  |  |  |  |  |  |  |  |  | 
 
    The weighted-average grant date per share fair value of stock
    awards granted during the three months ended March 31, 2008
    and 2007 was $21.58 and $32.01, respectively. The total
    intrinsic value of stock awards exercised during the three
    months ended March 31, 2008 and 2007 was $32.9 million
    and $3.9 million, respectively.
    
    14
 
 
    HERBALIFE
    LTD.
    
 
    NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
    
    (Unaudited)
 
    Employee
    Stock Purchase Plan
 
    During 2007, the Company adopted a qualified employee stock
    purchase plan, or ESPP, which was implemented during the first
    quarter of 2008. In connection with the adoption of the ESPP,
    the Company has reserved for issuance a total of 1 million
    common shares. Under the terms of the ESPP, rights to purchase
    common shares may be granted to eligible qualified employees
    subject to certain restrictions. The ESPP enables the
    Companys eligible employees, through payroll withholdings,
    to purchase a limited number of common shares at 85% of the fair
    market value of a common share at the purchase date. Purchases
    are made on a quarterly basis.
 
 
    As of March 31, 2008, the total amount of unrecognized tax
    benefits, related interest and penalties was $41.1 million,
    $8.5 million and $3.3 million, respectively. During
    the three months ended March 31, 2008, the Company recorded
    tax, interest and penalties related to uncertain tax positions
    of $0.7 million, $0.3 million and $1.5 million,
    respectively. The unrecognized tax benefits relate primarily to
    uncertainties from international transfer pricing issues and the
    deductibility of certain operating expenses in various
    jurisdictions. If the total amount of unrecognized tax benefits
    was recognized, $34.7 million of unrecognized tax benefits,
    $8.5 million of interest and $3.3 million of
    penalties, would impact the effective tax rate and
    $6.4 million would result in an increase to goodwill.
 
    During the three months ended March 31, 2008, the Company
    benefited from the terms of a tax holiday in the Peoples
    Republic of China. The tax holiday commenced on January 1,
    2008 and will terminate on December 31, 2012. Under the
    terms of the holiday, the Company is subject to a zero tax rate
    in China during the 2008 and 2009 years and a concessionary
    tax rate in China for the remaining years included in the
    holiday period.
 
    |  |  | 
    | 9. | Derivative
    Instruments and Hedging Activities | 
 
    Interest
    Rate Risk Management
 
    The Company engages in an interest rate hedging strategy for
    which the hedged transactions are forecasted interest payments
    on the Companys variable rate term loan. The hedged risk
    is the variability of forecasted interest rate cash flows, where
    the hedging strategy involves the purchase of interest rate
    swaps. For the outstanding cash flow hedges on interest rate
    exposures at March 31, 2008 the maximum length of time over
    which the Company is hedging these exposures is less than two
    years.
 
    Under its current credit facility, the Company is obligated to
    enter into interest rate hedges for up to 25% of the aggregate
    principal amount of the term loan for a minimum of three years.
    On August 23, 2006, the Company entered into a new interest
    rate swap agreement. The agreement provides for the Company to
    pay interest for a three-year period at a fixed rate of 5.26% on
    various notional amounts while receiving interest for the same
    period at the LIBOR rate on the same notional principal amounts.
    The swap has been designated as a cash flow hedge against the
    variability in LIBOR interest rate on the new term loan at LIBOR
    plus 1.50%, thereby fixing the Companys effective rate on
    the notional amounts at 6.76%. The Company formally assesses,
    both at inception and at least quarterly thereafter, whether the
    derivatives used in hedging transactions are effective in
    offsetting changes in cash flows of the hedged item. As of
    March 31, 2008 and December 31, 2007, the hedge
    relationship qualified as an effective hedge under
    SFAS No. 133, Accounting for Derivative Instruments
    and Hedging Activities. Consequently, all changes in the
    fair value of the derivative are deferred and recorded in other
    comprehensive income until the related forecasted transaction is
    recognized in the consolidated statements of income. The fair
    value of the interest rate swap agreement is based on
    third-party bank quotes and the Company recorded the interest
    rate swap as a liability at fair value of $2.5 million and
    $1.4 million as of March 31, 2008 and
    December 31, 2007, respectively.
    
    15
 
 
    HERBALIFE
    LTD.
    
 
    NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
    
    (Unaudited)
 
    Foreign
    Currency Instruments
 
    The Company also designates certain derivatives, such as foreign
    currency forward contracts, as freestanding derivatives for
    which hedge accounting does not apply. The changes in the fair
    market value of the derivatives are included in selling, general
    and administrative expenses in the Companys consolidated
    statements of income. The Company uses foreign currency forward
    contracts to hedge foreign-currency-denominated intercompany
    transactions and to partially mitigate the impact of foreign
    currency fluctuations. The fair value of the forward contracts
    are based on third-party bank quotes. As of March 31, 2008,
    all of the Companys outstanding foreign exchange forward
    contracts have maturity dates of one year or less. See
    Part I, Item 3  Quantitative and
    Qualitative Disclosures About Market Risk in this Quarterly
    Report on
    Form 10-Q
    for foreign currency instruments outstanding as of
    March 31, 2008.
 
    |  |  | 
    | 10. | Restructuring
    Reserve | 
 
    In July 2006, the Company initiated its realignment of its
    employee base as part of the first phase of its Realignment for
    Growth plan and during the fourth quarter of 2007, the Company
    initiated the second phase of its Realignment for Growth plan.
    The Company recorded $0.4 million and $1.5 million of
    professional fees, severance and related costs for the three
    months ended March 31, 2008 and 2007, respectively, related
    to the Realignment for Growth plan. All such amounts were
    included in selling, general and administrative expenses.
 
    The Company expects to complete its Realignment for Growth plan
    in 2008 and estimates that the corresponding severance and
    related cost that will be incurred for the full 2008 fiscal year
    will be approximately $3.0 million to $5.0 million.
 
    The following table summarizes the components of this reserve as
    of March 31, 2008 (in millions):
 
    |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  |  |  |  | Retention 
 |  |  |  |  |  |  |  | 
|  |  | Severance |  |  | Benefits |  |  | Others |  |  | Total |  | 
|  | 
| 
    Balance as of December 31, 2007
 |  | $ | 2.9 |  |  | $ |  |  |  | $ | 0.6 |  |  | $ | 3.5 |  | 
| 
    Charges
 |  |  | 0.4 |  |  |  |  |  |  |  |  |  |  |  | 0.4 |  | 
| 
    Cash payments
 |  |  | 1.6 |  |  |  |  |  |  |  | 0.2 |  |  |  | 1.8 |  | 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
    Balance as of March 31, 2008
 |  | $ | 1.7 |  |  | $ |  |  |  | $ | 0.4 |  |  | $ | 2.1 |  | 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
 
 
    Dividends
 
    During the second quarter of 2007, the Companys board of
    directors adopted a regular quarterly cash dividend program. On
    January 31, 2008, the Companys Board of Directors
    approved a quarterly cash dividend of $0.20 per common share in
    an aggregate amount of $12.9 million, for the fourth
    quarter of 2007 that was paid to shareholders of record on
    March 14, 2008.
 
    Share
    Repurchases
 
    On April 18, 2007, the Companys board of directors
    authorized the repurchase of up to $300 million of the
    Companys common shares during the next two years, at such
    times and prices as determined by Company management, as market
    conditions warrant. On August 23, 2007, the Companys
    board of directors approved an increase of $150 million to
    its previously authorized share repurchase program raising the
    total value of Company common shares authorized to be
    repurchased to $450 million. During the quarter ended
    March 31, 2008, the Company repurchased approximately
    0.4 million of its common shares through open market
    purchases at an aggregate cost of $17.7 million or an
    average cost of $39.28 per share.
    
    16
 
 
    HERBALIFE
    LTD.
    
 
    NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
    
    (Unaudited)
 
 
    Basic earnings per share represents net income for the period
    common shares were outstanding, divided by the weighted average
    number of common shares outstanding for the period. Diluted
    earnings per share represents net income divided by the weighted
    average number of shares outstanding, inclusive of the effect of
    dilutive securities such as outstanding stock options and
    warrants.
 
    The following are the share amounts used to compute the basic
    and diluted earnings per share for each period (in thousands):
 
    |  |  |  |  |  |  |  |  |  | 
|  |  | For the Three Months 
 |  | 
|  |  | Ended March 31, |  | 
|  |  | 2008 |  |  | 2007 |  | 
|  | 
| 
    Weighted average shares used in basic computations
 |  |  | 64,381 |  |  |  | 71,722 |  | 
| 
    Dilutive effect of exercise of options outstanding
 |  |  | 2,497 |  |  |  | 2,972 |  | 
| 
    Dilutive effect of warrants
 |  |  | 322 |  |  |  | 249 |  | 
|  |  |  |  |  |  |  |  |  | 
| 
    Weighted average shares used in diluted computations
 |  |  | 67,200 |  |  |  | 74,943 |  | 
|  |  |  |  |  |  |  |  |  | 
 
    Options to purchase 1.5 million and 0.3 million common
    shares were outstanding during the three months ended
    March 31, 2008 and 2007, respectively, but were not
    included in the computation of diluted earnings per share
    because the option exercise prices were greater than the average
    market price of a common share and therefore such options would
    be anti-dilutive.
    
    17
 
    |  |  | 
    | Item 2. | MANAGEMENTS
    DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
    OPERATIONS | 
 
    Overview
 
    Herbalife is a global network marketing company that sells
    weight management, nutritional supplements, energy &
    fitness products and personal care products. We pursue our
    mission of changing peoples lives by providing
    a financially rewarding business opportunity to distributors and
    quality products to distributors and their customers who seek a
    healthy lifestyle. We are one of the largest network marketing
    companies in the world with net sales of approximately
    $2.1 billion for the year ended December 31, 2007. As
    of March 31, 2008, we sell our products in 65 countries
    through a network of over 1.8 million independent
    distributors except in China, where we sell our products through
    retail stores and an employed sales force. We believe the
    quality of our products and the effectiveness of our
    distribution network, coupled with geographic expansion, have
    been the primary reasons for our success throughout our
    28-year
    operating history. Unless otherwise noted, the terms
    we, our, us,
    Company and Herbalife refer to Herbalife
    Ltd. and its subsidiaries.
 
    During the quarter ended June 30, 2007, we reorganized our
    product categories to better reflect how our distributors sell
    products and programs. Our products are grouped in four
    principal categories: weight management, targeted nutrition,
    energy & fitness and Outer Nutrition. Our products are
    often sold in programs that are comprised of a series of related
    products designed to simplify weight management and nutrition
    for consumers and maximize our distributors cross-selling
    opportunities.
 
    Industry-wide factors that affect us and our competitors include
    the increasing prevalence of obesity and the aging of the
    worldwide population, which are driving demand for nutrition and
    wellness-related products and the recruitment and retention of
    distributors.
 
    The opportunities and challenges upon which we are most focused
    are: retailing of our products, recruitment and retention of
    distributors, improving distributor productivity, entering new
    markets, further penetrating existing markets including China,
    globalizing successful distributor methods of operation such as
    Nutrition Clubs, introducing new products, developing niche
    market segments and further investing in our infrastructure.
 
    In late 2007, we changed our geographic regions from seven to
    five regions as part of our on-going Realignment for Growth
    plan. This updated regional structure allows us to better
    support the distributor leadership and enhance synergies within
    the regions. Under the new geographic regions, we report revenue
    from:
 
    |  |  |  | 
    |  |  | North America, which consists of the U.S., Canada and Jamaica; | 
|  | 
    |  |  | Mexico and Central America, which consists of Mexico, Costa
    Rica, El Salvador, Panama and Dominican Republic; | 
|  | 
    |  |  | South America, including Brazil; | 
|  | 
    |  |  | EMEA, which includes Europe, the Middle East and Africa; and | 
|  | 
    |  |  | Asia Pacific, which includes Asia, New Zealand and Australia. | 
 
    Historical information presented in this Quarterly Report on
    Form 10-Q
    relating to our geographic regions has been reclassified to
    conform with our current geographic presentation.
    
    18
 
    Volume
    Points by Geographic Region
 
    A key non-financial measure we focus on is Volume Points on a
    Royalty Basis, or Volume Points, which is essentially our
    weighted unit measure of product sales volume. It is a useful
    measure for us, as it excludes the impact of foreign currency
    fluctuations and ignores the differences generated by varying
    retail pricing across geographic markets. In general, an
    increase in Volume Points in a particular geographic region or
    country indicates an increase in local currency net sales.
 
    |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  | For the Three Months Ended March 31, |  | 
|  |  | 2008 |  |  | 2007 |  |  | % Change |  | 
|  |  | (Volume points in millions) |  | 
|  | 
| 
    North America
 |  |  | 178.1 |  |  |  | 162.2 |  |  |  | 9.8 | % | 
| 
    Mexico & Central America
 |  |  | 154.7 |  |  |  | 154.8 |  |  |  | (0.1 | )% | 
| 
    South America
 |  |  | 112.2 |  |  |  | 83.1 |  |  |  | 35.0 | % | 
| 
    EMEA
 |  |  | 137.1 |  |  |  | 140.4 |  |  |  | (2.4 | )% | 
| 
    Asia Pacific
 |  |  | 127.0 |  |  |  | 110.2 |  |  |  | 15.2 | % | 
|  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
    Worldwide
 |  |  | 709.1 |  |  |  | 650.7 |  |  |  | 9.0 | % | 
|  |  |  |  |  |  |  |  |  |  |  |  |  | 
 
    Number of
    New Sales Leaders by Geographic Region during the Reporting
    Period
 
    Another key non-financial measure on which we focus is the
    number of distributors qualified as new sales leaders under our
    compensation system. Excluding China, distributors qualify for
    supervisor status based on their Volume Points. The growth in
    the number of new sales leaders is a general indicator of the
    level of distributor recruitment, which generally drives net
    sales in a particular country or geographic region.
 
    |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  | For the Three Months Ended March 31, |  | 
|  |  | 2008 |  |  | 2007 |  |  | % Change |  | 
|  | 
| 
    North America
 |  |  | 9,010 |  |  |  | 9,008 |  |  |  | 0.0 | % | 
| 
    Mexico & Central America
 |  |  | 7,644 |  |  |  | 7,181 |  |  |  | 6.4 | % | 
| 
    South America
 |  |  | 12,491 |  |  |  | 8,877 |  |  |  | 40.7 | % | 
| 
    EMEA
 |  |  | 6,533 |  |  |  | 7,642 |  |  |  | (14.5 | )% | 
| 
    Asia Pacific (excluding China)
 |  |  | 8,777 |  |  |  | 9,354 |  |  |  | (6.2 | )% | 
|  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
    Total New Supervisors
 |  |  | 44,455 |  |  |  | 42,062 |  |  |  | 5.7 | % | 
| 
    New China Sales Employees
 |  |  | 4,350 |  |  |  | 2,164 |  |  |  | 101.0 | % | 
|  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
    Worldwide Total New Sales Leaders
 |  |  | 48,805 |  |  |  | 44,226 |  |  |  | 10.4 | % | 
|  |  |  |  |  |  |  |  |  |  |  |  |  | 
 
    Number of
    Supervisors and Retention Rates by Geographic Region as
    of
    Requalification Period
 
    Our compensation system requires each supervisor to re-qualify
    for such status each year, prior to February, in order to
    maintain their 50% discount on product and be eligible to
    receive royalty payments. In February of each year, we demote
    from the rank of supervisor those distributors who did not
    satisfy the supervisor re-qualification requirements during the
    preceding twelve months. The re-qualification requirement does
    not apply to new supervisors (i.e. those who became supervisors
    subsequent to the January re-qualification of the prior year).
 
    |  |  |  |  |  |  |  |  |  | 
| 
    Supervisor Statistics (Excluding China)
 |  | 2008 |  |  | 2007 |  | 
|  |  | (In thousands) |  | 
|  | 
| 
    January 1 total supervisors
 |  |  | 451.6 |  |  |  | 400.6 |  | 
| 
    January & February new supervisors
 |  |  | 28.6 |  |  |  | 26.7 |  | 
| 
    Demoted supervisors (did not requalify)
 |  |  | (167.7 | ) |  |  | (135.9 | ) | 
| 
    Other supervisors (resigned, etc)
 |  |  | (2.8 | ) |  |  | (1.4 | ) | 
|  |  |  |  |  |  |  |  |  | 
| 
    End of February total supervisors
 |  |  | 309.7 |  |  |  | 290.0 |  | 
|  |  |  |  |  |  |  |  |  | 
    
    19
 
    The distributor statistics below further highlight the
    calculation for retention.
 
    |  |  |  |  |  |  |  |  |  | 
| 
    Supervisor Retention (Excluding China)
 |  | 2008 |  |  | 2007 |  | 
|  |  | (In thousands) |  | 
|  | 
| 
    Supervisors needed to requalify
 |  |  | 284.0 |  |  |  | 236.2 |  | 
| 
    Demoted supervisors (did not requalify)
 |  |  | (167.7 | ) |  |  | (135.9 | ) | 
|  |  |  |  |  |  |  |  |  | 
| 
    Total requalified
 |  |  | 116.3 |  |  |  | 100.3 |  | 
|  |  |  |  |  |  |  |  |  | 
| 
    Retention rate
 |  |  | 41.0 | % |  |  | 42.5 | % | 
|  |  |  |  |  |  |  |  |  | 
 
    The table below reflects the number of sales leaders as of
    February (subsequent to the annual re-qualification date) and
    supervisor retention rate by year and by region.
 
    |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  |  |  |  | Supervisor Retention 
 |  | 
|  |  | Number of Sales Leaders |  |  | Rate |  | 
|  |  | 2008 |  |  | 2007 |  |  | 2008 |  |  | 2007 |  | 
|  | 
| 
    North America
 |  |  | 64,383 |  |  |  | 54,314 |  |  |  | 43.5 | % |  |  | 43.1 | % | 
| 
    Mexico & Central America
 |  |  | 62,418 |  |  |  | 62,683 |  |  |  | 44.4 | % |  |  | 55.2 | % | 
| 
    South America
 |  |  | 66,075 |  |  |  | 51,302 |  |  |  | 34.4 | % |  |  | 32.9 | % | 
| 
    EMEA
 |  |  | 59,446 |  |  |  | 64,862 |  |  |  | 46.6 | % |  |  | 46.2 | % | 
| 
    Asia Pacific (excluding China)
 |  |  | 57,355 |  |  |  | 56,871 |  |  |  | 34.3 | % |  |  | 35.0 | % | 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
    Total Supervisors
 |  |  | 309,677 |  |  |  | 290,032 |  |  |  | 41.0 | % |  |  | 42.5 | % | 
| 
    China Sales Employees
 |  |  | 25,294 |  |  |  | 8,759 |  |  |  |  |  |  |  |  |  | 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
    Worldwide Total Sales Leaders
 |  |  | 334,971 |  |  |  | 298,791 |  |  |  |  |  |  |  |  |  | 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
 
    The number of supervisors by geographic region as of the
    quarterly reporting dates will normally be higher than the
    number of supervisors by geographic region as of the
    requalification period because supervisors who do not re-qualify
    during the relevant twelve-month period will be dropped from the
    rank of supervisor the following February. Since supervisors
    purchase most of our products for resale to other distributors
    and consumers, comparisons of supervisor totals on a
    year-to-year, same period basis are good indicators of our
    recruitment and retention efforts in different geographic
    regions.
 
    The value of the average monthly purchase of Herbalife products
    by our sales leaders has remained relatively constant over time.
    Consequently, increases in our sales are driven primarily by our
    retention of supervisors and by our recruitment and retention of
    distributors, rather than through increases in the productivity
    of our overall supervisor base.
 
    We provide distributors with products, support materials,
    training, special events and a competitive compensation program.
    If a distributor wants to pursue the Herbalife business
    opportunity, the distributor is responsible for growing his or
    her business and personally pays for the sales activities
    related to attracting new customers and recruiting distributors
    by hosting events such as Herbalife Opportunity Meetings or
    Success Training Seminars; by advertising Herbalifes
    products; by purchasing and using promotional materials such as
    t-shirts, buttons and caps; by utilizing and paying for direct
    mail and print material such as brochures, flyers, catalogs,
    business cards, posters and banners and telephone book listings;
    by purchasing inventory for sale or use as samples; and by
    training, mentoring and following up (in person or via the phone
    or internet) with customers and recruits on how to use Herbalife
    products
    and/or
    pursue the Herbalife business opportunity.
 
    Presentation
 
    Retail sales represent the gross sales amounts on
    our invoices to distributors before distributor allowances, as
    defined below, and Net sales, which reflect
    distribution allowances and handling and freight income,
    represent what we collect and recognize as net sales in our
    financial statements. We discuss retail sales because of its
    fundamental role in our compensation systems, internal controls
    and operations, including its role as the basis upon which
    distributor discounts, royalties and bonuses are awarded. In
    addition, it is used as the basis for certain
    
    20
 
    information included in daily and monthly reports reviewed by
    our management. However, such a measure is not in accordance
    with Generally Accepted Accounting Principles in the U.S., or
    GAAP. You should not consider retail sales in isolation from,
    nor as a substitute for, net sales and other consolidated income
    or cash flow statement data prepared in accordance with GAAP, or
    as a measure of profitability or liquidity. A reconciliation of
    net sales to retail sales is presented below under Results
    of Operations. Product sales represent the
    actual product purchase price paid to us by our distributors,
    after giving effect to distributor discounts referred to as
    distributor allowances, which approximate 50% of
    retail sales prices. Distributor allowances as a percentage of
    retail sales may vary by country depending upon regulatory
    restrictions that limit or otherwise restrict distributor
    allowances.
 
    Our gross profit consists of net sales less
    cost of sales, which represents the prices we pay to
    our raw material suppliers and manufacturers of our products as
    well as costs related to product shipments, duties and tariffs,
    freight expenses relating to shipment of products to
    distributors and importers and similar expenses.
 
    Royalty overrides are our most significant expense
    and consist of:
 
    |  |  |  | 
    |  |  | royalty overrides and production bonuses which total
    approximately 15% and 7%, respectively, of the retail sales of
    weight management, targeted nutrition, energy &
    fitness, Outer Nutrition and promotional products; | 
|  | 
    |  |  | the Mark Hughes bonus payable to some of our most senior
    distributors in the aggregate amount of up to 1% of retail sales
    of weight management, targeted nutrition, energy &
    fitness and Outer Nutrition; and | 
|  | 
    |  |  | other discretionary incentive cash bonuses to qualifying
    distributors. | 
 
    Royalty overrides are generally earned based on retail sales and
    approximate in the aggregate about 22% of retail sales or
    approximately 36% of our net sales. Royalty overrides together
    with distributor allowances represent the potential earnings to
    distributors of up to approximately 73% of retail sales. The
    compensation to distributors is generally for the development,
    retention and improved productivity of their distributor sales
    organizations and is paid to several levels of distributors on
    each sale. Due to restrictions on direct selling in China, our
    full-time employed sales representatives in China are
    compensated with wages, bonuses and benefits instead of the
    distributors earnings, distributor allowances and royalty
    overrides. Because of local country regulatory constraints, we
    may be required to modify our typical distributor incentive
    plans as described above. Consequently, the total distributor
    discount percentage may vary over time. We also offer reduced
    distributor allowances and pay reduced royalty overrides with
    respect to certain products worldwide.
 
    Our operating margins consist of net sales less cost
    of sales and royalty overrides.
 
    Selling, general and administrative expenses
    represent our operating expenses, components of which include
    labor and benefits, sales events, professional fees, travel and
    entertainment, distributor marketing, occupancy costs,
    communication costs, bank fees, depreciation and amortization,
    foreign exchange gains and losses and other miscellaneous
    operating expenses.
 
    Most of our sales to distributors outside the United States are
    made in the respective local currencies. In preparing our
    financial statements, we translate revenues into
    U.S. dollars using average exchange rates. Additionally,
    the majority of our purchases from our suppliers generally are
    made in U.S. dollars. Consequently, a strengthening of the
    U.S. dollar versus a foreign currency can have a negative
    impact on our reported sales and operating margins and can
    generate transaction losses on intercompany transactions.
    Throughout the last five years, foreign currency exchange rates
    have fluctuated significantly. From time to time, we enter into
    foreign exchange forward contracts to mitigate our foreign
    currency exchange risk as discussed in further detail in
    Part I, Item 3  Quantitative and
    Qualitative Disclosures about Market Risk.
 
    Summary
    Financial Results
 
    Net sales for the three months ended March 31, 2008
    increased 19.0% to $604.4 million from $508.1 million
    for the same period in 2007. The increase was primarily due to
    growth in several of the Companys top countries including,
    the U.S., Venezuela, China, and Italy with increases of 14.3%,
    299.6%, 111.5% and 29.7%, respectively, as compared to the same
    period in 2007. The increase in these countries reflects a
    robust supervisor base, the continued success of our
    distributors with various operating methods like the Nutrition
    Club DMO,
    Internet/Sampling
    DMO and Wellness Coach DMO, and distributor momentum from our
    recent sales extravaganzas. Overall, the
    
    21
 
    appreciation of foreign currencies had a $36.3 million
    favorable impact on net sales for the three months ended
    March 31, 2008, representing 37.7% of the total net sales
    increase of $96.3 million.
 
    Net income for the three months ended March 31, 2008
    increased 51.5% to $62.4 million, or $0.93 per diluted
    share, compared to $41.2 million, or $0.55 per diluted
    share, for the same period in 2007. The increase was driven by
    revenue growth in many of our markets, expansion in operating
    profit margins, and a lower effective tax rate, partially offset
    by higher labor costs, sales events costs, advertising and
    promotion expenses and depreciation expense.
 
    Net income for the three months ended March 31, 2007
    included a $1.0 million unfavorable after tax impact in
    connection with the Realignment for Growth plan and a
    $3.6 million charge for an increase in tax reserve.
 
    Results
    of Operations
 
    Our results of operations for the periods described below are
    not necessarily indicative of results of operations for future
    periods, which depend upon numerous factors, including our
    ability to recruit new distributors and retain existing
    distributors, open new markets, further penetrate existing
    markets, introduce new products and programs that will help our
    distributors increase their retail efforts and develop niche
    market segments.
 
    The following table sets forth selected results of our
    operations expressed as a percentage of net sales for the
    periods indicated.
 
    |  |  |  |  |  |  |  |  |  | 
|  |  | Three Months Ended |  | 
|  |  | March 31, 
 |  |  | March 31, 
 |  | 
|  |  | 2008 |  |  | 2007 |  | 
|  | 
| 
    Operations:
 |  |  |  |  |  |  |  |  | 
| 
    Net sales
 |  |  | 100.0 | % |  |  | 100.0 | % | 
| 
    Cost of sales
 |  |  | 19.5 |  |  |  | 21.1 |  | 
|  |  |  |  |  |  |  |  |  | 
| 
    Gross profit
 |  |  | 80.5 |  |  |  | 78.9 |  | 
| 
    Royalty overrides
 |  |  | 35.2 |  |  |  | 35.5 |  | 
| 
    Selling, general and administrative expenses
 |  |  | 30.5 |  |  |  | 29.4 |  | 
|  |  |  |  |  |  |  |  |  | 
| 
    Operating income
 |  |  | 14.8 |  |  |  | 14.0 |  | 
| 
    Interest expense, net
 |  |  | 0.6 |  |  |  | 0.4 |  | 
|  |  |  |  |  |  |  |  |  | 
| 
    Income before income taxes
 |  |  | 14.2 |  |  |  | 13.6 |  | 
| 
    Income taxes
 |  |  | 3.9 |  |  |  | 5.5 |  | 
|  |  |  |  |  |  |  |  |  | 
| 
    Net income
 |  |  | 10.3 | % |  |  | 8.1 | % | 
|  |  |  |  |  |  |  |  |  | 
    
    22
 
    Three
    months ended March 31, 2008 compared to three months ended
    March 31, 2007
 
    Net
    Sales
 
    The following chart reconciles retail sales to net sales:
 
    Sales by
    Geographic Region
 
    |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  | Three Months Ended March 31, |  | 
|  |  | 2008 |  |  | 2007 |  | 
|  |  |  |  |  |  |  |  |  |  |  | Handling 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  | Handling 
 |  |  |  |  |  | Change 
 |  | 
|  |  | Retail 
 |  |  | Distributor 
 |  |  | Product 
 |  |  | & Freight 
 |  |  | Net 
 |  |  | Retail 
 |  |  | Distributor 
 |  |  | Product 
 |  |  | & Freight 
 |  |  | Net 
 |  |  | in Net 
 |  | 
|  |  | Sales |  |  | Allowance |  |  | Sales |  |  | Income |  |  | Sales |  |  | Sales |  |  | Allowance |  |  | Sales |  |  | Income |  |  | Sales |  |  | Sales |  | 
|  |  | (Dollars in millions) |  | 
|  | 
| 
    North America
 |  | $ | 189.5 |  |  | $ | (90.2 | ) |  | $ | 99.3 |  |  | $ | 19.3 |  |  | $ | 118.6 |  |  | $ | 168.4 |  |  | $ | (80.2 | ) |  | $ | 88.2 |  |  | $ | 16.3 |  |  | $ | 104.5 |  |  |  | 13.5 | % | 
| 
    Mexico & Central America
 |  |  | 163.6 |  |  |  | (80.0 | ) |  |  | 83.6 |  |  |  | 14.0 |  |  |  | 97.6 |  |  |  | 161.3 |  |  |  | (78.4 | ) |  |  | 82.9 |  |  |  | 13.0 |  |  |  | 95.9 |  |  |  | 1.8 | % | 
| 
    South America
 |  |  | 184.8 |  |  |  | (95.2 | ) |  |  | 89.6 |  |  |  | 12.4 |  |  |  | 102.0 |  |  |  | 102.7 |  |  |  | (49.4 | ) |  |  | 53.3 |  |  |  | 7.6 |  |  |  | 60.9 |  |  |  | 67.5 | % | 
| 
    EMEA
 |  |  | 257.0 |  |  |  | (124.2 | ) |  |  | 132.8 |  |  |  | 25.2 |  |  |  | 158.0 |  |  |  | 234.1 |  |  |  | (112.7 | ) |  |  | 121.4 |  |  |  | 21.8 |  |  |  | 143.2 |  |  |  | 10.3 | % | 
| 
    Asia Pacific
 |  |  | 198.9 |  |  |  | (83.5 | ) |  |  | 115.4 |  |  |  | 12.8 |  |  |  | 128.2 |  |  |  | 164.7 |  |  |  | (72.6 | ) |  |  | 92.1 |  |  |  | 11.5 |  |  |  | 103.6 |  |  |  | 23.7 | % | 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
    Worldwide
 |  | $ | 993.8 |  |  | $ | (473.1 | ) |  | $ | 520.7 |  |  | $ | 83.7 |  |  | $ | 604.4 |  |  | $ | 831.2 |  |  | $ | (393.3 | ) |  | $ | 437.9 |  |  | $ | 70.2 |  |  | $ | 508.1 |  |  |  | 19.0 | % | 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
 
    Changes in net sales are directly associated with the recruiting
    and retention of our distributor force, retailing of our
    products, the quality and completeness of the product offerings
    that the distributor force has to sell and the number of
    countries in which we operate. Managements role, both
    in-country and at the corporate level is to provide distributors
    with a competitive and broad product line, encourage strong
    teamwork and leadership among the Chairmans Club and
    Presidents Team distributors and offer leading edge
    business tools to make doing business with Herbalife simple.
    Management uses the distributor marketing program coupled with
    educational and motivational tools and promotions to incentivize
    distributors to increase recruiting, retention and retailing,
    which in turn affect net sales. Such tools include Company
    sponsored sales events such as Extravaganzas and World Team
    Schools where large groups of distributors gather, thus allowing
    them to network with other distributors, learn recruiting,
    retention and retailing techniques from our leading distributors
    and become more familiar with how to market and sell our
    products and business opportunities. Accordingly, management
    believes that these development and motivation programs increase
    the productivity of the supervisor network. The expenses for
    such programs are included in selling, general and
    administrative expenses. Sales are driven by several factors,
    including the number and productivity of distributors and
    supervisors who continually build, educate and motivate their
    respective distribution and sales organizations. We also use
    event and non-event product promotions to motivate distributors
    to increase recruiting, retention and retailing activities.
    These promotions have prizes ranging from qualifying for events
    to product prizes and vacations. The costs of these promotions
    are included in selling, general and administrative expenses.
 
    The factors described above have helped distributors increase
    their business, which in turn has driven growth in our business.
    The discussion below of net sales by geographic region further
    details some of the above factors and describes unique growth
    factors specific to certain major countries. We believe that the
    correct business foundation, coupled with ongoing training and
    promotional initiatives, is required to increase recruiting and
    retention of distributors and retailing our products. The
    correct business foundation includes strong country management
    that works closely with the distributor leadership, unified
    distributor leadership, a broad product line that appeals to
    local consumer needs, a favorable regulatory environment, a
    scalable and stable technology platform and an attractive
    distributor marketing plan. Initiatives, such as Success
    Training Seminars, World Team Schools, Promotional Events and
    regional Extravaganzas, are integral components of developing a
    highly motivated and educated distributor sales organization
    that will work toward increasing the recruitment and retention
    of distributors.
 
    Our strategy will continue to include creating and maintaining
    growth within existing markets, while expanding into new
    markets. We expect to increase our spending in selling, general
    and administrative expenses to maintain or stimulate sales
    growth, while making strategic investments in new initiatives
    and in new markets. In addition, new ideas and DMOs are being
    generated in our regional markets and globalized where
    applicable, either by distributors, country management or
    corporate management. Examples of DMOs include the Nutrition
    Clubs in Mexico, the Total Plan in Brazil, the Wellness Coach in
    France and the Internet/Sampling in the
    U.S. Managements
    
    23
 
    strategy is to review the applicability of expanding successful
    country initiatives throughout a region, and where appropriate,
    financially support the globalization of these initiatives.
 
    North
    America
 
    The North America region reported net sales of
    $118.6 million for the three months ended March 31,
    2008. Net sales increased $14.1 million, or 13.5%, for the
    three months ended March 31, 2008, as compared to the same
    period in 2007. In local currency, net sales increased by 12.9%
    for the three months ended March 31, 2008, as compared to
    the same period in 2007. The fluctuation of foreign currency
    rates had a positive impact of $0.6 million on net sales
    for the three months ended March 31, 2008. The overall
    increase was a result of net sales growth in the U.S. of
    $14.3 million, or 14.3%, for the three months ended
    March 31, 2008, as compared to the same period in 2007.
 
    The increase in net sales in North America was led by
    distributor momentum behind the Nutrition Club DMO, and its
    extension into Commercial Clubs and Central Clubs, along with
    the emergence of the Weight Loss Challenge DMO and the
    Internet/Sampling DMO in the United States.
 
    New supervisors in the region remained flat for the three months
    ended March 31, 2008, as compared to the same period in
    2007. New supervisor growth in the United States was 1.3%.
 
    We believe the fiscal year 2008 net sales in North America
    should continue to show year over year positive growth primarily
    as a result of continued momentum in the United States behind
    expansion of the club concept, Weight Loss Challenge and
    Internet/Sampling DMOs.
 
    Mexico
    and Central America
 
    The Mexico and Central America region reported net sales of
    $97.6 million for the three months ended March 31,
    2008. Net sales increased $1.7 million, or 1.8%, for the
    three months ended March 31, 2008, as compared to the same
    period in 2007. In local currency, net sales decreased by 0.3%
    for the three months ended March 31, 2008, as compared to
    the same period in 2007. The fluctuation of foreign currency
    rates had a favorable impact of $2.0 million on net sales
    for the three months ended March 31, 2008. Net sales in
    Mexico had a decline of $0.4 million, or 0.5% for the three
    months ended March 31, 2008, as compared to the same period
    in 2007.
 
    New supervisors in the region increased 6.4% for the three
    months ended March 31, 2008, as compared to the same period
    in 2007. Mexicos new supervisors increased by 5.7% for the
    three months ended March 31, 2008.
 
    The focus of both the Mexico management team and distributor
    leadership in 2007 was to build a solid foundation for long-term
    growth including infrastructure enhancements and training. In
    the second quarter of 2008, we will sponsor the Club of
    Club Challenges as a catalyst for Nutrition Club growth
    and drive penetration deeper across the market.
 
    We believe the fiscal year 2008 net sales in Mexico and
    Central America should show year over year positive growth as a
    result of infrastructure enhancements, and better trained
    distributors driving penetration across Mexico, and focusing on
    retailing and recruiting via the Club of Clubs
    Challenge.
 
    South
    America
 
    The South America region reported net sales of
    $102.0 million for the three months ended March 31,
    2008. Net sales increased $41.1 million or 67.5% for the
    three months ended March 31, 2008, as compared to the same
    period in 2007. In local currency, net sales increased 54.2% for
    the three months ended March 31, 2008, as compared to the
    same period in 2007. The fluctuation of foreign currency rates
    had an $8.1 million favorable impact on net sales for the
    three months ended March 31, 2008. The increase was
    attributable to net sales increases in Brazil, Venezuela,
    Argentina and Peru.
 
    New supervisors in the region increased 40.7% for the three
    months ended March 31, 2008, as compared to the same period
    in 2007. This was driven by new supervisor growth in Venezuela
    and Argentina, which increased 301.9% and 31.2%, respectively,
    offset by declines in decline in Brazil 29.7% and Colombia 10.4%.
    
    24
 
    In Brazil, the regions largest market, net sales increased
    7.1% for the three months ended March 31, 2008, as compared
    to the same period in 2007, demonstrating the markets
    success in transitioning into a more balanced mix of recruiting,
    retailing and retention via the Nutrition Club DMO.
 
    Venezuela, the regions second largest market, experienced
    strong growth with net sales up 299.6% or $18.7 million for
    the three months ended March 31, 2008, as compared to the
    same period in 2007, reflecting strong distributor leadership
    focused on recruiting additional distributors and retailing
    metrics. This growth is consistent with the growth rates in the
    third and fourth quarters of 2007.
 
    In February 2008, the South America region hosted extravaganza
    events in Argentina and Venezuela with over 20,000 distributors
    in attendance. In March 2008, the region hosted a Brazil
    northeast extravaganza in Fortaleza, Brazil.
 
    We believe the fiscal year 2008 net sales in South America
    should continue to show year over year positive growth primarily
    as a result of continued momentum in Venezuela and other key
    South America markets coupled with modest growth in Brazil.
 
    EMEA
 
    The EMEA region reported net sales of $158.0 million for
    the three months ended March 31, 2008. Net sales increased
    $14.8 million, or 10.3%, for the three months ended
    March 31, 2008, as compared to the same period in 2007. In
    local currency, net sales decreased 1.7% for the three months
    ended March 31, 2008, as compared to the same period in
    2007. The fluctuation of foreign currency rates had a favorable
    impact on net sales of $17.3 million for the three months
    ended March 31, 2008.
 
    Among the largest markets in the region, Spain, France and
    Italy, reported net sales increases of 30.2%, 26.3% and 29.7%,
    respectively, as compared to the same period in 2007. Germany
    net sales declined 17.5% as it transitions to daily consumption
    models including Nutrition Clubs, while sales in the Netherlands
    remained flat compared to the same period in 2007. Growth in
    these western markets has been driven by the Wellness Coach DMO
    along with adoption of the Internet/Sampling DMO. In addition,
    Eastern European countries have shown signs of potential
    long-term growth including a net sales increase in Russia of
    64.6% driven by adoption of the Nutrition Club concept in the
    form of a Breakfast Club DMO.
 
    For the three months ended March 31, 2008, new supervisors
    for the region decreased 14.5%, with gains in Spain, France, and
    Italy which were up 16.2%, 10.8%, and 20.7% respectively,
    offsetting declines in Germany and the Netherlands of 55.6% and
    6.6%, respectively.
 
    In April and May 2008, EMEA will host a series of Spring
    Spectaculars and Leadership Development Weekends in local
    markets across the region.
 
    We expect 2008 net sales to have modest gains driven by
    continued momentum in key western markets and with eastern
    markets building momentum as we continue to develop and
    implement strategies for growth.
 
    Asia
    Pacific
 
    The Asia Pacific region reported net sales of
    $128.2 million for the three months ended March 31,
    2008. Net sales increased $24.6 million, or 23.7%, for the
    three months ended March 31, 2008, as compared to the same
    period in 2007. In local currency, net sales increased 15.7% for
    the three months ended March 31, 2008, as compared to same
    period in 2007. The fluctuation of foreign currency rates had a
    favorable impact of $8.4 million on net sales for the three
    months ended March 31, 2008. The increase in net sales in
    Asia Pacific was attributable to the increases in our four
    largest markets, Taiwan, China, Japan and South Korea.
 
    Net sales in Taiwan, our largest market in the region, increased
    $3.9 million, or 14.8%, for the three months ended March 31
    2008, as compared to the same period in 2007. Adoption of the
    Nutrition Club DMO, in the form of Commercial Clubs, has fueled
    growth in this country.
 
    Net sales in China increased $12.9 million, or 111.5%, for
    three months ended March 31, 2008, as compared to the same
    period in 2007. As of March 31, 2008, we are operating 88
    stores in China across 29 Chinese provinces, an
    
    25
 
    increase of 26 stores from March 31, 2007 and a reduction
    of 2 stores from December 31, 2007 reflecting the
    refinement in the Companys real estate strategy.
 
    Net sales in Japan, our third largest market in the region,
    increased $2.0 million, or 10.4%, for the three months
    ended March 31, 2008, as compared to the same period in
    2007 driven by the Internet/Sampling DMO.
 
    Net sales in South Korea increased $0.9 million, or 6.2%,
    for the three months ended March 31, 2008, as compared to
    the same period in 2007 from enhanced retailing and recruiting.
 
    New supervisors in the region excluding China decreased 6.2% for
    the three months ended March 31, 2008, as compared to the
    same period in 2007. New supervisors for Taiwan decreased 1.0%,
    while new supervisors for Japan and South Korea increased 1.0%
    and 11.1%, respectively.
 
    In March 2008, Herbalife hosted its annual global Herbalife
    Honors event in Singapore, where President Team members from
    around the world met and shared best practices and where
    Herbalife management gave distributors approximately
    $34 million in Mark Hughes bonus awards related to 2007.
    Herbalife is the sponsor of the Los Angeles Galaxys Asia
    tour, where the team played exhibition games in March in Hong
    Kong, Seoul, Korea and Shanghai, China.
 
    We believe the fiscal year 2008 net sales in Asia Pacific
    should continue to show positive year over year growth,
    primarily as a result of the expansion of our direct selling
    business in China along with the continued growth in Taiwan and
    improving business trends in Japan.
 
    Sales by
    Product Category
 
    |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  | Three Months Ended March 31, |  | 
|  |  | 2008 |  |  | 2007 |  | 
|  |  |  |  |  |  |  |  |  |  |  | Handling 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  | Handling 
 |  |  |  |  |  |  |  | 
|  |  | Retail 
 |  |  | Distributor 
 |  |  | Product 
 |  |  | & Freight 
 |  |  | Net 
 |  |  | Retail 
 |  |  | Distributor 
 |  |  | Product 
 |  |  | & Freight 
 |  |  | Net 
 |  |  | % Change in 
 |  | 
|  |  | Sales |  |  | Allowance |  |  | Sales |  |  | Income |  |  | Sales |  |  | Sales |  |  | Allowance |  |  | Sales |  |  | Income |  |  | Sales |  |  | Net Sales |  | 
|  |  | (Dollars in millions) |  | 
|  | 
| 
    Weight Management
 |  | $ | 644.3 |  |  | $ | (317.8 | ) |  | $ | 326.5 |  |  | $ | 54.3 |  |  | $ | 380.8 |  |  | $ | 540.2 |  |  | $ | (265.1 | ) |  | $ | 275.1 |  |  | $ | 45.6 |  |  | $ | 320.7 |  |  |  | 18.7 | % | 
| 
    Targeted Nutrition
 |  |  | 212.6 |  |  |  | (104.9 | ) |  |  | 107.7 |  |  |  | 17.9 |  |  |  | 125.6 |  |  |  | 173.5 |  |  |  | (85.2 | ) |  |  | 88.3 |  |  |  | 14.7 |  |  |  | 103.0 |  |  |  | 21.9 | % | 
| 
    Energy and Fitness
 |  |  | 40.6 |  |  |  | (20.0 | ) |  |  | 20.6 |  |  |  | 3.4 |  |  |  | 24.0 |  |  |  | 34.4 |  |  |  | (16.9 | ) |  |  | 17.5 |  |  |  | 2.9 |  |  |  | 20.4 |  |  |  | 17.6 | % | 
| 
    Outer Nutrition
 |  |  | 68.1 |  |  |  | (33.6 | ) |  |  | 34.5 |  |  |  | 5.7 |  |  |  | 40.2 |  |  |  | 61.3 |  |  |  | (30.1 | ) |  |  | 31.2 |  |  |  | 5.2 |  |  |  | 36.4 |  |  |  | 10.4 | % | 
| 
    Literature, Promotional and Other
 |  |  | 28.2 |  |  |  | 3.2 |  |  |  | 31.4 |  |  |  | 2.4 |  |  |  | 33.8 |  |  |  | 21.8 |  |  |  | 4.0 |  |  |  | 25.8 |  |  |  | 1.8 |  |  |  | 27.6 |  |  |  | 22.5 | % | 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
    Total
 |  | $ | 993.8 |  |  | $ | (473.1 | ) |  | $ | 520.7 |  |  | $ | 83.7 |  |  | $ | 604.4 |  |  | $ | 831.2 |  |  | $ | (393.3 | ) |  | $ | 437.9 |  |  | $ | 70.2 |  |  | $ | 508.1 |  |  |  | 19.0 | % | 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
 
    Our emphasis on the science of weight management, energy and
    nutrition has resulted in product introductions such as
    Niteworks®
    and Garden
    7®,
    Best
    Defense®,
    Liftoff®,
    H3Otm
    and a new Kids Line. Due to the launch of these
    products together with the continued positive sales momentum
    discussed above, net sales of weight management products,
    targeted nutrition products and energy and fitness products
    increased for the three months ended March 31, 2008, as
    compared to the same period in 2007. The increase in Outer
    Nutrition was primarily driven by higher sales of our Anti-Aging
    line for the three months ended March 31, 2008, as compared
    to the same period in 2007. We expect growth rates within our
    product categories to vary from time to time as we launch new
    products.
 
    Gross
    Profit
 
    Gross profit was $486.8 million for the three months ended
    March 31, 2008, as compared to $400.8 million for the
    same period in 2007. As a percentage of net sales, gross profit
    for the three months ended March 31, 2008 increased to
    80.5% as compared to 78.9% for the same period in 2007. The
    increase in gross profit percentage in the first quarter of 2008
    was primarily due to foreign exchange fluctuations. Also
    contributing to the increase were higher freight and excise
    taxes in certain countries during the three months ended
    March 31, 2007. Generally, gross profit percentages do not
    vary significantly as a percentage of net sales other than due
    to product or country mix, ongoing cost reduction initiatives
    and provisions for slow moving and obsolete inventory. We are
    experiencing ingredient and product price pressure in the areas
    of soy, dairy products, plastics, and transportation reflecting
    
    26
 
    current global economic trends. We believe that we have the
    ability to mitigate some of these cost increases through
    improved optimization of our supply chain coupled with select
    increases in the retail prices of our products.
 
    Royalty
    Overrides
 
    Royalty overrides as a percentage of net sales was 35.2% for the
    three months ended March 31, 2008, as compared to 35.5% in
    the same period of 2007. The decrease for the three months ended
    March 31, 2008 was primarily due to changes in the mix of
    products and countries, and the increase in sales in China where
    compensation to our full-time employee sales representatives is
    included in selling, general and administrative expenses as
    opposed to royalty overrides where it is included for all other
    distributors under our worldwide marking plan. Generally, this
    ratio varies slightly from period to period due to changes in
    the mix of products and countries because full royalty overrides
    are not paid on certain products and in certain countries. Due
    to the structure of our global compensation plan, we expect to
    see slight fluctuations in royalty overrides as a percent of net
    sales.
 
    Selling,
    General and Administrative Expenses
 
    Selling, general and administrative expenses as a percentage of
    net sales was 30.5% for the three months ended March 31,
    2008, as compared to 29.4% for the same period of 2007.
 
    For the three months ended March 31, 2008, selling, general
    and administrative expenses increased $35.0 million to
    $184.4 million from $149.4 million for the same period
    in 2007. The increase included $12.7 million in higher
    salaries and benefits due primarily to normal merit increases
    and higher compensation costs associated with full-time employee
    sales representatives in China, $5.8 million higher
    distributor sales events costs, $3.0 million increase in
    non-income tax expenses, $2.4 million in higher advertising
    and promotion expenses and $2.1 million in higher
    depreciation and amortization related mostly to the development
    of our technology infrastructure and the expansion and
    relocation to new facilities. The increases were partially
    offset by $2.0 million lower foreign exchange losses and
    $1.5 million lower professional fees.
 
    We expect 2008 selling, general and administrative expenses to
    increase in absolute dollars over 2007 levels reflecting general
    salary merit increases, continued investments in China, and
    various sales growth initiatives including sales events and
    promotions. As a result of these initiatives, selling, general
    and administrative expenses as a percentage of net sales should
    remain at or below 2007 levels.
 
    Net
    Interest Expense
 
    Net interest expense is as follows:
 
    |  |  |  |  |  |  |  |  |  | 
|  |  | Three Months Ended |  | 
|  |  | March 31, 
 |  |  | March 31, 
 |  | 
| 
    Net Interest Expense
 |  | 2008 |  |  | 2007 |  | 
|  |  | (Dollars in millions) |  | 
|  | 
| 
    Interest expense
 |  |  | 5.5 |  |  |  | 3.6 |  | 
| 
    Interest income
 |  |  | (1.7 | ) |  |  | (1.4 | ) | 
|  |  |  |  |  |  |  |  |  | 
| 
    Net interest expense
 |  | $ | 3.8 |  |  | $ | 2.2 |  | 
|  |  |  |  |  |  |  |  |  | 
 
    The increase in interest expense for the three months ended
    March 31, 2008 as compared to the same period in 2007 was
    primarily due to the higher balance of long term borrowings,
    partially offset by lower interest rates, in 2008 as compared to
    2007. See Liquidity and Capital Resources
    below for further discussion on our senior secured credit
    facility.
 
    Income
    Taxes
 
    Income taxes were $23.5 million for the three months ended
    March 31, 2008, as compared to $27.7 million for the
    same period in 2007. As a percentage of pre-tax income, the
    effective income tax rate was 27.4% for the three months ended
    March 31, 2008, as compared to 40.2% for the same period in
    2007. The decrease in the effective tax rate for the three
    months ended March 31, 2008, as compared to the same period
    in 2007, was primarily due to a decrease in the operating
    effective tax rate reflecting country mix, the tax holiday in
    China coupled with the
    
    27
 
    favorable impact of our global entity structuring and planning
    contrasting with an increase in unrecognized tax benefits during
    the quarter ended March 31, 2007.
 
    Restructuring
    Costs
 
    In July 2006, the Company initiated its realignment of its
    employee base as part of the first phase of its Realignment for
    Growth plan and during the fourth quarter of 2007, the Company
    initiated the second phase of its Realignment for Growth plan.
    The Company recorded $0.4 million and $1.5 million of
    professional fees, severance and related costs for the three
    months ended March 31, 2008 and 2007, respectively, related
    to the realignment plan. All such amounts were included in
    selling, general and administrative expenses.
 
    The Company expects to complete its Realignment for Growth plan
    in 2008 and estimates that the corresponding severance and
    related cost that will be incurred for the full fiscal
    2008 year will be approximately $3.0 million to
    $5.0 million.
 
    Liquidity
    and Capital Resources
 
    We have historically met our working capital and capital
    expenditure requirements, including funding for expansion of
    operations, through net cash flows provided by operating
    activities. Our principal source of liquidity is our operating
    cash flows. Variations in sales of our products would directly
    affect the availability of funds. There are no material
    restrictions on the ability to transfer and remit funds among
    our international affiliated companies.
 
    For the three months ended March 31, 2008, we generated
    $62.8 million of operating cash flow, as compared to
    $46.1 million for the same period in 2007. The increase in
    cash generated from operations was primarily due to an increase
    in operating income of $18.5 million driven by a 19.0%
    growth in net sales for the three months ended March 31,
    2008 compared to the same period in 2007.
 
    Capital expenditures, including capital leases, for the three
    months ended March 31, 2008 were $24.6 million, as
    compared to $9.1 million for the same period in 2007. The
    majority of these expenditures represented investments in
    management information systems, the development of our
    distributor internet initiatives, and the expansion of our
    facilities domestically and internationally. We expect to incur
    capital expenditures of approximately $95.1 million in 2008.
 
    We entered into a $300.0 million senior secured credit
    facility, comprised of a $200.0 million term loan and a
    revolving credit facility of $100.0 million, with a
    syndicate of financial institutions as lenders in July 2006. The
    term loan matures on July 21, 2013 and the revolving credit
    facility is available until July 21, 2012. The term loan
    bears interest at LIBOR plus a margin of 1.5%, or the base rate,
    which represents the prime rate offered by major
    U.S. banks, plus a margin of 0.50%. The revolving credit
    facility bears interest at LIBOR plus a margin of 1.25%, or the
    base rate, which represents the prime rate offered by major
    U.S. banks, plus a margin of 0.25%. In March 2007, we made
    a prepayment of $29.5 million on our term loan borrowings.
    In September 2007, the credit agreement was amended increasing
    the revolving credit facility by $150.0 million to fund the
    increase in the share repurchase program. During 2007, we
    borrowed an aggregate amount of $293.7 million under the
    revolving credit facility to fund our share repurchase program
    and paid $85.0 million of the revolving credit facility.
    During the first quarter of 2008, the Company paid
    $30.0 million of the revolving credit facility.
 
    The following summarizes our contractual obligations including
    interest at March 31, 2008, and the effect such obligations
    are expected to have on our liquidity and cash flows in future
    periods:
 
    |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  | Payments Due by Period |  | 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2013 & 
 |  | 
|  |  | Total |  |  | 2008 |  |  | 2009 |  |  | 2010 |  |  | 2011 |  |  | 2012 |  |  | Thereafter |  | 
|  |  | (Dollars in millions) |  | 
|  | 
| 
    Borrowings under the senior credit facility
 |  | $ | 390.3 |  |  | $ | 11.3 |  |  | $ | 14.9 |  |  | $ | 14.8 |  |  | $ | 14.8 |  |  | $ | 190.3 |  |  | $ | 144.2 |  | 
| 
    Capital leases
 |  |  | 6.9 |  |  |  | 2.3 |  |  |  | 2.1 |  |  |  | 1.0 |  |  |  | 0.7 |  |  |  | 0.7 |  |  |  | 0.1 |  | 
| 
    Operating leases
 |  |  | 132.1 |  |  |  | 25.8 |  |  |  | 27.1 |  |  |  | 20.7 |  |  |  | 13.2 |  |  |  | 11.2 |  |  |  | 34.1 |  | 
| 
    Other
 |  |  | 17.0 |  |  |  | 2.7 |  |  |  | 4.9 |  |  |  | 4.7 |  |  |  | 4.7 |  |  |  |  |  |  |  |  |  | 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
    Total
 |  | $ | 546.3 |  |  | $ | 42.1 |  |  | $ | 49.0 |  |  | $ | 41.2 |  |  | $ | 33.4 |  |  | $ | 202.2 |  |  | $ | 178.4 |  | 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
    
    28
 
    Off
    Balance Sheet Arrangements
 
    At March 31, 2008 and December 31, 2007, we had no
    material off-balance-sheet arrangements as defined in
    Item 303(a)(4)(ii) of
    Regulation S-K.
 
    Share
    Repurchases
 
    On April 18, 2007, our board of directors authorized the
    repurchase of up to $300 million of our common shares
    during the next two years, at such times and prices as
    determined by our management, as market conditions warrant. On
    August 23, 2007, our board of directors approved an
    increase of $150 million, raising the total value of our
    common shares authorized to be repurchased to $450 million.
    During 2007, we repurchased approximately 9.1 million
    common shares through open market purchases at an aggregate cost
    of $365.8 million, or an average cost of $40.39 per share.
    During the first quarter 2008, we repurchased approximately
    0.4 million common shares through open market purchases at
    an aggregate cost of $17.7 million, or an average cost of
    $39.28 per share.
 
    Dividends
 
    During the second quarter of 2007, our board of directors
    adopted a regular quarterly cash dividend program. The aggregate
    amount of dividends paid and declared during fiscal year 2007
    was $41.5 million. On January 31, 2008, our board of
    directors approved a quarterly cash dividend of $0.20 per common
    share or $12.9 million, for the fourth quarter of 2007 that
    was paid to shareholders of record on March 14, 2008.
 
    Working
    Capital and Operating Activities
 
    As of March 31, 2008 and December 31, 2007, we had
    positive working capital of $127.0 million and
    $111.5 million, respectively. Cash and cash equivalents
    were $191.1 million at March 31, 2008, compared to
    $187.4 million at December 31, 2007.
 
    We expect that cash and funds provided from operations and
    available borrowings under our new revolving credit facility
    will provide sufficient working capital to operate our business,
    to make expected capital expenditures and to meet foreseeable
    liquidity requirements, including debt service on our term loan.
    There can be no assurance, however, that our business will
    service our debt, or fund our other liquidity needs.
 
    The majority of our purchases from suppliers are generally made
    in U.S. dollars, while sales to our distributors generally
    are made in local currencies. Consequently, strengthening of the
    U.S. dollar versus a foreign currency can have a negative
    impact on operating margins and can generate transaction losses
    on intercompany transactions. For discussion of our foreign
    exchange contracts and other hedging arrangements, see
    Part 1, Item 3  Quantitative and
    Qualitative Disclosures about Market Risks.
 
    Currency restrictions enacted by the Venezuelan government in
    2003 have become more restrictive and have impacted the ability
    of our subsidiary in Venezuela, or Herbalife Venezuela, to
    obtain US dollars at the official foreign exchange rate to pay
    for imported products. Unless official foreign exchange is made
    more readily available, the results of Herbalife
    Venezuelas operations could be negatively impacted as it
    may need to obtain more US dollars from non-government sources
    where the exchange rate is weaker than the official rate.
 
    At March 31, 2008, Herbalife Venezuela had cash balances of
    approximately $33.0 million, primarily denominated in
    bolivars. During 2008, Herbalife Venezuela expects to convert
    its bolivars to US dollars using the official foreign exchange
    rate for some of its imports and dividends. As a result, we
    continue to use the official foreign exchange rate to translate
    the financial statements of Herbalife Venezuela into US dollars.
    We continue to monitor the political and economic environment in
    Venezuela and any potential changes which may affect our
    operations or our ability to repatriate cash. Herbalife
    Venezuelas net sales represented less than 5% of
    consolidated worldwide net sales for the three months ended
    March 31, 2008.
    
    29
 
    Contingencies
 
    We are from time to time engaged in routine litigation. We
    regularly review all pending litigation matters in which we are
    involved and establish reserves deemed appropriate by management
    for these litigation matters when a probable loss estimate can
    be made.
 
    Herbalife International and certain of its independent
    distributors have been named as defendants in a purported class
    action lawsuit filed February 17, 2005, in the Superior
    Court of California, County of San Francisco, and served on
    Herbalife International on March 14, 2005
    (Minton v. Herbalife International, et al). The case
    was transferred to the Los Angeles County Superior Court. The
    plaintiff is challenging the marketing practices of certain
    Herbalife International independent distributors and Herbalife
    International under various state laws prohibiting endless
    chain schemes, insufficient disclosure in assisted
    marketing plans, unfair and deceptive business practices and
    fraud and deceit. The plaintiff alleges that the Freedom Group
    system operated by certain independent distributors of Herbalife
    International products places too much emphasis on recruiting
    and encourages excessively large purchases of product and
    promotional materials by distributors. The plaintiff also
    alleges that Freedom Group pressured distributors to disseminate
    misleading promotional materials. The plaintiff seeks to hold
    Herbalife International vicariously liable for the actions of
    its independent distributors and is seeking damages and
    injunctive relief. On January 24, 2007, the Superior Court
    denied class certification of all claims, except for the claim
    under California law prohibiting endless chain
    schemes. That claim was granted California-only class
    certification, provided that class counsel is able to substitute
    in as a plaintiff a California resident with claims typical of
    the class. We believe that we have meritorious defenses to the
    suit.
 
    Herbalife International and certain of its distributors were
    defendants in a class action lawsuit filed July 16, 2003,
    in the Circuit Court of Ohio County in the State of West
    Virginia (Mey v. Herbalife International, Inc., et
    al). The complaint alleged that certain telemarketing
    practices of certain Herbalife International distributors
    violated the Telephone Consumer Protection Act, or TCPA, and
    sought to hold Herbalife International vicariously liable for
    the practices of its independent distributors. More
    specifically, the plaintiffs complaint alleged that
    several of Herbalife Internationals distributors used
    pre-recorded telephone messages and faxes to contact prospective
    customers in violation of the TCPAs prohibition of such
    practices. Without in any way acknowledging liability or
    wrongdoing by us or our independent distributors, we and the
    other defendants have reached a binding settlement with the
    plaintiffs. Under the terms of the settlement, the defendants
    collectively paid $7 million into a fund to be distributed
    to qualifying class members. The relevant amount paid by us was
    previously fully reserved in our financial statements. The
    settlement received the final approval of the Court in January
    2008.
 
    As a marketer of dietary and nutritional supplements and other
    products that are ingested by consumers or applied to their
    bodies, we have been and are currently subjected to various
    product liability claims. The effects of these claims to date
    have not been material to us, and the reasonably possible range
    of exposure on currently existing claims is not material to us.
    We believe that we have meritorious defenses to the allegations
    contained in the lawsuits. We currently maintain product
    liability insurance with an annual deductible of
    $10 million.
 
    Certain of our subsidiaries have been subject to tax audits by
    governmental authorities in their respective countries. In
    certain of these tax audits, governmental authorities are
    proposing that significant amounts of additional taxes and
    related interest and penalties are due. We and our tax advisors
    believe that there are substantial defenses to their allegations
    that additional taxes are owed, and we are vigorously contesting
    the additional proposed taxes and related charges.
 
    These matters may take several years to resolve, and we cannot
    be sure of their ultimate resolution. However, it is the opinion
    of management that adverse outcomes, if any, will not likely
    result in a material effect on our financial condition and
    operating results. This opinion is based on our belief that any
    losses we suffer would not be material and that we have
    meritorious defenses. Although we have reserved an amount that
    we believe represents the likely
    
    30
 
    outcome of the resolution of these disputes, if we are incorrect
    in our assessment, we may have to record additional expenses.
 
    Critical
    Accounting Policies
 
    Our Consolidated Financial Statements are prepared in conformity
    with GAAP, which require us to make estimates and assumptions
    that affect the reported amounts of assets and liabilities and
    disclosures of contingent assets and liabilities at the date of
    the financial statements and the reported amounts of revenue and
    expenses during the year. Actual results could differ from those
    estimates. We consider the following policies to be most
    critical in understanding the judgments that are involved in
    preparing the financial statements and the uncertainties that
    could impact our operating results, financial condition and cash
    flows.
 
    We are a network marketing company that sells a wide range of
    weight management products, nutritional supplements and personal
    care products within one industry segment as defined under
    SFAS No. 131, Disclosures about Segments of an
    Enterprise and Related Information, or SFAS 131. Our
    products are manufactured by third party providers and then sold
    to independent distributors who sell Herbalife products to
    retail consumers or other distributors. We sell products in 65
    countries throughout the world and we are organized and managed
    by geographic region. We have elected to aggregate our operating
    segments into one reporting segment, as management believes that
    our operating segments have similar operating characteristics
    and similar long term operating performance. In making this
    determination, management believes that the operating segments
    are similar in the nature of the products sold, the product
    acquisition process, the types of customers products are sold
    to, the methods used to distribute the products, and the nature
    of the regulatory environment.
 
    Revenue is recognized when products are shipped and title passes
    to the independent distributor or importer. Amounts billed for
    freight and handling costs are included in net sales. We
    generally receive the net sales price in cash or through credit
    card payments at the point of sale. Related royalty overrides
    and allowances for product returns are recorded when the
    merchandise is shipped.
 
    Allowances for product returns, primarily in connection with our
    buyback program, are provided at the time the product is
    shipped. This accrual is based upon historic return rates for
    each country and the relevant return pattern, which reflects
    anticipated returns to be received over a period of up to
    12 months following the original sale. Historically,
    product returns and buybacks have not been significant. Product
    returns and buybacks were approximately 0.8% and 0.9% of retail
    sales for the three months ended March 31, 2008 and 2007,
    respectively. No material changes in estimates have been
    recognized for the three months ended March 31, 2008 and
    2007.
 
    We record reserves against our inventory to provide for
    estimated obsolete or unsalable inventory based on assumptions
    about future demand for our products and market conditions. If
    future demand and market conditions are less favorable than
    managements assumptions, additional reserves could be
    required. Likewise, favorable future demand and market
    conditions could positively impact future operating results if
    previously reserved for inventory is sold. We reserved for
    obsolete and slow moving inventory totaling $11.5 million
    and $12.0 million as of March 31, 2008 and
    December 31, 2007, respectively.
 
    In accordance with SFAS No. 144, Accounting for the
    Impairment or Disposal of Long-Lived Assets, such as
    property, plant, and equipment, and purchased intangibles
    subject to amortization, are reviewed for impairment whenever
    events or changes in circumstances indicate that the carrying
    amount of an asset may not be recoverable. Recoverability of
    assets to be held and used is measured by a comparison of the
    carrying amount of an asset to estimated undiscounted future
    cash flows expected to be generated by the asset. If the
    carrying amount of an asset exceeds its estimated future cash
    flows, an impairment charge is recognized by the amount by which
    the carrying amount of the asset exceeds the fair value of the
    asset. Assets to be disposed of would be separately presented in
    the balance sheet and reported at the lower of the carrying
    amount or fair value less costs to sell, and are no longer
    depreciated. The assets and liabilities of a disposed group
    classified as held for sale would be presented separately in the
    appropriate asset and liability sections of the balance sheet.
 
    Goodwill and other intangibles not subject to amortization are
    tested annually for impairment, and are tested for impairment
    more frequently if events and circumstances indicate that the
    asset might be impaired. An impairment loss is recognized to the
    extent that the carrying amount exceeds the assets fair
    value. This
    
    31
 
    determination is made at the reporting unit level and consists
    of two steps. First, the Company determines the fair value of a
    reporting unit and compares it to its carrying amount. Second,
    if the carrying amount of a reporting unit exceeds its fair
    value, an impairment loss is recognized for any excess of the
    carrying amount of the reporting units goodwill and other
    intangibles over the implied fair value. The implied fair value
    is determined by allocating the fair value of the reporting unit
    in a manner similar to a purchase price allocation, in
    accordance with SFAS No. 141, Business
    Combinations. The residual fair value after this allocation
    is the implied fair value of the reporting units goodwill
    and other intangibles. As of March 31, 2008 and
    December 31, 2007 we had goodwill of approximately
    $111.5 million and marketing franchise of
    $310.0 million. No goodwill impairment was needed during
    the three months ended March 31, 2008.
 
    Contingencies are accounted for in accordance with
    SFAS No. 5, Accounting for Contingencies, or
    SFAS 5. SFAS 5 requires that we record an estimated
    loss from a loss contingency when information available prior to
    issuance of our financial statements indicates that it is
    probable that an asset has been impaired or a liability has been
    incurred at the date of the financial statements and the amount
    of the loss can be reasonably estimated. Accounting for
    contingencies such as legal and income tax matters requires us
    to use judgment. Many of these legal and tax contingencies can
    take years to be resolved. Generally, as the time period
    increases over which the uncertainties are resolved, the
    likelihood of changes to the estimate of the ultimate outcome
    increases.
 
    Deferred income tax assets have been established for net
    operating loss carryforwards of certain foreign subsidiaries and
    have been reduced by a valuation allowance to reflect them at
    amounts estimated to be ultimately realized. The net operating
    loss carryforwards expire in varying amounts over a future
    period of time. Realization of the income tax carryforwards is
    dependent on generating sufficient taxable income prior to
    expiration of the carryforwards. Although realization is not
    assured, we believe it is more likely than not that the net
    carrying value of the income tax carryforwards will be realized.
    The amount of the income tax carryforwards that is considered
    realizable, however, could change if estimates of future taxable
    income during the carryforward period are adjusted.
 
    We account for stock-based compensation in accordance with
    SFAS No. 123R, Share-Based Payment, or
    SFAS 123R. Under the fair value recognition provisions of
    this statement, share-based compensation cost is measured at the
    grant date based on the value of the award and is recognized as
    expense over the vesting period. Determining the fair value of
    share-based awards at the grant date requires judgment,
    including estimating our stock price volatility and employee
    stock award exercise behaviors. Our expected volatility is
    primarily based upon the historical volatility of our common
    shares and, due to the limited period of public trading data for
    our common shares, it is also validated against the volatility
    of a company peer group. The expected life of awards is based on
    observed historical exercise patterns, which can vary over time.
    As stock-based compensation expense recognized in the Statements
    of Income is based on awards ultimately expected to vest, the
    amount of expense has been reduced for estimated forfeitures.
    SFAS 123R requires forfeitures to be estimated at the time
    of grant and revised, if necessary, in subsequent periods if
    actual forfeitures differ from those estimates. Forfeitures were
    estimated based on historical experience.
 
    We account for uncertain tax positions in accordance with
    FIN 48, Income taxes, or FIN 48. FIN 48
    addressed the determination of how tax benefits claimed or
    expected to be claimed on a tax return should be recorded in the
    financial statements. Under FIN 48, we must recognize the
    tax benefit from an uncertain tax position only if it is more
    likely than not that the tax position will be sustained on
    examination by the taxing authorities, based on the technical
    merits of the position. The tax benefits recognized in the
    financial statements from such a position are measured based on
    the largest benefit that has a greater than fifty percent
    likelihood of being realized upon ultimate resolution. The
    impact of the adoption of FIN 48 did not have a material
    impact on our results of operations, financial condition or
    liquidity.
 
    New
    Accounting Pronouncements
 
    In March 2008, the FASB issued SFAS No. 161,
    Disclosures about Derivative Instruments and Hedging
    Activities  An Amendment of FASB Statement
    No. 133, or SFAS 161. SFAS 161 expands the
    disclosure requirements for derivative instruments and hedging
    activities. This Statement specifically requires entities to
    provide enhanced disclosures addressing the following:
    (a) how and why an entity uses derivative instruments,
    (b) how derivative instruments and related hedged items are
    accounted for under Statement 133 and its related
    
    32
 
    interpretations, and (c) how derivative instruments and
    related hedged items affect an entitys financial position,
    financial performance, and cash flows. SFAS 161 is
    effective for fiscal years and interim periods beginning after
    November 15, 2008. We are currently evaluating the
    potential impact, if any, of the adoption of SFAS 161 on
    our consolidated financial statements.
 
    In February 2008, the FASB issued FASB Staff Position
    FAS 157-2,
    or FSP
    FAS 157-2.
    FSP
    FAS 157-2
    will delay the effective date of SFAS 157 for all
    nonfinancial assets and nonfinancial liabilities, except those
    that are recognized or disclosed at fair value in the financial
    statements on a recurring basis (at least annually). FSP
    FAS 157-2
    partially defers the effective date of SFAS 157 to fiscal
    years beginning after November 15, 2008, and interim
    periods within those fiscal years for items within the scope of
    FSP 157-2.
    We are currently evaluating the potential impact, if any, of the
    adoption of FSP
    FAS 157-2
    on our consolidated financial statements.
 
    In December 2007, the FASB issued SFAS, No. 141 (revised
    2007), Business Combinations, or SFAS 141R, which
    replaces FASB Statement No. 141. SFAS 141R establishes
    principles and requirements for how an acquirer recognizes and
    measures in its financial statements the identifiable assets
    acquired, the liabilities assumed, any non controlling interest
    in the acquiree and the goodwill acquired. SFAS 141R also
    modifies the recognition for preacquisition contingencies, such
    as environmental or legal issues, restructuring plans and
    acquired research and development value in purchase accounting.
    SFAS 141R amends SFAS No. 109, Accounting for
    Income Taxes, to require the acquirer to recognize changes
    in the amount of its deferred tax benefits that are recognizable
    because of a business combination either in income from
    continuing operations in the period of the combination or
    directly in contributed capital, depending on the circumstances.
    SFAS 141R also establishes disclosure requirements which
    will enable users to evaluate the nature and financial effects
    of the business combination. SFAS 141R is effective as of
    the beginning of an entitys fiscal year that begins after
    December 15, 2008. We are currently evaluating the
    potential impact, if any, of the adoption of SFAS 141R on
    our consolidated financial statements.
 
    |  |  | 
    | Item 3. | QUANTITATIVE
    AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK | 
 
    We are exposed to market risks, which arise during the normal
    course of business from changes in interest rates and foreign
    currency exchange rates. On a selected basis, we use derivative
    financial instruments to manage or hedge these risks. All
    hedging transactions are authorized and executed pursuant to
    written guidelines and procedures.
 
    We have adopted SFAS No. 133, Accounting for
    Derivative Instruments and Hedging Activities, or
    SFAS 133. SFAS 133, as amended and interpreted,
    established accounting and reporting standards for derivative
    instruments, including certain derivative instruments embedded
    in other contracts, and for hedging activities. All derivatives,
    whether designated in hedging relationships or not, are required
    to be recorded on the balance sheet at fair value. If the
    derivative is designated as a fair-value hedge, the changes in
    the fair value of the derivative and the underlying hedged item
    are recognized concurrently in earnings. If the derivative is
    designated as a cash-flow hedge, changes in the fair value of
    the derivative are recorded in other comprehensive income, or
    OCI, and are recognized in the statement of operations when the
    hedged item affects earnings. SFAS 133 defines the
    requirements for designation and documentation of hedging
    relationships as well as ongoing effectiveness assessments in
    order to use hedge accounting. For a derivative that does not
    qualify as a hedge, changes in fair value are recognized
    concurrently in earnings.
 
    A discussion of our primary market risk exposures and
    derivatives is presented below.
 
    Foreign
    Exchange Risk
 
    We enter into foreign exchange derivatives in the ordinary
    course of business primarily to reduce exposure to currency
    fluctuations attributable to intercompany transactions and
    translation of local currency revenue. All of these foreign
    exchange contracts are designated as free standing derivatives
    for which hedge accounting does not apply.
 
    Foreign exchange forward contracts are used to hedge advances
    between subsidiaries and to partially mitigate the impact of
    foreign currency fluctuations. The objective of these contracts
    is to neutralize the impact of foreign currency movements on the
    subsidiarys operating results. The fair value of forward
    contracts is based on third-party bank quotes. All of our
    foreign exchange forward contracts have a maturity of one year
    or less as of March 31, 2008.
    
    33
 
    The following table provides information about the details of
    our foreign exchange forward contracts as of March 31, 2008:
 
    |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  | Average 
 |  |  |  |  |  |  |  | 
|  |  | Contract 
 |  |  | Notional 
 |  |  | Fair 
 |  | 
| 
    Foreign Currency
 |  | Rate |  |  | Amount |  |  | Value |  | 
|  |  |  |  |  | (In millions) |  |  | (In millions) |  | 
|  | 
| 
    At March 31, 2008
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
    Buy EUR sell MXN
 |  |  | 16.98 |  |  | $ | 60.4 |  |  | $ | (0.3 | ) | 
| 
    Buy SEK sell EUR
 |  |  | 9.40 |  |  | $ | 2.6 |  |  | $ |  |  | 
| 
    Buy GBP sell EUR
 |  |  | 0.79 |  |  | $ | 3.5 |  |  | $ |  |  | 
| 
    Buy MYR sell EUR
 |  |  | 5.04 |  |  | $ | 0.7 |  |  | $ |  |  | 
| 
    Buy NZD sell EUR
 |  |  | 1.97 |  |  | $ | 0.8 |  |  | $ |  |  | 
| 
    Buy DKK sell EUR
 |  |  | 7.46 |  |  | $ | 1.7 |  |  | $ |  |  | 
| 
    Buy PLN sell EUR
 |  |  | 3.53 |  |  | $ | 0.2 |  |  | $ |  |  | 
| 
    Buy NOK sell EUR
 |  |  | 8.03 |  |  | $ | 2.4 |  |  | $ |  |  | 
| 
    Buy YEN sell EUR
 |  |  | 156.87 |  |  | $ | 24.2 |  |  | $ |  |  | 
| 
    Buy TWD sell EUR
 |  |  | 47.02 |  |  | $ | 5.3 |  |  | $ | (0.1 | ) | 
| 
    Buy EUR sell USD
 |  |  | 1.57 |  |  | $ | 15.2 |  |  | $ | 0.1 |  | 
| 
    Buy BRL sell USD
 |  |  | 1.74 |  |  | $ | 6.9 |  |  | $ |  |  | 
| 
    Buy KRW sell USD
 |  |  | 990.50 |  |  | $ | 2.5 |  |  | $ |  |  | 
| 
    Buy INR sell USD
 |  |  | 40.02 |  |  | $ | 6.5 |  |  | $ |  |  | 
| 
    Buy USD sell EUR
 |  |  | 1.53 |  |  | $ | 165.1 |  |  | $ | (4.4 | ) | 
| 
    Buy USD sell JPY
 |  |  | 98.92 |  |  | $ | 27.4 |  |  | $ | (0.1 | ) | 
| 
    Buy USD sell MXN
 |  |  | 10.96 |  |  | $ | 128.3 |  |  | $ | (0.6 | ) | 
|  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
    Total forward contracts
 |  |  |  |  |  | $ | 453.7 |  |  | $ | (5.4 | ) | 
|  |  |  |  |  |  |  |  |  |  |  |  |  | 
 
    All our foreign subsidiaries, excluding those operating in
    hyper-inflationary environments, designate their local
    currencies as their functional currency. At March 31, 2008
    and December 31, 2007, the total amount of our foreign
    subsidiary cash was $174.7 million and $154.8 million,
    respectively, of which $7.6 million and $8.4 million,
    respectively, was invested in U.S. dollars.
 
    Interest
    Rate Risk
 
    As of March 31, 2008, the aggregate annual maturities of
    the senior secured credit facility entered into on July 2006, as
    amended, were: 2008-$1.1 million; 2009-$1.5 million;
    2010-$1.5 million; 2011-$1.5 million;
    2012-$180.2 million and $140.9 million thereafter. The
    fair value of the senior secured credit facility approximates
    its carrying value of $326.7 million as of March 31,
    2008 and $357.1 million as of December 31, 2007. The
    senior secured credit facility bears a variable interest rate,
    and on March 31, 2008 and December 31, 2007, the
    average interest rate was 4.07% and 6.26%, respectively.
 
    Under our senior secured credit facility, we are obligated to
    enter into an interest rate hedge for up to 25% of the aggregate
    principal amount of term loan for a minimum of three years. On
    August 23, 2006, we entered into a new interest rate swap
    agreement. This agreement provides for us to pay interest for a
    three-year period at a fixed rate of 5.26% on the initial
    notional principal amount of $180.0 million while receiving
    interest for the same period at the LIBOR rate on the same
    notional principal amount. The notional amount is scheduled to
    be reduced by $20 million in the second, third and fourth
    quarters of each year commencing January 1, 2007,
    throughout the term of the swap. The swap has been designated as
    a cash flow hedge against the variability in LIBOR interest rate
    on the new term loan at LIBOR plus 1.50%, thereby fixing our
    effective rate on the notional amounts at 6.76%. As of
    December 31, 2007 the swap notional amount was reduced to
    $100.0 million as scheduled. As of March 31, 2008, the
    swap notional amount was $100.0 million. As of
    March 31, 2008 and December 31, 2007, we recorded the
    interest rate swap as a liability at fair value of
    $2.5 million and $1.4 million, respectively, with the
    offsetting amounts recorded in other comprehensive income.
    
    34
 
    |  |  | 
    | Item 4. | CONTROLS
    AND PROCEDURES | 
 
    Evaluation of Disclosure Controls and
    Procedures.  Our management, including our Chief
    Executive Officer and Chief Financial Officer, has evaluated the
    effectiveness of our disclosure controls and procedures (as such
    term is defined in
    Rules 13a-15(e)
    and
    15d-15(e)
    under the Securities Exchange Act of 1934, as amended, or the
    Exchange Act) as of the end of the period covered by this
    Quarterly Report on
    Form 10-Q.
    Based on such evaluation, our Chief Executive Officer and our
    Chief Financial Officer have concluded that our disclosure
    controls and procedures were effective as of March 31, 2008.
 
    Changes in Internal Control over Financial
    Reporting.  There were no changes in our internal
    control over financial reporting (as defined in
    Rules 13a-15(f)
    and 15d-(f)
    under the Exchange Act) that occurred during the fiscal quarter
    ended March 31, 2008 that have materially affected, or are
    reasonably likely to materially affect, our internal control
    over financial reporting.
 
    FORWARD
    LOOKING STATEMENTS
 
    This document contains forward-looking statements
    within the meaning of Section 27A of the Securities Act of
    1933, as amended and Section 21E of the Securities Exchange
    Act of 1934, as amended. All statements other than statements of
    historical fact are forward-looking statements for
    purposes of federal and state securities laws, including any
    projections of earnings, revenue or other financial items; any
    statements of the plans, strategies and objectives of management
    for future operations; any statements concerning proposed new
    services or developments; any statements regarding future
    economic conditions or performance; any statements of belief;
    and any statements of assumptions underlying any of the
    foregoing. Forward-looking statements may include the words
    may, will, estimate,
    intend, continue, believe,
    expect or anticipate and any other
    similar words.
 
    Although we believe that the expectations reflected in any of
    our forward-looking statements are reasonable, actual results
    could differ materially from those projected or assumed in any
    of our forward-looking statements. Our future financial
    condition and results of operations, as well as any
    forward-looking statements, are subject to change and to
    inherent risks and uncertainties, such as those disclosed or
    incorporated by reference in our filings with the Securities and
    Exchange Commission. Important factors that could cause our
    actual results, performance and achievements, or industry
    results to differ materially from estimates or projections
    contained in our forward-looking statements include, among
    others, the following:
 
    |  |  |  | 
    |  |  | our relationship with, and our ability to influence the actions
    of, our distributors; | 
|  | 
    |  |  | adverse publicity associated with our products or network
    marketing organization; | 
|  | 
    |  |  | uncertainties relating to interpretation and enforcement of
    recently enacted legislation in China governing direct selling; | 
|  | 
    |  |  | our inability to obtain the necessary licenses to expand our
    direct selling business in China; | 
|  | 
    |  |  | adverse changes in the Chinese economy, Chinese legal system or
    Chinese governmental policies; | 
|  | 
    |  |  | improper action by our employees or international distributors
    in violation of applicable law; | 
|  | 
    |  |  | changing consumer preferences and demands; | 
|  | 
    |  |  | loss or departure of any member of our senior management team
    which could negatively impact our distributor relations and
    operating results; | 
|  | 
    |  |  | the competitive nature of our business; | 
|  | 
    |  |  | regulatory matters governing our products, including potential
    governmental or regulatory actions concerning the safety or
    efficacy of our products, and network marketing program
    including the direct selling market in which we operate; | 
|  | 
    |  |  | risks associated with operating internationally, including
    foreign exchange and devaluation risks; | 
|  | 
    |  |  | our dependence on increased penetration of existing markets; | 
    
    35
 
 
    |  |  |  | 
    |  |  | contractual limitations on our ability to expand our business; | 
|  | 
    |  |  | our reliance on our information technology infrastructure and
    outside manufacturers; | 
|  | 
    |  |  | the sufficiency of trademarks and other intellectual property
    rights; | 
|  | 
    |  |  | product concentration; | 
|  | 
    |  |  | our reliance on our management team; | 
|  | 
    |  |  | uncertainties relating to the application of transfer pricing,
    duties, value added taxes, and similar tax regulations; | 
|  | 
    |  |  | taxation relating to our distributors; | 
|  | 
    |  |  | product liability claims; and | 
|  | 
    |  |  | whether we will purchase any of our shares in the open markets
    or otherwise. | 
 
    Additional factors that could cause actual results to differ
    materially from our forward-looking statements are set forth in
    this Quarterly Report on
    Form 10-Q,
    including under the heading Risk Factors,
    Managements Discussion and Analysis of Financial
    Condition and Results of Operations and in our
    Consolidated Financial Statements and the related Notes.
 
    Forward-looking statements in this Quarterly Report on
    Form 10-Q
    speak only as of the date hereof, and forward-looking statements
    in documents attached that are incorporated by reference speak
    only as of the date of those documents. We do not undertake any
    obligation to update or release any revisions to any
    forward-looking statement or to report any events or
    circumstances after the date hereof or to reflect the occurrence
    of unanticipated events, except as required by law.
 
    PART II.
    OTHER INFORMATION
 
    |  |  | 
    | Item 1. | LEGAL
    PROCEEDINGS | 
 
    See discussion under Note 4 to the Notes to the
    Consolidated Financial Statements included in Item 1 of
    Part I of this Quarterly Report on
    Form 10-Q,
    which is incorporated herein by reference.
 
    On September 20, 2007, the Company was orally advised by
    the Los Angeles Regional Office of the Securities and Exchange
    Commission, or the SEC, that the SEC had issued a formal order
    of investigation into the timing of trading in Herbalife
    securities by a former mid-level employee. The Company does not
    believe these trades involve the Company itself. In addition, on
    November 1, 2007, the Company received a voluntary request
    for the production of documents from the staff of the Los
    Angeles Regional Office of the SEC regarding the extent of
    personal use of Herbalife products by the Companys
    distributors and the Companys related policies and
    procedures. The SEC has advised the Company that its inquiry
    should not be construed as an adverse reflection on any person,
    the Company or its common shares, or as an indication from the
    SEC or its staff that any violation of law has occurred. The
    Company is cooperating fully with the staff of the SEC in these
    matters.
 
 
    Our
    failure to establish and maintain distributor relationships for
    any reason could negatively impact sales of our products and
    harm our financial condition and operating
    results.
 
    We distribute our products exclusively through over
    1.8 million independent distributors, and we depend upon
    them directly for substantially all of our sales. To increase
    our revenue, we must increase the number of, or the productivity
    of, our distributors. Accordingly, our success depends in
    significant part upon our ability to recruit, retain and
    motivate a large base of distributors. There is a high rate of
    turnover among our distributors, a characteristic of the network
    marketing business. The loss of a significant number of
    distributors for any reason could negatively impact sales of our
    products and could impair our ability to attract new
    distributors. In our efforts to attract and retain distributors,
    we compete with other network marketing organizations, including
    those in the
    
    36
 
    weight management, dietary and nutritional supplement and
    personal care and cosmetic product industries. Our operating
    results could be harmed if our existing and new business
    opportunities and products do not generate sufficient interest
    to retain existing distributors and attract new distributors.
 
    In light of the high year-over-year rate of turnover in our
    distributor base, we have our supervisors re-qualify annually in
    order to help us maintain a more accurate count of their
    numbers. For the latest twelve month re-qualification period
    ending January 2008, 41.0% of our supervisors re-qualified.
    Distributors who purchase our product for personal consumption
    or for short-term income goals may stay with us for several
    months to one year. Supervisors who have committed time and
    effort to build a sales organization will generally stay for
    longer periods. Distributors have highly variable levels of
    training, skills and capabilities. The turnover rate of our
    distributors, and our operating results, can be adversely
    impacted if we, and our senior distributor leadership, do not
    provide the necessary mentoring, training and business support
    tools for new distributors to become successful sales people in
    a short period of time.
 
    We estimate that, of our over 1.8 million independent
    distributors, we had approximately 351,000 sales leaders as of
    March 31, 2008. These sales leaders, together with their
    downline sales organizations, account for substantially all of
    our revenues. Our distributors, including our sales leaders, may
    voluntarily terminate their distributor agreements with us at
    any time. The loss of a group of leading sales leaders, together
    with their downline sales organizations, or the loss of a
    significant number of distributors for any reason, could
    negatively impact sales of our products, impair our ability to
    attract new distributors and harm our financial condition and
    operating results.
 
    Since
    we cannot exert the same level of influence or control over our
    independent distributors as we could were they our own
    employees, our distributors could fail to comply with our
    distributor policies and procedures, which could result in
    claims against us that could harm our financial condition and
    operating results.
 
    Excluding our China sales employees, our distributors are
    independent contractors and, accordingly, we are not in a
    position to directly provide the same direction, motivation and
    oversight as we would if distributors were our own employees. As
    a result, there can be no assurance that our distributors will
    participate in our marketing strategies or plans, accept our
    introduction of new products, or comply with our distributor
    policies and procedures.
 
    Extensive federal, state and local laws regulate our business,
    products and network marketing program. Because we have expanded
    into foreign countries, our policies and procedures for our
    independent distributors differ due to the different legal
    requirements of each country in which we do business. While we
    have implemented distributor policies and procedures designed to
    govern distributor conduct and to protect the goodwill
    associated with Herbalife trademarks and tradenames, it can be
    difficult to enforce these policies and procedures because of
    the large number of distributors and their independent status.
    Violations by our independent distributors of applicable law or
    of our policies and procedures in dealing with customers could
    reflect negatively on our products and operations and harm our
    business reputation. In addition, it is possible that a court
    could hold us civilly or criminally accountable based on
    vicarious liability because of the actions of our independent
    distributors.
 
    Adverse
    publicity associated with our products, ingredients or network
    marketing program, or those of similar companies, could harm our
    financial condition and operating results.
 
    The size of our distribution force and the results of our
    operations may be significantly affected by the publics
    perception of the Company and similar companies. This perception
    is dependent upon opinions concerning:
 
    |  |  |  | 
    |  |  | the safety and quality of our products and ingredients; | 
|  | 
    |  |  | the safety and quality of similar products and ingredients
    distributed by other companies; | 
|  | 
    |  |  | our distributors; | 
|  | 
    |  |  | our network marketing program; and | 
|  | 
    |  |  | the direct selling business generally. | 
    
    37
 
 
    Adverse publicity concerning any actual or purported failure of
    our Company or our independent distributors to comply with
    applicable laws and regulations regarding product claims and
    advertising, good manufacturing practices, the regulation of our
    network marketing program, the licensing of our products for
    sale in our target markets or other aspects of our business,
    whether or not resulting in enforcement actions or the
    imposition of penalties, could have an adverse effect on the
    goodwill of our Company and could negatively affect our ability
    to attract, motivate and retain distributors, which would
    negatively impact our ability to generate revenue. We cannot
    ensure that all distributors will comply with applicable legal
    requirements relating to the advertising, labeling, licensing or
    distribution of our products.
 
    In addition, our distributors and consumers
    perception of the safety and quality of our products and
    ingredients as well as similar products and ingredients
    distributed by other companies can be significantly influenced
    by media attention, publicized scientific research or findings,
    widespread product liability claims and other publicity
    concerning our products or ingredients or similar products and
    ingredients distributed by other companies. Adverse publicity,
    whether or not accurate or resulting from consumers use or
    misuse of our products, that associates consumption of our
    products or ingredients or any similar products or ingredients
    with illness or other adverse effects, questions the benefits of
    our or similar products or claims that any such products are
    ineffective, inappropriately labeled or have inaccurate
    instructions as to their use, could negatively impact our
    reputation or the market demand for our products.
 
    From time to time we receive inquiries from government agencies
    and third parties requesting information concerning our
    products. We fully cooperate with these inquiries including,
    when requested, by the submission of detailed technical dossiers
    addressing product composition, manufacturing, process control,
    quality assurance, and contaminant testing. We understand that
    such materials are undergoing review by regulators in certain
    markets. In the course of one such inquiry the Spanish Ministry
    of Health elected to issue a press release to inform the public
    of their on-going inquiry and dialogue with our Company. We are
    confident in the safety of our products when used as directed.
    However, there can be no assurance that regulators in these or
    other markets will not take actions that might delay or prevent
    the introduction of new products, or require the reformulation
    or the temporary or permanent withdrawal of certain of our
    existing products from their markets.
 
    Adverse publicity relating to us, our products or our
    operations, including our network marketing program or the
    attractiveness or viability of the financial opportunities
    provided thereby, has had, and could again have, a negative
    effect on our ability to attract, motivate and retain
    distributors. In the mid-1980s, our products and marketing
    program became the subject of regulatory scrutiny in the United
    States, resulting in large part from claims and representations
    made about our products by our independent distributors,
    including impermissible therapeutic claims. The resulting
    adverse publicity caused a rapid, substantial loss of
    distributors in the United States and a corresponding reduction
    in sales beginning in 1985. We expect that negative publicity
    will, from time to time, continue to negatively impact our
    business in particular markets.
 
    Our
    failure to appropriately respond to changing consumer
    preferences and demand for new products or product enhancements
    could significantly harm our distributor and customer
    relationships and product sales and harm our financial condition
    and operating results.
 
    Our business is subject to changing consumer trends and
    preferences, especially with respect to weight management
    products. Our continued success depends in part on our ability
    to anticipate and respond to these changes, and we may not
    respond in a timely or commercially appropriate manner to such
    changes. Furthermore, the nutritional supplement industry is
    characterized by rapid and frequent changes in demand for
    products and new product introductions and enhancements. Our
    failure to accurately predict these trends could negatively
    impact consumer opinion of our products, which in turn could
    harm our customer and distributor relationships and cause the
    loss of sales. The success of our new product offerings and
    enhancements depends upon a number of factors, including our
    ability to:
 
    |  |  |  | 
    |  |  | accurately anticipate customer needs; | 
|  | 
    |  |  | innovate and develop new products or product enhancements that
    meet these needs; | 
|  | 
    |  |  | successfully commercialize new products or product enhancements
    in a timely manner; | 
    
    38
 
 
    |  |  |  | 
    |  |  | price our products competitively; | 
|  | 
    |  |  | manufacture and deliver our products in sufficient volumes and
    in a timely manner; and | 
|  | 
    |  |  | differentiate our product offerings from those of our
    competitors. | 
 
    If we do not introduce new products or make enhancements to meet
    the changing needs of our customers in a timely manner, some of
    our products could be rendered obsolete, which could negatively
    impact our revenues, financial condition and operating results.
 
    Due to
    the high level of competition in our industry, we might fail to
    retain our customers and distributors, which would harm our
    financial condition and operating results.
 
    The business of marketing weight management and nutrition
    products is highly competitive and sensitive to the introduction
    of new products or weight management plans, including various
    prescription drugs, which may rapidly capture a significant
    share of the market. These market segments include numerous
    manufacturers, distributors, marketers, retailers and physicians
    that actively compete for the business of consumers both in the
    United States and abroad. In addition, we anticipate that we
    will be subject to increasing competition in the future from
    sellers that utilize electronic commerce. Some of these
    competitors have longer operating histories, significantly
    greater financial, technical, product development, marketing and
    sales resources, greater name recognition, larger established
    customer bases and better-developed distribution channels than
    we do. Our present or future competitors may be able to develop
    products that are comparable or superior to those we offer,
    adapt more quickly than we do to new technologies, evolving
    industry trends and standards or customer requirements, or
    devote greater resources to the development, promotion and sale
    of their products than we do. For example, if our competitors
    develop other diet or weight loss treatments that prove to be
    more effective than our products, demand for our products could
    be reduced. Accordingly, we may not be able to compete
    effectively in our markets and competition may intensify.
 
    We are also subject to significant competition for the
    recruitment of distributors from other network marketing
    organizations, including those that market weight management
    products, dietary and nutritional supplements and personal care
    products as well as other types of products. We compete for
    global customers and distributors with regard to weight
    management, nutritional supplement and personal care products.
    Our competitors include both direct selling companies such as
    NuSkin Enterprises, Natures Sunshine, Alticor/Amway,
    Melaleuca, Avon Products, Oriflame and Mary Kay, as well as
    retail establishments such as Weight Watchers, Jenny Craig,
    General Nutrition Centers, Wal-Mart and retail pharmacies.
 
    In addition, because the industry in which we operate is not
    particularly capital intensive or otherwise subject to high
    barriers to entry, it is relatively easy for new competitors to
    emerge who will compete with us for our distributors and
    customers. In addition, the fact that our distributors may
    easily enter and exit our network marketing program contributes
    to the level of competition that we face. For example, a
    distributor can enter or exit our network marketing system with
    relative ease at any time without facing a significant
    investment or loss of capital because (1) we have a low
    upfront financial cost to become a Herbalife distributor,
    (2) we do not require any specific amount of time to work
    as a distributor, (3) we do not insist on any special
    training to be a distributor and (4) we do not prohibit a
    new distributor from working with another company. Our ability
    to remain competitive therefore depends, in significant part, on
    our success in recruiting and retaining distributors through an
    attractive compensation plan, the maintenance of an attractive
    product portfolio and other incentives. We cannot ensure that
    our programs for recruitment and retention of distributors will
    be successful, and if they are not, our financial condition and
    operating results would be harmed.
 
    We are
    affected by extensive laws, governmental regulations,
    administrative determinations, court decisions and similar
    constraints both domestically and abroad, and our failure or our
    distributors failure to comply with these restraints could
    lead to the imposition of significant penalties or claims, which
    could harm our financial condition and operating
    results.
 
    In both domestic and foreign markets, the formulation,
    manufacturing, packaging, labeling, distribution, importation,
    exportation, licensing, sale and storage of our products are
    affected by extensive laws, governmental
    
    39
 
    regulations, administrative determinations, court decisions and
    similar constraints. Such laws, regulations and other
    constraints may exist at the federal, state or local levels in
    the United States and at all levels of government in foreign
    jurisdictions. There can be no assurance that we or our
    distributors are in compliance with all of these regulations.
    Our failure or our distributors failure to comply with
    these regulations or new regulations could lead to the
    imposition of significant penalties or claims and could
    negatively impact our business. In addition, the adoption of new
    regulations or changes in the interpretations of existing
    regulations may result in significant compliance costs or
    discontinuation of product sales and may negatively impact the
    marketing of our products, resulting in significant loss of
    sales revenues.
 
    In April, 2006, the FTC issued a notice of proposed rulemaking
    which, if implemented in its originally proposed form, would
    have regulated all sellers of business opportunities
    in the United States. As originally proposed this rule would
    have applied to us and, if adopted in its proposed form, could
    have adversely impacted our U.S. business. On
    March 18, 2008, the FTC issued a revised proposed rule and,
    as indicated in the announcement accompanying the proposed rule,
    the revised proposal does not attempt to cover multilevel
    marketing companies such as Herbalife. If the revised rule were
    implemented as it is now proposed, we believe that it would not
    significantly impact our U.S. business. Based on
    information currently available, we anticipate that the rule may
    require a year or more to become final.
 
    Governmental regulations in countries where we plan to commence
    or expand operations may prevent or delay entry into those
    markets. In addition, our ability to sustain satisfactory levels
    of sales in our markets is dependent in significant part on our
    ability to introduce additional products into such markets.
    However, governmental regulations in our markets, both domestic
    and international, can delay or prevent the introduction, or
    require the reformulation or withdrawal, of certain of our
    products. For example, during the third quarter of 1995, we
    received inquiries from certain governmental agencies within
    Germany and Portugal regarding our product,
    Thermojetics®
    Instant Herbal Beverage, relating to the caffeine content of
    the product and the status of the product as an instant
    tea, which was disfavored by regulators, versus a
    beverage. Although we initially suspended the
    product sale in Germany and Portugal at the request of the
    regulators, we successfully reintroduced it once regulatory
    issues were satisfactorily resolved. In another example, during
    the second quarter of 2008 the Spanish Ministry of Health issued
    a press release informing the public of its on-going inquiry
    into the safety of our Companys products sold in Spain.
    Any such regulatory action, whether or not it results in a final
    determination adverse to us, could create negative publicity,
    with detrimental effects on the motivation and recruitment of
    distributors and, consequently, on sales.
 
    On June 25, 2007, the FDA published its final rule for
    cGMPs affecting the manufacture, packing, and holding of dietary
    supplements. The final rule requires identity testing on all
    incoming dietary ingredients, but permits the use of
    certificates of analysis or other documentation to verify the
    reliability of the ingredient suppliers. On the same date the
    FDA also published an interim final rule that outlined a
    petition process for manufacturers to request an exemption to
    the cGMP requirement for 100 percent identity testing of
    specific dietary ingredients used in the processing of dietary
    supplements. Under the interim final rule the manufacturer may
    be exempted from the dietary ingredient testing requirement if
    it can provide sufficient documentation that the reduced
    frequency of testing requested would still ensure the identity
    of the dietary ingredient. The final rule includes a phased-in
    effective date based on the size of the manufacturer. The final
    rule and the interim final rule became effective August 24,
    2007. To limit any disruption for dietary supplements produced
    by small businesses the final rule has a three year phase in for
    small businesses. Herbalife has until June 25, 2008 to
    comply with the FDAs cGMP final rule with respect to
    dietary supplements sold by Herbalife in the United States that
    the Company produces at its Suzhou, China facility. With respect
    to dietary supplements sold in the United States produced for
    Herbalife by contract manufacturers who have over
    500 employees they must be compliant with the FDAs
    final cGMP rules by June 2009, and with respect to dietary
    supplements sold by Herbalife in the United States that are
    produced by contract manufacturers having fewer than
    20 employees, they must be compliant with the FDAs
    final cGMP rule by June 2010. These rules apply only to
    manufacturers and holders of finished products and not to
    ingredient suppliers unless the ingredient supplier is
    manufacturing a final dietary supplement. The final rule differs
    from the FDAs 2003 proposed rule as it does not contain
    language regarding the regulatory status of excipients and other
    ingredients that are not dietary ingredients.
    Instead, the final rule relies on a requirement to comply with
    all other relevant regulations. Further, the final rule does not
    call for any specific finished product testing program nor does
    it require 100% testing of all finished
    
    40
 
    products. Instead the final rule calls for a
    scientifically valid system for ensuring that
    finished products meet all specifications. Although we, in
    consultation with experts in the field, are currently evaluating
    the likely impact of the final rule and the interim final rule
    on our business and the contract manufacturers we utilize to
    manufacture our products, it is likely that the final cGMP rules
    will result in additional costs and possibly the need to seek
    alternate suppliers.
 
    Our
    network marketing program could be found to be not in compliance
    with current or newly adopted laws or regulations in one or more
    markets, which could prevent us from conducting our business in
    these markets and harm our financial condition and operating
    results.
 
    Our network marketing program is subject to a number of federal
    and state regulations administered by the FTC and various state
    agencies in the United States as well as regulations on direct
    selling in foreign markets administered by foreign agencies. We
    are subject to the risk that, in one or more markets, our
    network marketing program could be found not to be in compliance
    with applicable law or regulations. Regulations applicable to
    network marketing organizations generally are directed at
    preventing fraudulent or deceptive schemes, often referred to as
    pyramid or chain sales schemes, by
    ensuring that product sales ultimately are made to consumers and
    that advancement within an organization is based on sales of the
    organizations products rather than investments in the
    organization or other non-retail sales-related criteria. The
    regulatory requirements concerning network marketing programs do
    not include bright line rules and are inherently
    fact-based, and thus, even in jurisdictions where we believe
    that our network marketing program is in full compliance with
    applicable laws or regulations governing network marketing
    systems, we are subject to the risk that these laws or
    regulations or the enforcement or interpretation of these laws
    and regulations by governmental agencies or courts can change.
    The failure of our network marketing program to comply with
    current or newly adopted regulations could negatively impact our
    business in a particular market or in general.
 
    We are also subject to the risk of private party challenges to
    the legality of our network marketing program. The multi-level
    marketing programs of other companies have been successfully
    challenged in the past, and in a current lawsuit, allegations
    have been made challenging the legality of our network marketing
    program in Belgium. Test Ankoop-Test Achat, a Belgian consumer
    protection organization, sued Herbalife International Belgium,
    S.V., or HIB, on August 26, 2004, alleging that HIB
    violated Article 84 of the Belgian Fair Trade Practices Act
    by engaging in pyramid selling, i.e., establishing a
    network of professional or non-professional sales people who
    hope to make a profit more through the expansion of that network
    than through the sale of products to end-consumers. The
    plaintiff is seeking a payment of 25,000 (equal to
    approximately $39,500 as of March 31, 2008) per
    purported violation as well as costs of the trial. For the year
    ended December 31, 2007, our net sales in Belgium were
    approximately $16.0 million. Currently, the lawsuit is in
    the pleading stage. The plaintiffs filed their initial brief on
    September 27, 2005. We filed a reply brief on May 9,
    2006. There is no date yet for the oral hearings. An adverse
    judicial determination with respect to our network marketing
    program, or in proceedings not involving us directly but which
    challenge the legality of multi-level marketing systems, in
    Belgium or in any other market in which we operate, could
    negatively impact our business.
 
    We learned on November 5, 2007 that Barry Minkow of the
    Fraud Discovery Institute had published a letter, dated
    October 29, 2007, to certain officials of the government of
    the Peoples Republic of China. The letter includes
    numerous allegations of allegedly wrongful conduct by Herbalife
    and its employees in China and elsewhere. Mr. Minkows
    letter attacks, among other things, our business practices in
    China as illegal under Chinese law. Contrary to the allegations
    in the letter, we have acted in a responsible manner with regard
    to our business plans in China including retaining knowledgeable
    Chinese counsel to assist it in complying with Chinese law. In
    connection with our application for our direct selling license
    in China, our plan and methods for business in China were
    reviewed by members of the state and provincial governments of
    China and an initial license was granted in March 2007 and a
    subsequent expansion of that license was granted in July 2007.
    In addition, we have designed and implemented systems and
    financial and operational controls intended to ensure compliance
    with applicable law. Mr. Minkow has subsequently published
    additional allegations regarding the Company, the Companys
    senior management team, and the Companys business
    practices in China and elsewhere. We believe that our plan and
    methods for business in China and elsewhere are in compliance
    with applicable law and we believe that the alleged
    
    41
 
    misrepresentations from the Companys senior management
    team are unfounded, without basis or substantiation, and do not
    constitute misrepresentations.
 
    A
    substantial portion of our business is conducted in foreign
    markets, exposing us to the risks of trade or foreign exchange
    restrictions, increased tariffs, foreign currency fluctuations
    and similar risks associated with foreign
    operations.
 
    Approximately 80% of our net sales for the year ended
    December 31, 2007, were generated outside the
    United States, exposing our business to risks associated
    with foreign operations. For example, a foreign government may
    impose trade or foreign exchange restrictions or increased
    tariffs, which could negatively impact our operations. We are
    also exposed to risks associated with foreign currency
    fluctuations. For instance, purchases from suppliers are
    generally made in U.S. dollars while sales to distributors
    are generally made in local currencies. Accordingly,
    strengthening of the U.S. dollar versus a foreign currency
    could have a negative impact on us. Although we engage in
    transactions to protect against risks associated with foreign
    currency fluctuations, we cannot be certain any hedging activity
    will effectively reduce our exchange rate exposure. Our
    operations in some markets also may be adversely affected by
    political, economic and social instability in foreign countries.
    As we continue to focus on expanding our existing international
    operations, these and other risks associated with international
    operations may increase, which could harm our financial
    condition and operating results.
 
    Currency restrictions enacted by the Venezuelan government in
    2003 have become more restrictive and have impacted the ability
    of our subsidiary in Venezuela, or Herbalife Venezuela, to
    obtain U.S. dollars at the official foreign exchange rate to pay
    for imported products. Unless our ability to obtain U.S. dollars
    at the official foreign exchange rate is made more readily
    available, the results of Herbalife Venezuelas operations
    could be negatively impacted as it may need to obtain U.S.
    dollars from non-government sources where the exchange rate is
    weaker than the official rate.
 
    Our
    expansion in China is subject to general, as well as
    industry-specific, economic, political and legal developments
    and risks in China and requires that we utilize a different
    business model from which we use elsewhere in the
    world.
 
    Our expansion of operations into China is subject to risks and
    uncertainties related to general economic, political and legal
    developments in China, among other things. The Chinese
    government exercises significant control over the Chinese
    economy, including but not limited to controlling capital
    investments, allocating resources, setting monetary policy,
    controlling foreign exchange and monitoring foreign exchange
    rates, implementing and overseeing tax regulations, providing
    preferential treatment to certain industry segments or companies
    and issuing necessary licenses to conduct business. Accordingly,
    any adverse change in the Chinese economy, the Chinese legal
    system or Chinese governmental, economic or other policies could
    have a material adverse effect on our business in China and our
    prospects generally.
 
    In August 2005, China published regulations governing direct
    selling (effective December 1, 2005) and prohibiting
    pyramid promotional schemes (effective November 1, 2005),
    and a number of administrative methods and proclamations were
    issued in September 2005 and in September 2006. These
    regulations require us to use a business model different from
    that which we offer in other markets. To allow us to operate
    under these regulations, we have created and introduced a model
    specifically for China. In China, we have Company-operated
    retail stores that sell through employed sales management
    personnel to customers and preferred customers. We provide
    training and certification procedures for sales personnel in
    China. We also have non-employee sales representatives who sell
    through our retail stores. Our sales representatives are also
    permitted by the terms of our direct selling license to sell
    away from fixed retail locations in the Jiangsu province. These
    features are not common to the business model we employ
    elsewhere in the world, and based on the direct selling licenses
    we have received and the terms of those which we hope to receive
    in the future to conduct a direct selling enterprise in China,
    our business model in China will continue in some part to
    incorporate such features. The direct selling regulations
    require us to apply for various approvals to conduct a direct
    selling enterprise in China. The process for obtaining the
    necessary licenses to conduct a direct selling business is
    protracted and cumbersome and involves multiple layers of
    Chinese governmental authorities and numerous governmental
    employees at each layer. While direct selling licenses are
    centrally issued, such licenses are generally valid only in the
    jurisdictions within which related approvals have been obtained.
    Such
    
    42
 
    approvals are generally awarded on local and provincial bases,
    and the approval process requires involvement with multiple
    ministries at each level. Our participation and conduct during
    the approval process is guided not only by distinct Chinese
    practices and customs, but is also subject to applicable laws of
    China and the other jurisdictions in which we operate our
    business, including the U.S., and our internal code of ethics.
    There is always a risk that in attempting to comply with local
    customs and practices in China during the application process or
    otherwise, we will fail to comply with requirements applicable
    to us in China itself or in other jurisdictions, and any such
    failure to comply with applicable requirements could prevent us
    from obtaining the direct selling licenses or related local or
    provincial approvals. Furthermore, we rely on certain key
    personnel in China to assist us during the approval process, and
    the loss of any such key personnel could delay or hinder our
    ability to obtain licenses or related approvals. For all of the
    above reasons, there can be no assurance that we will obtain
    additional direct-selling licenses, or obtain related approvals
    to expand into any or all of the localities or provinces in
    China that are important to our business. Our inability to
    obtain, retain, or renew any or all of the licenses or related
    approvals that are required for us to operate in China would
    negatively impact our business.
 
    Additionally, although certain regulations have been published
    with respect to obtaining such approvals, operating under such
    approvals and otherwise conducting business in China, others are
    pending, and there is uncertainty regarding the interpretation
    and enforcement of Chinese regulations. The regulatory
    environment in China is evolving, and officials in the Chinese
    government exercise broad discretion in deciding how to
    interpret and apply regulations. We cannot be certain that our
    business model will continue to be deemed by national or local
    Chinese regulatory authorities to be compliant with any such
    regulations. In the past, the Chinese government has rigorously
    monitored the direct selling market in China, and has taken
    serious action against companies that the government believed
    were engaging in activities they regarded to be in violation of
    applicable law, including shutting down their businesses and
    imposing substantial fines. As a result, there can be no
    guarantee that the Chinese governments current or future
    interpretation and application of the existing and new
    regulations will not negatively impact our business in China,
    result in regulatory investigations or lead to fines or
    penalties against us or our Chinese distributors.
 
    Chinese regulations prevent persons who are not Chinese
    nationals from engaging in direct selling in China. We cannot
    guarantee that any of our distributors living outside of China
    or any of our independent sales representatives or employed
    sales management personnel in China have not engaged or will not
    engage in activities that violate our policies in this market,
    or that violate Chinese law or other applicable law, and
    therefore result in regulatory action and adverse publicity.
 
    Recently, China enacted a labor contract law which is expected
    to become effective in 2008. We are reviewing the new law to
    determine what changes, if any, will be required in our
    employment contracts and contractual relations with our
    employees, which include certain of our salespersons. There is
    no guarantee that the new law will not adversely impact us,
    force us to change our treatment of our distributor employees,
    or cause us to change our operating plan for China.
 
    If our operations in China are successful, we may experience
    rapid growth in China, and there can be no assurances that we
    will be able to successfully manage rapid expansion of
    manufacturing operations and a rapidly growing and dynamic sales
    force. There also can be no assurances that we will not
    experience difficulties in dealing with or taking employment
    related actions (such as hiring, terminations and salary
    administration, including social benefit payments) with respect
    to our employed sales representatives, particularly given the
    highly regulated nature of the employment relationship in China.
    If we are unable to effectively manage such growth and expansion
    of our retail stores, manufacturing operations or our employees,
    our government relations may be compromised and our operations
    in China may be harmed.
 
    Our China business model, particularly with regard to sales
    management responsibilities and remuneration, differs from our
    traditional business model. There is a risk that such changes
    and transitions may not be understood by our distributors or
    employees, may be viewed negatively by our distributors or
    employees, or may not be correctly utilized by our distributors
    or employees. If that is the case, our business could be
    negatively impacted.
    
    43
 
    If we
    fail to further penetrate existing markets or successfully
    expand our business into new markets, then the growth in sales
    of our products, along with our operating results, could be
    negatively impacted.
 
    The success of our business is to a large extent contingent on
    our ability to continue to grow by entering new markets and
    further penetrating existing markets. Our ability to further
    penetrate existing markets or to successfully expand our
    business into additional countries in Eastern Europe, Southeast
    Asia, South America or elsewhere, to the extent we believe that
    we have identified attractive geographic expansion opportunities
    in the future, is subject to numerous factors, many of which are
    out of our control.
 
    In addition, government regulations in both our domestic and
    international markets can delay or prevent the introduction, or
    require the reformulation or withdrawal, of some of our
    products, which could negatively impact our business, financial
    condition and results of operations. Also, our ability to
    increase market penetration in certain countries may be limited
    by the finite number of persons in a given country inclined to
    pursue a direct selling business opportunity or consumers
    willing to purchase Herbalife products. Moreover, our growth
    will depend upon improved training and other activities that
    enhance distributor retention in our markets. While we have
    recently experienced significant growth in certain of our
    markets, we cannot assure you that such growth levels will
    continue in the immediate or long term future. Furthermore, our
    efforts to support growth in such international markets could be
    hampered to the extent that our infrastructure in such markets
    is deficient when compared to our more developed markets, such
    as the U.S. Therefore, we cannot assure you that our
    general efforts to increase our market penetration and
    distributor retention in existing markets will be successful. If
    we are unable to continue to expand into new markets or further
    penetrate existing markets, our operating results would suffer.
 
    Our
    contractual obligation to sell our products only through our
    Herbalife distributor network and to refrain from changing
    certain aspects of our marketing plan may limit our
    growth.
 
    We are a party to an agreement with our distributors that
    provides assurances that a change in ownership will not
    negatively affect certain aspects of their business. Through
    this agreement, we committed to our distributors that we will
    not sell Herbalife products through any distribution channel
    other than our network of independent Herbalife distributors.
    Thus, we are contractually prohibited from expanding our
    business by selling Herbalife products through other
    distribution channels that may be available to our competitors,
    such as over the internet, through wholesale sales, by
    establishing retail stores or through mail order systems. Since
    this is an open-ended commitment, there can be no assurance that
    we will be able to take advantage of innovative new distribution
    channels that are developed in the future.
 
    In addition, our agreement with our distributors provides that
    we will not change certain aspects of our marketing plan without
    the consent of a specified percentage of our distributors. For
    example, our agreement with our distributors provides that we
    may increase, but not decrease, the discount percentages
    available to our distributors for the purchase of products or
    the applicable royalty override percentages, including
    roll-ups,
    and production and other bonus percentages available to our
    distributors at various qualification levels within our
    distributor hierarchy. We may not modify the eligibility or
    qualification criteria for these discounts, royalty overrides
    and production and other bonuses unless we do so in a manner to
    make eligibility
    and/or
    qualification easier than under the applicable criteria in
    effect as of the date of the agreement. Our agreement with our
    distributors further provides that we may not vary the criteria
    for qualification for each distributor tier within our
    distributor hierarchy, unless we do so in such a way so as to
    make qualification easier.
 
    Although we reserved the right to make these changes to our
    marketing plan without the consent of our distributors in the
    event that changes are required by applicable law or are
    necessary in our reasonable business judgment to account for
    specific local market or currency conditions to achieve a
    reasonable profit on operations, there can be no assurance that
    our agreement with our distributors will not restrict our
    ability to adapt our marketing plan to the evolving requirements
    of the markets in which we operate. As a result, our growth may
    be limited.
 
    We
    depend on the integrity and reliability of our information
    technology infrastructure, and any related inadequacies may
    result in substantial interruptions to our
    business.
 
    Our ability to timely provide products to our distributors and
    their customers, and services to our distributors, depends on
    the integrity of our information technology system, which we are
    in the process of upgrading, including
    
    44
 
    the reliability of software and services supplied by our
    vendors. We are implementing an Oracle enterprise-wide
    technology solution, a scalable and stable open architecture
    platform, to enhance our and our distributors efficiency
    and productivity. In addition, we are upgrading our
    internet-based marketing and distributor services platform,
    MyHerbalife.com.
 
    The most important aspect of our information technology
    infrastructure is the system through which we record and track
    distributor sales, volume points, royalty overrides, bonuses and
    other incentives. We have encountered, and may encounter in the
    future, errors in our software or our enterprise network, or
    inadequacies in the software and services supplied by our
    vendors, although to date none of these errors or inadequacies
    has had a meaningful adverse impact on our business. Any such
    errors or inadequacies that we may encounter in the future may
    result in substantial interruptions to our services and may
    damage our relationships with, or cause us to lose, our
    distributors if the errors or inadequacies impair our ability to
    track sales and pay royalty overrides, bonuses and other
    incentives, which would harm our financial condition and
    operating results. Such errors may be expensive or difficult to
    correct in a timely manner, and we may have little or no control
    over whether any inadequacies in software or services supplied
    to us by third parties are corrected, if at all.
 
    Since
    we rely on independent third parties for the manufacture and
    supply of our products, if these third parties fail to reliably
    supply products to us at required levels of quality, then our
    financial condition and operating results would be
    harmed.
 
    All of our products are manufactured by outside companies,
    except for a small amount of products manufactured in our own
    manufacturing facility in China. We cannot assure you that our
    outside manufacturers will continue to reliably supply products
    to us at the levels of quality, or the quantities, we require,
    especially under the FDAs recently adopted cGMP
    regulations.
 
    Our supply contracts generally have a two-year term. Except for
    force majeure events such as natural disasters and other acts of
    God, and non-performance by Herbalife, our manufacturers
    generally cannot unilaterally terminate these contracts. These
    contracts can generally be extended by us at the end of the
    relevant time period and we have exercised this right in the
    past. Globally we have over 40 suppliers of our products. For
    our major products, we have both primary and secondary
    suppliers. Our major suppliers include Natures Bounty for
    protein powders, Fine Foods (Italy) for protein powders and
    nutritional supplements, PharmaChem Labs for teas and
    Niteworks®
    and JB Labs for fiber. In the event any of our third-party
    manufacturers were to become unable or unwilling to continue to
    provide us with products in required volumes and at suitable
    quality levels, we would be required to identify and obtain
    acceptable replacement manufacturing sources. There is no
    assurance that we would be able to obtain alternative
    manufacturing sources on a timely basis. An extended
    interruption in the supply of products would result in the loss
    of sales. In addition, any actual or perceived degradation of
    product quality as a result of reliance on third party
    manufacturers may have an adverse effect on sales or result in
    increased product returns and buybacks.
 
    If we
    fail to protect our trademarks and tradenames, then our ability
    to compete could be negatively affected, which would harm our
    financial condition and operating results.
 
    The market for our products depends to a significant extent upon
    the goodwill associated with our trademark and tradenames. We
    own, or have licenses to use, the material trademark and trade
    name rights used in connection with the packaging, marketing and
    distribution of our products in the markets where those products
    are sold. Therefore, trademark and trade name protection is
    important to our business. Although most of our trademarks are
    registered in the United States and in certain foreign countries
    in which we operate, we may not be successful in asserting
    trademark or trade name protection. In addition, the laws of
    certain foreign countries may not protect our intellectual
    property rights to the same extent as the laws of the United
    States. The loss or infringement of our trademarks or tradenames
    could impair the goodwill associated with our brands and harm
    our reputation, which would harm our financial condition and
    operating results.
 
    Unlike in most of the other markets in which we operate, limited
    protection of intellectual property is available under Chinese
    law. Accordingly, we face an increased risk in China that
    unauthorized parties may attempt to copy or otherwise obtain or
    use our trademarks, copyrights, product formulations or other
    intellectual property. Further,
    
    45
 
    since Chinese commercial law is relatively undeveloped, we may
    have limited legal recourse in the event we encounter
    significant difficulties with intellectual property theft or
    infringement. As a result, we cannot assure you that we will be
    able to adequately protect our product formulations or other
    intellectual property.
 
    We permit the limited use of our trademarks by our independent
    distributors to assist them in the marketing of our products. It
    is possible that doing so may increase the risk of unauthorized
    use or misuse of our trademarks in markets where their
    registration status differs from that asserted by our
    independent distributors, or they may be used in association
    with claims or products in a manner not permitted under
    applicable laws and regulations. Were this to occur it is
    possible that this could diminish the value of these marks or
    otherwise impair our further use of these marks.
 
    If our
    distributors fail to comply with labeling laws, then our
    financial condition and operating results would be
    harmed.
 
    Although the physical labeling of our products is not within the
    control of our independent distributors, our distributors must
    nevertheless advertise our products in compliance with the
    extensive regulations that exist in certain jurisdictions, such
    as the United States, which considers product advertising to be
    labeling for regulatory purposes.
 
    Our products are sold principally as foods, dietary supplements
    and cosmetics and are subject to rigorous FDA and related legal
    regimens limiting the types of therapeutic claims that can be
    made for our products. The treatment or cure of disease, for
    example, is not a permitted claim for these products. While we
    train and attempt to monitor our distributors marketing
    materials, we cannot ensure that all such materials comply with
    applicable regulations, including bans on therapeutic claims. If
    our distributors fail to comply with these restrictions, then we
    and our distributors could be subjected to claims, financial
    penalties, mandatory product recalls or relabeling requirements,
    which could harm our financial condition and operating results.
    Although we expect that our responsibility for the actions of
    our independent distributors in such an instance would be
    dependent on a determination that we either controlled or
    condoned a noncompliant advertising practice, there can be no
    assurance that we could not be held vicariously responsible for
    the actions of our independent distributors.
 
    If our
    intellectual property is not adequate to provide us with a
    competitive advantage or to prevent competitors from replicating
    our products, or if we infringe the intellectual property rights
    of others, then our financial condition and operating results
    would be harmed.
 
    Our future success and ability to compete depend upon our
    ability to timely produce innovative products and product
    enhancements that motivate our distributors and customers, which
    we attempt to protect under a combination of copyright,
    trademark and trade secret laws, confidentiality procedures and
    contractual provisions. However, our products are generally not
    patented domestically or abroad, and the legal protections
    afforded by common law and contractual proprietary rights in our
    products provide only limited protection and may be
    time-consuming and expensive to enforce
    and/or
    maintain. Further, despite our efforts, we may be unable to
    prevent third parties from infringing upon or misappropriating
    our proprietary rights or from independently developing
    non-infringing products that are competitive with, equivalent to
    and/or
    superior to our products.
 
    Monitoring infringement
    and/or
    misappropriation of intellectual property can be difficult and
    expensive, and we may not be able to detect any infringement or
    misappropriation of our proprietary rights. Even if we do detect
    infringement or misappropriation of our proprietary rights,
    litigation to enforce these rights could cause us to divert
    financial and other resources away from our business operations.
    Further, the laws of some foreign countries do not protect our
    proprietary rights to the same extent as do the laws of the
    United States.
 
    Additionally, third parties may claim that products we have
    independently developed infringe upon their intellectual
    property rights. For example, in a recently settled lawsuit
    Unither Pharma, Inc. and others had alleged that sales by
    Herbalife International of (1) its
    Niteworks®
    and Prelox Blue products and (2) its former products
    Womans Advantage with DHEA and Optimum Performance
    infringed on patents that are licensed to or owned by those
    parties. Although we do not believe that we are infringing on
    any third party intellectual property rights, there can be no
    assurance that one or more of our products will not be found to
    infringe upon other third party intellectual property rights in
    the future.
    
    46
 
 
    Since
    one of our products constitutes a significant portion of our
    retail sales, significant decreases in consumer demand for this
    product or our failure to produce a suitable replacement should
    we cease offering it would harm our financial condition and
    operating results.
 
    Our Formula 1 meal replacement product constitutes a significant
    portion of our sales, accounting for approximately 27.0%, 28.4%
    and 30% of retail sales for the fiscal years ended
    December 31, 2005, 2006 and 2007, respectively. If consumer
    demand for this product decreases significantly or we cease
    offering this product without a suitable replacement, then our
    financial condition and operating results would be harmed.
 
    If we
    lose the services of members of our senior management team, then
    our financial condition and operating results would be
    harmed.
 
    We depend on the continued services of our Chairman and Chief
    Executive Officer, Michael O. Johnson, and our current senior
    management team as they work closely with the senior distributor
    leadership to create an environment of inspiration, motivation
    and entrepreneurial business success. Although we have entered
    into employment agreements with certain members of our senior
    management team, and do not believe that any of them are
    planning to leave or retire in the near term, we cannot assure
    you that our senior managers will remain with us. The loss or
    departure of any member of our senior management team could
    adversely impact our distributor relations and operating
    results. If any of these executives do not remain with us, our
    business could suffer. Also, the loss of key personnel,
    including our regional and country managers, could negatively
    impact our ability to implement our business strategy, and our
    continued success will also be dependent on our ability to
    retain existing, and attract additional, qualified personnel to
    meet our needs. We currently do not maintain key
    person life insurance with respect to our senior
    management team.
 
    The
    covenants in our existing indebtedness limit our discretion with
    respect to certain business matters, which could limit our
    ability to pursue certain strategic objectives and in turn harm
    our financial condition and operating results.
 
    Our credit facility contains numerous financial and operating
    covenants that restrict our and our subsidiaries ability
    to, among other things:
 
    |  |  |  | 
    |  |  | pay dividends, redeem share capital or capital stock and make
    other restricted payments and investments; | 
|  | 
    |  |  | incur additional debt or issue preferred shares; | 
|  | 
    |  |  | impose dividend or other distribution restrictions on our
    subsidiaries; | 
|  | 
    |  |  | create liens on our and our subsidiaries assets; | 
|  | 
    |  |  | engage in transactions with affiliates; | 
|  | 
    |  |  | guarantee other indebtedness; and | 
|  | 
    |  |  | merge, consolidate or sell all or substantially all of our
    assets and the assets of our subsidiaries. | 
 
    In addition, our credit facility requires us to meet certain
    financial ratios and financial conditions. Our ability to comply
    with these covenants may be affected by events beyond our
    control, including prevailing economic, financial and industry
    conditions. Failure to comply with these covenants could result
    in a default causing all amounts to become due and payable under
    our credit facility, which is secured by substantially all of
    our assets, which the lenders thereunder could proceed to
    foreclose against.
 
    If we
    do not comply with transfer pricing, customs duties, and similar
    regulations, then we may be subjected to additional taxes,
    duties, interest and penalties in material amounts, which could
    harm our financial condition and operating
    results.
 
    As a multinational corporation, in many countries including the
    United States we are subject to transfer pricing and other tax
    regulations designed to ensure that our intercompany
    transactions are consummated at prices that have not been
    manipulated to produce a desired tax result, that appropriate
    levels of income are reported as earned by our United States or
    local entities, and that we are taxed appropriately on such
    transactions. In addition, our operations are subject to
    regulations designed to ensure that appropriate levels of
    customs duties are assessed on the importation of our products.
    We are currently subject to pending or proposed audits that are
    at various levels of review, assessment or appeal in a number of
    jurisdictions involving transfer pricing issues, income taxes,
    customs duties, value added taxes,
    
    47
 
    withholding taxes, sales and use and other taxes and related
    interest and penalties in material amounts. In one such case we
    are currently appealing a tax assessment in Spain. The Company
    believes that it has meritorious defenses. In some
    circumstances, additional taxes, interest and penalties have
    been assessed and we will be required to pay the assessments or
    post surety, in order to challenge the assessments. We have
    reserved in the consolidated financial statements an amount that
    we believe represents the most likely outcome of the resolution
    of these disputes, but if we are incorrect in our assessment we
    may have to pay the full amount asserted. Ultimate resolution of
    these matters may take several years, and the outcome is
    uncertain. If the United States Internal Revenue Service or the
    taxing authorities of any other jurisdiction were to
    successfully challenge our transfer pricing practices or our
    positions regarding the payment of income taxes, customs duties,
    value added taxes, withholding taxes, sales and use, and other
    taxes, we could become subject to higher taxes and our earnings
    would be adversely affected.
 
    We may
    be held responsible for certain taxes or assessments relating to
    the activities of our distributors, which could harm our
    financial condition and operating results.
 
    Our distributors are subject to taxation, and in some instances,
    legislation or governmental agencies impose an obligation on us
    to collect taxes, such as value added taxes, and to maintain
    appropriate records. In addition, we are subject to the risk in
    some jurisdictions of being responsible for social security and
    similar taxes with respect to our distributors. In the event
    that local laws and regulations or the interpretation of local
    laws and regulations change to require us to treat our
    independent distributors as employees, or that our distributors
    are deemed by local regulatory authorities in one or more of the
    jurisdictions in which we operate to be our employees rather
    than independent contractors under existing laws and
    interpretations, we may be held responsible for social security
    and related taxes those jurisdictions, plus any related
    assessments and penalties, which could harm our financial
    condition and operating results.
 
    We may
    incur material product liability claims, which could increase
    our costs and harm our financial condition and operating
    results.
 
    Our products consist of herbs, vitamins and minerals and other
    ingredients that are classified as foods or dietary supplements
    and are not subject to pre-market regulatory approval in the
    United States. Our products could contain contaminated
    substances, and some of our products contain some ingredients
    that do not have long histories of human consumption. We conduct
    limited clinical studies on some key products but not all
    products. Previously unknown adverse reactions resulting from
    human consumption of these ingredients could occur. As a
    marketer of dietary and nutritional supplements and other
    products that are ingested by consumers or applied to their
    bodies, we have been, and may again be, subjected to various
    product liability claims, including that the products contain
    contaminants, the products include inadequate instructions as to
    their uses, or the products include inadequate warnings
    concerning side effects and interactions with other substances.
    It is possible that widespread product liability claims could
    increase our costs, and adversely affect our revenues and
    operating income. Moreover, liability claims arising from a
    serious adverse event may increase our costs through higher
    insurance premiums and deductibles, and may make it more
    difficult to secure adequate insurance coverage in the future.
    In addition, our product liability insurance may fail to cover
    future product liability claims, thereby requiring us to pay
    substantial monetary damages and adversely affecting our
    business. Finally, given the higher level of self-insured
    retentions that we have accepted under our current product
    liability insurance policies, which are as high as approximately
    $10 million, in certain cases we may be subject to the full
    amount of liability associated with any injuries, which could be
    substantial.
 
    Several years ago, a number of states restricted the sale of
    dietary supplements containing botanical sources of ephedrine
    alkaloids and on February 6, 2004, the FDA banned the use
    of such ephedrine alkaloids. Until late 2002, we had sold
    Thermojetics®
    original green herbal tablets,
    Thermojetics®
    green herbal tablets and
    Thermojetics®
    gold herbal tablets, all of which contained ephedrine alkaloids.
    Accordingly, we run the risk of product liability claims related
    to the ingestion of ephedrine alkaloids contained in those
    products. Currently, we have been named as a defendant in
    product liability lawsuits seeking to link the ingestion of
    certain of the aforementioned products to subsequent alleged
    medical problems suffered by plaintiffs. Although we believe
    that we have meritorious defenses to the allegations contained
    in these lawsuits, and are vigorously defending these claims,
    there can be no assurance that we will prevail in our defense of
    any or all of these matters.
    
    48
 
 
    We are
    subject to, among other things, requirements regarding the
    effectiveness of internal control over financial reporting. In
    connection with these requirements, we conduct regular audits of
    our business and operations. Our failure to identify or correct
    deficiencies and areas of weakness in the course of these audits
    could adversely affect our financial condition and operating
    results.
 
    We are required to comply with various corporate governance and
    financial reporting requirements under the Sarbanes-Oxley Act of
    2002, as well as new rules and regulations adopted by the SEC,
    the Public Company Accounting Oversight Board and the New York
    Stock Exchange. In particular, we are required to include
    management and auditor reports on the effectiveness of internal
    controls over financial reporting as part of our annual reports
    on
    Form 10-K,
    pursuant to Section 404 of the Sarbanes-Oxley Act. We
    expect to continue to spend significant amounts of time and
    money on compliance with these rules. Our failure to correct any
    noted weaknesses in internal controls over financial reporting
    could result in the disclosure of material weaknesses which
    could have a material adverse effect upon the market value of
    our stock.
 
    On a regular and on-going basis, we conduct audits through our
    internal audit department of various aspects of our business and
    operations. These internal audits are conducted to insure
    compliance with our policies and to strengthen our operations
    and related internal controls. The Audit Committee of our Board
    of Directors regularly reviews the results of these internal
    audits and, when appropriate, suggests remedial measures and
    actions to correct noted deficiencies or strengthen areas of
    weakness. There can be no assurance that these internal audits
    will uncover all material deficiencies or areas of weakness in
    our operations or internal controls. If left undetected and
    uncorrected, such deficiencies and weaknesses could have a
    material adverse effect on our financial condition and results
    of operations.
 
    From time to time, the results of these internal audits may
    necessitate that we conduct further investigations into aspects
    of our business or operations. At the time of the filing of our
    Quarterly Report on
    Form 10-Q
    for the quarter ended September 30, 2006, one such
    investigation was pending. This investigation concerned certain
    activities related to one of our foreign subsidiaries and
    related matters, and involved possible violations of applicable
    law. The then pending review of this investigation necessitated
    our filing of a request for extension on
    Form 12b-25
    with the SEC. This investigation was completed in the fourth
    quarter of 2006, and the Audit Committee of our Board of
    Directors has adopted, and we have implemented, a remediation
    plan in response to the related findings. We believe the results
    of this investigation will not have a material adverse effect on
    our financial condition or results of operations. In addition,
    our business practices and operations may periodically be
    investigated by one or more of the many governmental authorities
    with jurisdiction over our worldwide operations. In the event
    that these investigations produce unfavorable results, we may be
    subjected to fines, penalties or loss of licenses or permits
    needed to operate in certain jurisdictions, any one of which
    could have a material adverse effect on our financial condition
    or operating results.
 
    Holders
    of our common shares may face difficulties in protecting their
    interests because we are incorporated under Cayman Islands
    law.
 
    Our corporate affairs are governed by our amended and restated
    memorandum and articles of association, and by the Companies Law
    (2007 Revision) and the common law of the Cayman Islands. The
    rights of our shareholders and the fiduciary responsibilities of
    our directors under Cayman Islands law are not as clearly
    established as under statutes or judicial precedent in existence
    in jurisdictions in the United States. Therefore, shareholders
    may have more difficulty in protecting their interests in the
    face of actions by our management or board of directors than
    would shareholders of a corporation incorporated in a
    jurisdiction in the United States, due to the comparatively less
    developed nature of Cayman Islands law in this area.
 
    Unlike many jurisdictions in the United States, Cayman Islands
    law does not specifically provide for shareholder appraisal
    rights on a merger or consolidation of a company. This may make
    it more difficult for shareholders to assess the value of any
    consideration they may receive in a merger or consolidation or
    to require that the offer give shareholders additional
    consideration if they believe the consideration offered is
    insufficient.
 
    Shareholders of Cayman Islands exempted companies such as
    Herbalife have no general rights under Cayman Islands law to
    inspect corporate records and accounts or to obtain copies of
    lists of our shareholders. Our directors have discretion under
    our articles of association to determine whether or not, and
    under what conditions, our corporate records may be inspected by
    our shareholders, but are not obliged to make them available to
    our
    
    49
 
    shareholders. This may make it more difficult for you to obtain
    the information needed to establish any facts necessary for a
    shareholder motion or to solicit proxies from other shareholders
    in connection with a proxy contest.
 
    Subject to limited exceptions, under Cayman Islands law, a
    minority shareholder may not bring a derivative action against
    the board of directors. Maples and Calder, our Cayman Islands
    counsel, has informed us that they are not aware of any reported
    class action or derivative action having been brought in a
    Cayman Islands court.
 
    Provisions
    of our articles of association and Cayman Islands corporate law
    may impede a takeover or make it more difficult for shareholders
    to change the direction or management of the Company, which
    could reduce shareholders opportunity to influence
    management of the Company.
 
    Our articles of association permit our board of directors to
    issue preference shares from time to time, with such rights and
    preferences as they consider appropriate. Our board of directors
    could authorize the issuance of preference shares with terms and
    conditions and under circumstances that could have an effect of
    discouraging a takeover or other transaction.
 
    In addition, our articles of association contain certain other
    provisions which could have an effect of discouraging a takeover
    or other transaction or preventing or making it more difficult
    for shareholders to change the direction or management of our
    Company, including a classified board, the inability of
    shareholders to act by written consent, a limitation on the
    ability of shareholders to call special meetings of shareholders
    and advance notice provisions. As a result, our shareholders may
    have less input into the management of our Company than they
    might otherwise have if these provisions were not included in
    our articles of association.
 
    Unlike many jurisdictions in the United States, Cayman Islands
    law does not provide for mergers as that term is understood
    under corporate law in the United States. However, Cayman
    Islands law does have statutory provisions that provide for the
    reconstruction and amalgamation of companies, which are commonly
    referred to in the Cayman Islands as schemes of
    arrangement. The procedural and legal requirements
    necessary to consummate these transactions are more rigorous and
    take longer to complete than the procedures typically required
    to consummate a merger in the United States. Under Cayman
    Islands law and practice, a scheme of arrangement in relation to
    a solvent Cayman Islands company must be approved at a
    shareholders meeting by each class of shareholders, in
    each case, by a majority of the number of holders of each class
    of a companys shares that are present and voting (either
    in person or by proxy) at such a meeting, which holders must
    also represent 75% in value of such class issued that are
    present and voting (either in person or by proxy) at such
    meeting (excluding the shares owned by the parties to the scheme
    of arrangement).
 
    The convening of these meetings and the terms of the
    amalgamation must also be sanctioned by the Grand Court of the
    Cayman Islands. Although there is no requirement to seek the
    consent of the creditors of the parties involved in the scheme
    of arrangement, the Grand Court typically seeks to ensure that
    the creditors have consented to the transfer of their
    liabilities to the surviving entity or that the scheme of
    arrangement does not otherwise have a material adverse effect on
    the creditors interests. Furthermore, the Grand Court will
    only approve a scheme of arrangement if it is satisfied that:
 
    |  |  |  | 
    |  |  | the statutory provisions as to majority vote have been complied
    with; | 
|  | 
    |  |  | the shareholders have been fairly represented at the meeting in
    question; | 
|  | 
    |  |  | the scheme of arrangement is such as a businessman would
    reasonably approve; and | 
|  | 
    |  |  | the scheme or arrangement is not one that would more properly be
    sanctioned under some other provision of the Companies Law. | 
 
    There
    is uncertainty as to shareholders ability to enforce
    certain foreign civil liabilities in the Cayman
    Islands.
 
    We are incorporated as an exempted company with limited
    liability under the laws of the Cayman Islands. A material
    portion of our assets are located outside of the United States.
    As a result, it may be difficult for our shareholders to enforce
    judgments against us or judgments obtained in U.S. courts
    predicated upon the civil liability provisions of the federal
    securities laws of the United States or any state of the United
    States.
    
    50
 
    We have been advised by our Cayman Islands counsel, Maples and
    Calder, that although there is no statutory enforcement in the
    Cayman Islands of judgments obtained in the United States, the
    courts of the Cayman Islands will  based on the
    principle that a judgment by a competent foreign court imposes
    upon the judgment debtor an obligation to pay the sum for which
    judgment has been given  recognize and enforce a
    foreign judgment of a court of competent jurisdiction if such
    judgment is final, for a liquidated sum, not in respect of taxes
    or a fine or penalty, is not inconsistent with a Cayman Islands
    judgment in respect of the same matters, and was not obtained in
    a manner, and is not of a kind, the enforcement of which is
    contrary to the public policy of the Cayman Islands. There is
    doubt, however, as to whether the Grand Court of the Cayman
    Islands will (1) recognize or enforce judgments of
    U.S. courts predicated upon the civil liability provisions
    of the federal securities laws of the United States or any state
    of the United States, or (2) in original actions brought in
    the Cayman Islands, impose liabilities predicated upon the civil
    liability provisions of the federal securities laws of the
    United States or any state of the United States, on the grounds
    that such provisions are penal in nature.
 
    The Grand Court of the Cayman Islands may stay proceedings if
    concurrent proceedings are being brought elsewhere.
 
    |  |  | 
    | Item 2. | UNREGISTERED
    SALES OF EQUITY SECURITIES AND USE OF PROCEEDS | 
 
    (a) None.
 
    (b) None.
 
    (c) On April 18, 2007, we announced that our board of
    directors authorized the repurchase of up to $300 million
    of our common shares during the next two years, at such times
    and prices as determined by management, as market conditions
    warrant. On August 23, 2007, our board of directors
    approved an increase of $150 million to this share
    repurchase program raising the total value of common shares
    authorized to be repurchased to $450 million.
 
    The following is a summary of our repurchases of common shares
    during the three months ended March 31, 2008:
 
    |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  |  |  |  |  |  |  | Total Number 
 |  |  |  |  | 
|  |  |  |  |  |  |  |  | of Shares 
 |  |  | Approximate Dollar 
 |  | 
|  |  |  |  |  |  |  |  | Purchased as 
 |  |  | Value of Shares 
 |  | 
|  |  | Total Number 
 |  |  | Average Price 
 |  |  | Part of Publicly 
 |  |  | that May Yet Be 
 |  | 
|  |  | of Shares 
 |  |  | Paid per 
 |  |  | Announced 
 |  |  | Purchased Under the 
 |  | 
| 
    Period
 |  | Purchased |  |  | Share |  |  | Plans or Programs |  |  | Plans or Programs |  | 
|  | 
| 
    January 1  January 31
 |  |  | 449,400 |  |  | $ | 39.28 |  |  |  | 449,400 |  |  | $ | 66,815,828 |  | 
| 
    February 1  February 29
 |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 66,815,828 |  | 
| 
    March 1  March 31
 |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 66,815,828 |  | 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
    Total
 |  |  | 449,400 |  |  | $ | 39.28 |  |  |  | 449,400 |  |  | $ | 66,815,828 |  | 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
 
    |  |  | 
    | Item 3. | DEFAULTS
    UPON SENIOR SECURITIES | 
 
    None.
 
    |  |  | 
    | Item 4. | SUBMISSION
    OF MATTERS TO A VOTE OF SECURITY HOLDERS | 
 
    None.
 
    |  |  | 
    | Item 5. | OTHER
    INFORMATION | 
 
    (a) None.
 
    (b) None.
 
 
    (a) Exhibit Index:
    
    51
 
    EXHIBIT INDEX
 
    |  |  |  |  |  |  |  | 
| Exhibit 
 |  |  |  |  | 
| 
    Number
 |  | 
    Description
 |  | 
    Reference
 | 
|  | 
|  | 2 | .1 |  | Agreement and Plan of Merger, dated April 10, 2002, by and among
    Herbalife International, Inc., WH Holdings (Cayman Islands) Ltd.
    and WH Acquisition Corp. |  | (a) | 
|  | 3 | .1 |  | Form of Amended and Restated Memorandum and Articles of
    Association of Herbalife Ltd. |  | (d) | 
|  | 4 | .1 |  | Form of Share Certificate |  | (d) | 
|  | 10 | .1 |  | Form of Indemnity Agreement between Herbalife International Inc.
    and certain officers and directors of Herbalife International
    Inc. |  | (a) | 
|  | 10 | .2 |  | Office lease agreement between Herbalife International of
    America Inc. and State Teachers Retirement System, dated
    July 11, 1995 |  | (a) | 
|  | 10 | .3# |  | Herbalife International of America, Inc.s Senior Executive
    Deferred Compensation Plan, effective January 1, 1996, as amended |  | (a) | 
|  | 10 | .4# |  | Herbalife International of America, Inc.s Management
    Deferred Compensation Plan, effective January 1, 1996, as amended |  | (a) | 
|  | 10 | .5 |  | Master Trust Agreement between Herbalife International of
    America, Inc. and Imperial Trust Company, Inc., effective
    January 1, 1996 |  | (a) | 
|  | 10 | .6# |  | Herbalife International Inc. 401K Profit Sharing Plan and Trust,
    as amended |  | (a) | 
|  | 10 | .7 |  | Trust Agreement for Herbalife 2001 Executive Retention Plan,
    effective March 15, 2001 |  | (a) | 
|  | 10 | .8# |  | Herbalife 2001 Executive Retention Plan, effective March 15, 2001 |  | (a) | 
|  | 10 | .9 |  | Notice to Distributors regarding Amendment to Agreements of
    Distributorship, dated as of July 18, 2002 between Herbalife
    International, Inc. and each Herbalife Distributor |  | (a) | 
|  | 10 | .10 |  | Indemnity Agreement dated as of July 31, 2002, by and among WH
    Holdings (Cayman Islands) Ltd., WH Acquisition Corp., Whitney
    & Co., LLC, Whitney V, L.P., Whitney Strategic
    Partners V, L.P., GGC Administration, L.L.C., Golden Gate
    Private Equity, Inc., CCG Investments (BVI), L.P., CCG
    Associates-AI, LLC, CCG Investment Fund-AI, LP, CCG AV,
    LLC-Series C, CCG AV, LLC-Series C, CCG AV, LLC-Series E, CCG
    Associates-QP, LLC and WH Investments Ltd. |  | (a) | 
|  | 10 | .11# |  | Independent Directors Stock Option Plan of WH Holdings
    (Cayman Islands) Ltd. |  | (a) | 
|  | 10 | .12# |  | WH Holdings (Cayman Islands) Ltd. Stock Incentive Plan, as
    restated, dated as of November 5, 2003 |  | (a) | 
|  | 10 | .13# |  | Non-Statutory Stock Option Agreement, dated as of April 3, 2003
    between WH Holdings (Cayman Islands) Ltd. and Michael O. Johnson |  | (a) | 
|  | 10 | .14# |  | Side Letter Agreement dated as of April 3, 2003 by and among WH
    Holdings (Cayman Islands) Ltd., Michael O. Johnson and the
    Shareholders listed therein |  | (a) | 
|  | 10 | .15# |  | Form of Non-Statutory Stock Option Agreement (Non-Executive
    Agreement) |  | (a) | 
|  | 10 | .16# |  | Form of Non-Statutory Stock Option Agreement (Executive
    Agreement) |  | (a) | 
|  | 10 | .17 |  | Indemnity Agreement, dated as of February 9, 2004, among WH
    Capital Corporation and Gregory Probert |  | (a) | 
|  | 10 | .18 |  | Indemnity Agreement, dated as of February 9, 2004, among WH
    Capital Corporation and Brett R. Chapman |  | (a) | 
|  | 10 | .19 |  | Stock Subscription Agreement of WH Capital Corporation, dated as
    of February 9, 2004, between WH Capital Corporation and WH
    Holdings (Cayman Islands) Ltd. |  | (a) | 
|  | 10 | .20 |  | First Amendment to Amended and Restated WH Holdings (Cayman
    Islands) Ltd. Stock Incentive Plan, dated November 5, 2003 |  | (a) | 
|  | 10 | .21 |  | Registration Rights Agreement, dated as of July 31, 2002, by and
    among WH Holdings (Cayman Islands) Ltd., Whitney V, L.P.,
    Whitney Strategic Partners V, L.P., WH Investments Ltd.,
    CCG Investments (BVI), L.P., CCG Associates-QP, LLC, CCG
    Associates-AI, LLC, CCG Investment Fund-AI, L.P., CCG AV,
    LLC-Series C and CCG AV, LLC-Series E. |  | (b) | 
|  | 10 | .22 |  | Share Purchase Agreement, dated as of July 31, 2002, by and
    among WH Holdings (Cayman Islands) Ltd., Whitney Strategic
    Partners V, L.P., WH Investments Ltd., Whitney V,
    L.P., CCG Investments (BVI), L.P., CCG Associates-QP, LLC, CCG
    Associates-AI, LLC, CCG Investment Fund-AI, LP, CCG AV,
    LLC-Series C and CCG AV, LLC-Series E. |  | (b) | 
    
    52
 
    |  |  |  |  |  |  |  | 
| Exhibit 
 |  |  |  |  | 
| 
    Number
 |  | 
    Description
 |  | 
    Reference
 | 
|  | 
|  | 10 | .23 |  | Form of Indemnification Agreement between Herbalife Ltd. and the
    directors and certain officers of Herbalife Ltd. |  | (c) | 
|  | 10 | .24# |  | Herbalife Ltd. 2004 Stock Incentive Plan, effective December 1,
    2004 |  | (c) | 
|  | 10 | .25 |  | Termination Agreement, dated as of December 1, 2004, between
    Herbalife Ltd., Herbalife International, Inc. and Whitney &
    Co., LLC. |  | (d) | 
|  | 10 | .26 |  | Termination Agreement, dated as of December 1, 2004, between
    Herbalife Ltd., Herbalife International Inc. and GGC
    Administration, L.L.C. |  | (d) | 
|  | 10 | .27 |  | Indemnification Agreement, dated as of December 13, 2004, by and
    among Herbalife Ltd., Herbalife International, Inc.,
    Whitney V, L.P., Whitney Strategic Partners V, L.P.,
    CCG Investments (BVI), L.P., CCG Associates-QP, LLC, CCG
    Associates-AI, LLC, CCG Investment Fund-AI, LP, CCG AV,
    LLC-Series C, CCG AV, LLC-Series E, CCG CI, LLC and GGC
    Administration, LLC. |  | (d) | 
|  | 10 | .28# |  | Amendment No. 1 to Herbalife Ltd. 2004 Stock Incentive Plan |  | (e) | 
|  | 10 | .29# |  | Form of Stock Bonus Award Agreement |  | (e) | 
|  | 10 | .30# |  | Employment Agreement Effective as of January 1, 2005 between
    Herbalife Ltd. and Henry Burdick |  | (f) | 
|  | 10 | .31# |  | Form of 2004 Herbalife Ltd. 2004 Stock Incentive Plan Stock
    Option Agreement |  | (g) | 
|  | 10 | .32# |  | Form of 2004 Herbalife Ltd. 2004 Stock Incentive Plan
    Non-Employee Director Stock Option Agreement |  | (g) | 
|  | 10 | .33 |  | Service Agreement by and between Herbalife Europe Limited and
    Wynne Roberts ESQ, dated as of September 6, 2005 |  | (h) | 
|  | 10 | .34# |  | Independent Directors Deferred Compensation and Stock Unit Plan |  | (i) | 
|  | 10 | .35# |  | Independent Directors Stock Unit Award Agreement |  | (i) | 
|  | 10 | .36# |  | Form of Herbalife Ltd. 2005 Stock Incentive Plan Stock Unit
    Award Agreement |  | (j) | 
|  | 10 | .37# |  | Form of Herbalife Ltd. 2005 Stock Incentive Plan Stock
    Appreciation Right Award Agreement |  | (j) | 
|  | 10 | .38# |  | Form of Herbalife Ltd. 2005 Stock Incentive Plan Stock Unit
    Award Agreement applicable to Mr. Michael O. Johnson |  | (k) | 
|  | 10 | .39# |  | Form of Herbalife Ltd. 2005 Stock Incentive Plan Stock
    Appreciation Right Award Agreement applicable to Mr. Michael O.
    Johnson |  | (k) | 
|  | 10 | .40# |  | Amendment to Herbalife Ltd. Independent Directors Deferred
    Compensation and Stock Unit Plan |  | (l) | 
|  | 10 | .41# |  | Form of Herbalife Ltd. 2005 Stock Incentive Plan Stock Unit
    Award Agreement applicable to Messrs. Gregory Probert, Brett R.
    Chapman and Richard Goudis |  | (m) | 
|  | 10 | .42# |  | Form of Herbalife Ltd. 2005 Stock Incentive Plan Stock
    Appreciation Right Award Agreement applicable to Messrs. Gregory
    Probert, Brett R. Chapman and Richard Goudis |  | (m) | 
|  | 10 | .43# |  | Employment agreement dated December 18, 2007 between Herbalife
    International of America, Inc. and Paul Noack |  | (n) | 
|  | 10 | .44# |  | Summary of Board Committee Compensation |  | (o) | 
|  | 10 | .45 |  | Form of Credit Agreement, dated as of July 21, 2006, by and
    among Herbalife International Inc., Herbalife Ltd., WH
    Intermediate Holdings Ltd., HBL Ltd., WH Luxembourg Holdings
    S.á.R.L., Herbalife International Luxembourg S.á.R.L.,
    HLF Luxembourg Holdings, S.á.R.L., WH Capital Corporation,
    WH Luxembourg Intermediate Holdings S.á.R.L., HV Holdings
    Ltd., Herbalife Distribution Ltd., Herbalife Luxembourg
    Distribution S.á.R.L., and the Subsidiary Guarantors party
    thereto in favor of Merrill Lynch Capital Corporation, as
    Collateral Agent |  | (p) | 
|  | 10 | .46 |  | Form of Security Agreement, dated as of July 21, 2006, by and
    among Herbalife International, Inc., Herbalife Ltd., WH
    Intermediate Holdings Ltd., HBL Ltd., WH Luxembourg Holdings
    S.á.R.L., Herbalife International Luxembourg S.á.R.L.,
    HLF Luxembourg Holdings, S.á.R.L., WH Capital Corporation,
    WH Luxembourg Intermediate Holdings S.á.R.L., HV Holdings
    Ltd., Herbalife Distribution Ltd., Herbalife Luxembourg
    Distribution S.á.R.L., and the Subsidiary Guarantors party
    thereto in favor of Merrill Lynch Capital Corporation, as
    Collateral Agent |  | (p) | 
|  | 10 | .47# |  | Amended and Restated Independent Directors Deferred Compensation
    and Stock Unit Plan |  | (p) | 
    53
 
    |  |  |  |  |  |  |  | 
| Exhibit 
 |  |  |  |  | 
| 
    Number
 |  | 
    Description
 |  | 
    Reference
 | 
|  | 
|  | 10 | .48# |  | Employment Agreement by and between Herbalife Ltd. and Gregory
    L. Probert dated October 10, 2006 |  | (q) | 
|  | 10 | .49# |  | Employment Agreement by and between Herbalife Ltd. and Brett R.
    Chapman dated October 10, 2006 |  | (q) | 
|  | 10 | .50# |  | Stock Unit Agreement by and between Herbalife Ltd. and Gregory
    L. Probert dated October 10, 2006 |  | (q) | 
|  | 10 | .51# |  | Stock Unit Agreement by and between Herbalife Ltd. and Brett R.
    Chapman dated October 10, 2006 |  | (q) | 
|  | 10 | .52# |  | Second Amendment dated October 10, 2006, to Stock Option
    Agreement by and between Herbalife Ltd. and Gregory L. Probert
    dated July 31, 2003 |  | (q) | 
|  | 10 | .53# |  | Amendment dated October 10, 2006, to Stock Option Agreement by
    and between Herbalife Ltd. and Gregory L. Probert dated
    September 1, 2004 |  | (q) | 
|  | 10 | .54# |  | Amendment dated October 10, 2006, to Stock Option Agreement by
    and between Herbalife Ltd. and Gregory L. Probert dated December
    1, 2004 |  | (q) | 
|  | 10 | .55# |  | Amendment dated October 10, 2006, to Stock Option Agreement by
    and between Herbalife Ltd. and Gregory L. Probert dated April
    27, 2005 |  | (q) | 
|  | 10 | .56# |  | Second Amendment dated October 10, 2006, to Stock Option
    Agreement by and between Herbalife Ltd. and Gregory L. Probert
    dated October 6, 2003 |  | (q) | 
|  | 10 | .57# |  | Amendment dated October 10, 2006, to Stock Option Agreement by
    and between Herbalife Ltd. and Brett R. Chapman dated September
    1, 2004 |  | (q) | 
|  | 10 | .58# |  | Amendment dated October 10, 2006, to Stock Option Agreement by
    and between Herbalife Ltd. and Brett R. Chapman dated December
    1, 2004 |  | (q) | 
|  | 10 | .59# |  | Amendment dated October 10, 2006, to Stock Option Agreement by
    and between Herbalife Ltd. and Brett R. Chapman dated April 27,
    2005 |  | (q) | 
|  | 10 | .60# |  | Employment Agreement by and between Herbalife Ltd. and Richard
    P. Goudis dated October 24, 2006 |  | (r) | 
|  | 10 | .61# |  | Stock Unit Agreement by and between Herbalife Ltd. and Richard
    P. Goudis dated October 24, 2006 |  | (r) | 
|  | 10 | .62# |  | Amendment dated October 24, 2006, to Stock Option Agreement by
    and between Herbalife Ltd. and Richard P. Goudis dated June 14,
    2004 |  | (r) | 
|  | 10 | .63# |  | Amendment dated October 24, 2006, to Stock Option Agreement by
    and between Herbalife Ltd. and Richard P. Goudis dated September
    1, 2004 |  | (r) | 
|  | 10 | .64# |  | Amendment dated October 24, 2006, to Stock Option Agreement by
    and between Herbalife Ltd. and Richard P. Goudis dated December
    1, 2004 |  | (r) | 
|  | 10 | .65# |  | Amendment dated October 24, 2006, to Stock Option Agreement by
    and between Herbalife Ltd. and Richard P. Goudis dated April 27,
    2005 |  | (r) | 
|  | 10 | .66# |  | Form of Herbalife Ltd. 2005 Stock Incentive Plan Stock Unit
    Award Agreement applicable to Michael O. Johnson |  | (s) | 
|  | 10 | .67# |  | Form of Herbalife Ltd. 2005 Stock Incentive Plan Stock
    Appreciation Right Award Agreement applicable to Michael O.
    Johnson |  | (s) | 
|  | 10 | .68# |  | Form of Herbalife Ltd. 2005 Stock Incentive Plan Stock Unit
    Award Agreement applicable to Messrs. Gregory L. Probert,
    Richard P. Goudis and Brett R. Chapman |  | (s) | 
|  | 10 | .69# |  | Form of Herbalife Ltd. 2005 Stock Incentive Plan Stock
    Appreciation Right Award Agreement applicable to Messrs. Gregory
    L. Probert, Richard P. Goudis and Brett R. Chapman |  | (s) | 
|  | 10 | .70# |  | Form of Herbalife Ltd. 2005 Stock Incentive Plan Stock Unit
    Award Agreement |  | (s) | 
|  | 10 | .71# |  | Form of Herbalife Ltd. 2005 Stock Incentive Plan Stock
    Appreciation Right Award Agreement |  | (s) | 
    54
 
    |  |  |  |  |  |  |  | 
| Exhibit 
 |  |  |  |  | 
| 
    Number
 |  | 
    Description
 |  | 
    Reference
 | 
|  | 
|  | 10 | .72 |  | First Amendment dated June 21, 2007, to Form of Credit
    Agreement, dated as of July 21, 2006, by and among Herbalife
    International Inc., Herbalife Ltd., WH Intermediate Holdings
    Ltd., HBL Ltd., WH Luxembourg Holdings S.á.R.L., Herbalife
    International Luxembourg S.á.R.L., HLF Luxembourg Holdings,
    S.á.R.L., WH Capital Corporation, WH Luxembourg
    Intermediate Holdings S.á.R.L., HV Holdings Ltd., Herbalife
    Distribution Ltd., Herbalife Luxembourg Distribution
    S.á.R.L., and the Subsidiary Guarantors party thereto in
    favor of Merrill Lynch Capital Corporation, as Collateral Agent |  | (t) | 
|  | 10 | .73 |  | Second Amendment dated September 17, 2007, to Form of Credit
    Agreement, dated as of July 21, 2006, by and among Herbalife
    International Inc., Herbalife Ltd., WH Intermediate Holdings
    Ltd., HBL Ltd., WH Luxembourg Holdings S.á.R.L., Herbalife
    International Luxembourg S.á.R.L., HLF Luxembourg Holdings,
    S.á.R.L., WH Capital Corporation, WH Luxembourg
    Intermediate Holdings S.á.R.L., HV Holdings Ltd., Herbalife
    Distribution Ltd., Herbalife Luxembourg Distribution
    S.á.R.L., and the Subsidiary Guarantors party thereto in
    favor of Merrill Lynch Capital Corporation, as Collateral Agent |  | (t) | 
|  | 10 | .74 |  | Third Amendment dated November 30, 2007, to Form of Credit
    Agreement, dated as of July 21, 2006, by and among Herbalife
    International Inc., Herbalife Ltd., WH Intermediate Holdings
    Ltd., HBL Ltd., WH Luxembourg Holdings S.á.R.L., Herbalife
    International Luxembourg S.á.R.L., HLF Luxembourg Holdings,
    S.á.R.L., WH Capital Corporation, WH Luxembourg
    Intermediate Holdings S.á.R.L., HV Holdings Ltd., Herbalife
    Distribution Ltd., Herbalife Luxembourg Distribution
    S.á.R.L., and the Subsidiary Guarantors party thereto in
    favor of Merrill Lynch Capital Corporation, as Collateral Agent |  | (u) | 
|  | 10 | .75 |  | Herbalife Ltd. Employee Stock Purchase Plan |  | (u) | 
|  | 10 | .76 |  | Fourth Amendment dated February 21, 2008, to Form of Credit
    Agreement, dated as of July 21, 2006, by and among Herbalife
    International Inc., Herbalife Ltd., WH Intermediate Holdings
    Ltd., HBL Ltd., WH Luxembourg Holdings S.á.R.L., Herbalife
    International Luxembourg S.á.R.L., HLF Luxembourg Holdings,
    S.á.R.L., WH Capital Corporation, WH Luxembourg
    Intermediate Holdings S.á.R.L., HV Holdings Ltd., Herbalife
    Distribution Ltd., Herbalife Luxembourg Distribution
    S.á.R.L., and the Subsidiary Guarantors party thereto in
    favor of Merrill Lynch Capital Corporation, as Collateral Agent |  | (u) | 
|  | 10 | .77# |  | Employment Agreement dated as of April 1, 2008 between Michael
    O. Johnson and Herbalife International of America, Inc. |  | (v) | 
|  | 10 | .78# |  | Stock Unit Award Agreement by and between Herbalife Ltd. and
    Michael O. Johnson, dated March 27, 2008. |  | (v) | 
|  | 10 | .79# |  | Stock Appreciation Right Award Agreement by and between
    Herbalife Ltd. and Michael O. Johnson, dated March 27, 2008. |  | (v) | 
|  | 10 | .80# |  | Stock Appreciation Right Award Agreement by and between
    Herbalife Ltd. and Michael O. Johnson, dated March 27, 2008. |  | (v) | 
|  | 10 | .81# |  | Amendment No. 1 to Employment Agreement dated as of  April 4,
    2008  between Gregory L. Probert and Herbalife International of
    America, Inc. |  | (w) | 
|  | 10 | .82# |  | Stock Unit Award Agreement by and between Herbalife Ltd. and
    Gregory L. Probert, dated April 4, 2008. |  | (w) | 
|  | 10 | .83# |  | Stock Appreciation Right Award Agreement by and between
    Herbalife Ltd. and Gregory L. Probert, dated April 4, 2008. |  | (w) | 
|  | 10 | .84# |  | Stock Appreciation Right Award Agreement by and between
    Herbalife Ltd. and Gregory L. Probert, dated April 4, 2008. |  | (w) | 
|  | 31 | .1 |  | Rule 13a-14(a) Certification of Chief Executive Officer |  | * | 
|  | 31 | .2 |  | Rule 13a-14(a) Certification of Chief Financial Officer |  | * | 
|  | 32 | .1 |  | Section 1350 Certification of Chief Executive Officer and Chief
    Financial Officer |  | * | 
 
 
    |  |  |  | 
    | * |  | Filed herewith. | 
|  | 
    | # |  | Management contract or compensatory plan or arrangement. | 
    55
 
 
    |  |  |  | 
    | (a) |  | Previously filed on October 1, 2004 as an Exhibit to the
    Companys registration statement on
    Form S-1
    (File
    No. 333-119485)
    and is incorporated herein by reference. | 
|  | 
    | (b) |  | Previously filed on November 9, 2004 as an Exhibit to
    Amendment No. 2 to the Companys registration
    statement on
    Form S-1
    (File
    No. 333-119485)
    and is incorporated herein by reference. | 
|  | 
    | (c) |  | Previously filed on December 2, 2004 as an Exhibit to
    Amendment No. 4 to the Companys registration
    statement on
    Form S-1
    (File
    No. 333-119485)
    and is incorporated herein by reference. | 
|  | 
    | (d) |  | Previously filed on December 14, 2004 as an Exhibit to
    Amendment No. 5 to the Companys registration
    statement on
    Form S-1
    (File
    No. 333-119485)
    and is incorporated herein by reference. | 
|  | 
    | (e) |  | Previously filed on February 17, 2005 as an Exhibit to the
    Companys registration statement on
    Form S-8
    (File
    No. 333-122871)
    and is incorporated herein by reference. | 
|  | 
    | (f) |  | Previously filed on May 13, 2005 as an Exhibit to the
    Companys Current Report on
    Form 8-K
    and is incorporated herein by reference. | 
|  | 
    | (g) |  | Previously filed on June 14, 2005 as an Exhibit to the
    Companys Current Report on
    Form 8-K
    and is incorporated herein by reference. | 
|  | 
    | (h) |  | Previously filed on September 23, 2005 as an Exhibit to the
    Companys Current Report on
    Form 8-K
    and is incorporated herein by reference. | 
|  | 
    | (i) |  | Previously filed on February 28, 2006 as an Exhibit to the
    Companys Annual Report on
    Form 10-K
    for the year ended December 31, 2005 and is incorporated
    herein by reference. | 
|  | 
    | (j) |  | Previously filed on March 29, 2006 as an Exhibit to the
    Companys Current Report on
    Form 8-K
    and is incorporated herein by reference. | 
|  | 
    | (k) |  | Previously filed on March 29, 2006 as an Exhibit to the
    Companys Current Report on
    Form 8-K
    and is incorporated herein by reference. | 
|  | 
    | (l) |  | Previously filed on March 30, 2006 as an Exhibit to the
    Companys Current Report on
    Form 8-K
    and is incorporated herein by reference. | 
|  | 
    | (m) |  | Previously filed on March 31, 2006 as an Exhibit to the
    Companys Current Report on
    Form 8-K
    and is incorporated herein by reference. | 
|  | 
    | (n) |  | Previously filed on December 20, 2007 as an Exhibit to the
    Companys Current Report on
    Form 8-K
    and is incorporated herein by reference. | 
|  | 
    | (o) |  | Previously filed on May 5, 2006 as an Exhibit to the
    Companys Current Report on
    Form 8-K
    and is incorporated herein by reference. | 
|  | 
    | (p) |  | Previously filed on November 13, 2006 as an Exhibit to the
    Companys Quarterly Report on
    Form 10-Q
    for the quarter ended September 30, 2006 and is
    incorporated by reference. | 
|  | 
    | (q) |  | Previously filed on October 12, 2006 as an Exhibit to the
    Companys Current Report on
    Form 8-K
    and is incorporated herein by reference. | 
|  | 
    | (r) |  | Previously filed on October 26, 2006 as an Exhibit to the
    Companys Current Report on
    Form 8-K
    and is incorporated herein by reference. | 
|  | 
    | (s) |  | Previously filed on May 29, 2007 as an Exhibit to the
    Companys Current Report on
    Form 8-K
    and is incorporated herein by reference. | 
|  | 
    | (t) |  | Previously filed on November 6, 2007 as an Exhibit to the
    Companys Quarterly Report on
    Form 10-Q
    for the quarter ended September 30, 2007 and is
    incorporated by reference. | 
|  | 
    | (u) |  | Previously filed on February 26, 2008 as an Exhibit to the
    Companys Annual Report on
    Form 10-K
    for the year ended December 31, 2007 and is incorporated
    herein by reference. | 
|  | 
    | (v) |  | Previously filed on April 7, 2008 as an Exhibit to the
    Companys Current Report on
    Form 8-K
    and is incorporated herein by reference. | 
|  | 
    | (w) |  | Previously filed on April 9, 2008 as an Exhibit to the
    Companys Current Report on
    Form 8-K
    and is incorporated herein by reference. | 
    
    56
 
 
    SIGNATURES
 
    Pursuant to the requirements of the Securities Exchange Act of
    1934, the Registrant has duly caused this report to be signed on
    its behalf by the undersigned, thereunto duly authorized.
 
    HERBALIFE LTD.
 
    Richard Goudis
    Chief Financial Officer
 
    Dated: April 30, 2008
    
    57